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The Fontan repair for single ventricle congenital heart diseases is a three-stage 
palliative surgical procedure, ultimately resulting in the bypass of the right side of the 
heart. This is accomplished by routing the systemic venous return directly to the lungs. 
Although this procedure reduces the mortality rate, its long-term outcome is considered 
far from optimal. Hence, over the years lots of modifications have been suggested on the 
initial form of Fontan surgery proposed by Fontan in 1971 [Fontan, 1971].  Total Cavo-
pulmonary connection (TCPC) is the current form of Fontan surgery commonly used 
these days. 
 
Understanding the hemodynamics of the TCPC may lead to further optimization 
of the connection design and surgical planning, which in turn may lead to improved 
surgical outcome. Numerous experimental and numerical studies are focused on 
achieving this goal. How ever no studies have so far attempted to quantify the geometric 
characteristics of patient-specific TCPC anatomies and see how it correlates with their 
hemodynamic parameters.  
 
This study develops a methodology to quantify the geometric characteristics of 
the complex TCPC anatomies using skeletonization approach.  The centerline 
approximation of the TCPC geometry is used to extract geometric parameters like vessel 
area, curvature and offset. These parameters are used to quantify geometric 
characteristics of various TCPC templates that include extra-cardiac (EC) and intra-atrial 
(IA) TCPCs, TCPCs with bi-lateral SVCs and TCPC geometries before and after the 
Fontan surgery. Correlation between the geometric parameters and the TCPC 







A semi automatic program has been developed to compute the geometric 
centerline using the method of iterative center of mass calculation.  Using this program 
the skeleton of TCPC geometries can be computed irrespective of the number of 
participating vessels at the connection.  
 
Since two types of TCPC anatomies, extra cardiac and intra atrial TCPCs, mainly 
dominate our database, these anatomies were analyzed in-depth. Comparison between 
these geometries showed that it is not the vessel cross-sectional area of the IVC baffle 
but the area variation across the vessel length is the significantly different parameter 
between the two groups. Also significant LPA narrowing was seen especially in patients 
with reconstructed aorta irrespective of their surgical preference. 
 
Analysis of the TCPC geometric parameters with their power loss showed that, it 
is the vessel diameters of the outlet vessels, i.e. the pulmonary arteries, which 
significantly affect the TCPC efficiency. This analysis was observed using previously 


















The incidence of single ventricle congenital heart problems in the USA is about 2 
out of every 1000 live births [Statistics - www.americanheart.org]. In these cases, mixing 
of oxygenated and deoxygenated blood occurs in the heart causing severe cyanosis. 
The Fontan repair for single ventricle correction is a three stage repair; ultimately 
resulting in the bypass of the right side of the heart .This is accomplished by routing the 
systemic venous return directly to the lungs [Fontan, 1971].  
Although this procedure reduces the mortality rate, its long-term outcome is 
considered far from optimal. Patients typically suffer from numerous long-term 
complications such as: ventricular dysfunction, protein losing enteropathy, arrhythmias 
and thromboembolism. To minimize these complications and improve long-term patient 
quality of life, it is necessary to improve the hemodynamic efficiency of this complex 
vascular connection, clinically known as the total cavo-pulmonary connection (TCPC) 
[de Leval, 1988]. Numerous studies have focused on optimizing the Fontan 
hemodynamics for over a decade. How ever none of them have attempted to quantify 
the geometric characteristics of patient-specific TCPC anatomies and see how it 
correlates with the hemodynamic parameters. . Many studies have shown that certain 
geometric characteristics of the TCPC and the associated vessels, mainly the pulmonary 
arteries (PA), play an important role in determining short-term and long-term patient 
outcomes [Hosein, 2007; Pekkan, 2005]. Factors such as PA stenosis degrade the flow 
efficiency and increase the risk factor for Fontan failure. Several in-vitro studies have 






to the superior vena cava (SVC), flaring of the VC anastomosis sites or enlarging the 
IVC anastomosis, in minimizing the energy dissipation at idealized TCPC junctions. 
To our knowledge, despite the above-mentioned studies, no quantitative data 
exists that characterizes the complex TCPC geometries of patients and correlates their 
hemodynamic efficiency/inefficiency with geometrical parameters. Furthermore, no 
studies exist that correlate anatomic or hemodynamic characteristics of the TCPC to 
patient cardiac performance (cardiac index (CI) or ventricular power output). Setting 
power losses across the TCPC connection in perspective to cardiac performance would 
test the fundamental premise behind the Fontan optimization study, which is that the 
TCPC resistance is indeed clinically significant.   
In this study, patient-specific Fontan anatomies are analyzed from both 
geometrical and hemodynamic stand points. Important geometric parameters are 
identified that differentiate: (1) the two main surgical protocols used to implement the 
TCPC, namely extra-cardiac (EC) and intra-atrial (IA) procedures; and (2) the two 
dominant pathologies of single ventricle heart defects, namely hypoplastic left heart 
syndrome (HLHS) and non-hypoplastic left heart syndrome (non-HLHS). Geometrical 
characteristics of bi-lateral SVCs, a subset of the TCPC anatomies with two superior 
venae cavae, are also quantified in this study. Lastly, the geometric features of TCPC 
models before and after the Fontan surgery are also analyzed.   
This thesis is organized as follows: Chapter 2 reviews of all relevant studies 
previously published and provides all necessary background information; Chapter 3 
outlines the overall hypothesis and specific aims of the present study; Chapter 4 details 
the methods developed to conduct this work; Chapter 5 presents the results with a 
quantitative geometric evaluation of 34 patient-specific Fontan anatomies (13 intra 
atrials, 13 extra cardiacs, 5 bi-lateral SVCs, and 3 pre Fontans); Chapter 6 discusses the 






to the hemodynamic data. Finally, Chapters 7, 8 and 9 are conclusions, limitations and 





























          CHAPTER 2 
                  BACKGROUND 
 
 
Prior to going into the details of methods developed for this thesis, this chapter 
first familiarizes the reader with the issue we are trying to tackle by providing all 
necessary background information on the physiology of the heart as well as on the 
different technical methodologies that will come into play. For clarity, this chapter is 
divided into three sections: First, the physiology of normal and single ventricle hearts is 
explained, then, a review on the previous efforts to understand the geometric features of 
Fontan anatomies is provided. And finally, the different skeletonization approaches 
available in literature, which is the heart f this study is discussed. 
 
2.1 The Cardiovascular System 
The cardiovascular system is composed of heart and blood vessels. The blood 
vessels constitute a closed delivery system, which transports blood around the body, 
circulating substances such as oxygen, carbon dioxide, nutrients, hormones and waste 
products. There are three main types of blood vessels:  
• Veins - the efferent blood vessels that return blood to the heart;  
• Arteries - the afferent blood vessels that carry blood away from the heart; 
• Capillaries - narrow, thin-walled blood vessels that form networks within the tissues and 
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Figure 2.1: Schematic of the cardiovascular system of human body. The impure blood 
going into the heart is shown in blue and the pure blood returning from the heart is 
shown in red.  
The principal function of the heart is to continuously pump blood around the 






primary circuits: the pulmonary and systemic circulations The pulmonary circuit 
describes the path going from the heart to the lungs and back, and the systemic 
circulation transports the blood between the heart and the remainder of the body. A 
picture of the cardiovascular system showing the blood vessels going from the heart to 
various parts of the body is shown in Figure 2.1 
 
2.2 Normal Heart Physiology 
The physiology of a normal heart is shown in Figure 2.2. Basically, the heart is 
composed of four chambers– the right and left atria and the right and left ventricles 
(Figure 2.2). A wall, called the septum, separates the right and left sides of the heart, 
which drive the blood through the pulmonary and systemic circuits, respectively. While it 
is convenient to describe the heart as two independent pumps (the left and the right), it 
is important to realize that they work in concert: both atria contract at the same time and 
both ventricles contract at the same time. 
 
De-oxygenated blood from the body comes into the right atrium through the 
venae cavae. The superior vena cava (SVC), which drains blood from the upper 
extremities of the body and inferior vena cava (IVC), which drains blood from the lower 
extremities are the major blood vessels connected to the right atrium. During atrial 
contraction this blood is emptied from the right atrium into the right ventricle. The 
tricuspid valve, one of the two atrioventricular valves of the heart regulates this blood 
flow. During ventricular contraction, the blood is then pumped to the right and left lungs 
through the left and right pulmonary arteries (LPA and RPA, respectively) in order to be 
oxygenated. The pulmonary valve also known as the semi lunar valve, controls this part 






through pulmonary veins. From there, the blood flows into the left ventricle and the 
atrioventricular valve that regulates the blood flow on this side of the heart chamber is 
the mitral valve (also known as bicuspid valve). From the left ventricle, the blood is 
pumped to the systemic circulation through the aorta. The valve between the left 




Figure 2.2: Schematic of a normal heart. White arrow indicates the direction of blood 






2.3 Congenital Heart Defects 
Congenital heart defect (CHD) describe heart defects that formed as the baby's 
heart was developing during pregnancy, before the baby is born. They are the leading 
cause of infant mortality in the western world accounting for about 20% of all infant death 
[Anderson, 2003; Rosano, 2000]. In US alone, one in every 100 babies is born with one 
or several CHDs [American Heart Association].  
CHDs can be broadly classified into two categories. 1) Problems that cause too 
much blood to pass through the lungs. These defects allow oxygen-rich blood that 
should be traveling to the body to re-circulate through the lungs, causing increased 
pressure and stress in the lungs. 2) Problems that cause too little blood to pass through 
the lungs. These defects allow oxygen-poor blood to travel to the body. In the latter 
scenario, the body does not receive enough oxygen and the baby will be cyanotic, or 
have a blue coloring. In some cases there will be a combination of several heart defects, 
making the problem even more complex. 
 
2.3.1 Single Ventricle Congenital Heart Defects 
Single ventricle (SV) heart problems fall into the second category of the above 
mentioned CHDs. In these cases, there is only one functioning ventricle that supplies 
blood to both the systemic and pulmonary circulation and the oxygenated blood coming 
back from the lungs mixes with the deoxygenated blood coming back from the systemic 
circulation in that only effective chamber. As a result, the blood that redistributed to the 
body lacks oxygen causing acute cyanosis in the new-borns. The major differences 
between the cardiovascular circulation associated with normal hearts and single 








Figure 2.3: Schematic showing a normal and single ventricle heart physiology.  In normal 




The following sections (2.3.1.1 to 2.3.1.5) detail some of the most common 
pathologies that lead to a single ventricle heart anatomy: 
 
2.3.1.1 Ventricular septal defect (VSD) 
  In this condition, there is a hole in the ventricular septum, which normally 
separates the right and left ventricles (Figure 2.4). Because of this opening, the higher 
pressure in the left ventricle pushes blood from the left ventricle into the right ventricle, 
thus retrieving blood from the systemic circulation and increasing the blood volume to be 
pumped by the right ventricle into the lungs. This condition results not only in poor 
oxygen saturation levels but also in increased right ventricular loading and potentially to 
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Figure 2.4: Ventricular Septal Defect (VSD). The opening is shown using the black line.  
 
 
2.3.1.2 Tricuspid atresia 
In tricuspid atresia, there is no tricuspid valve and hence no blood flows from the 
right atrium to the right ventricle (Figure 2.5). As a result, the right ventricle is small and 
under-developed. Survival depends on the presence of an opening in the wall between 
the atria (atrial septal defect) and/or the ventricles (ventricular septal defect). As a result, 
the venous blood that returns to the right atrium flows through the atrial septal defect into 
the left atrium. There, it mixes with the oxygen-rich blood coming from the lungs. Most of 
this mixed blood goes from the left ventricle into the aorta and to the body. The rest 
flows through the ventricular septal defect into the small right ventricle, and then through 










Figure 2.5: Tricuspid Atresia. The closed tricuspid valve, the atrial septal defect and 
associated under developed right ventricle is labeled in the figure.  
 
 
2.3.1.3 Transposition of the great arteries  
  With this congenital heart defect, the positions of the pulmonary artery 
and the aorta are reversed, thus: a) the aorta originates from the right ventricle, so that 
most of the blood returning to the heart from the body is pumped back to the body 
without going through the lungs b) the pulmonary artery originates from the left ventricle, 
so that most of the blood returning to the heart from the lungs goes back to the lungs 
(Figure 2.6). Similar to tricuspid atresia, this defect is only viable when combined with 
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Figure 2.6: Transposition of great arteries. The switched aorta (Ao) and pulmonary artery 
(PA) can be observed in the figure.  
 
2.3.1.4 Tetralogy of Fallot  
The tetralogy of Fallot (Figure 2.7) designates a combination of four congenital 
heart defects, namely: 
• A ventricular septal defect (VSD), that allows blood to pass from the right 
ventricle to the left ventricle without going through the lungs 
• A narrowing (stenosis) at or just beneath the pulmonary valve that partially blocks 
the flow of blood from the right side of the heart to the lungs 
• A right ventricle that is more muscular than normal 
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Figure 2.7: Tetralogy of Fallot (TOF or “Tet”). The VSD and obstruction of the right 
ventricle are labeled in the figure along with the aorta sitting above the VSD.  
 
2.3.1.5 Hypoplastic left heart syndrome 
In hypoplastic left heart syndrome, the left side of the heart is underdeveloped – 
including the aorta, aortic valve, left ventricle and mitral valve (Figure 2.8). Survival 
depends on the presence of two other concurrent defects: (1) an atrial septal defect 
(ASD), so that part of the blood returning from the lungs into the left atrium can be 
redirected to the right side of the heart, and (2) a patent ductus arteriosus (PDA), so that 
the blood pumped by the right ventricle into the pulmonary arteries may reach the aorta 








Figure 2.8: Hypoplastic Left Heart Syndrome (HLHS). Note the hypoplastic left ventricle 
and the narrowed aorta. ASD connecting right and left atria and the PDA connecting the 




2.4 Single Ventricle Correction Techniques 
2.4.1 Evolution of Fontan Repairs 
 
2.4.1.1 Historical Perspective 
Until the middle of 20th century, children born with SV heart problems had no 
hope of survival unless they had any other coexisting defects such as a septal defect or 






was not even a choice in those days. During mid 1940’s, by connecting pulmonary 
arteries (PA) and systemic arteries, a palliative correction procedure was developed 
[Blalock, 1945, Potts, 1946]. This started the beginning of a number of experimental 
procedures, which sought to develop better surgical solutions for single ventricle heart 
problems. 
In 1949, Rodbarg and Wagner performed the first right ventricular bypass in dogs 
[Rodbard, 1949]. In 1958 Glenn reported the clinical success of a cavopulmonary shunt 
that connected the SVC and the RPA so as to try and augment the pulmonary blood flow 
[Glenn, 1958]. However, these shunts enabled only short-term survival. Patients had to 
suffer many complications like ventricular dysfunction, pulmonary vascular diseases, and 
thrombosis of the shunt, which in turn affected their long-term survival [Kyger, 1975].  
 
2.4.1.2 The Fontan Repair 
 In 1971, Fontan and Baudet [Fontan, 1971] successfully implemented an 
atrio-pulmonary connection in a patient with tricuspid atresia, and the "Fontan" 
procedure or one of its many modifications became the major repair option in patients 
with single ventricle (SV) heart defect. The original Fontan procedure shown in Figure 
2.9 comprised 5 main steps: (1) end-to-side anastomosis of the distal end of the RPA to 
the SVC; (2) end-to-end anastomosis of the right atrial appendage to the proximal end of 
the RPA by means of an aortic homograft; (3) closure of the atrial septal defect; (4) 
insertion of a pulmonary valve homograft into the IVC; and (5) ligation of the main 
pulmonary artery (MPA). After this procedure there was separation between the 
systemic and pulmonary circuits, which improved the arterial oxygen saturation. 
However, placing a valve in the caval conduits resulted in many complications, 






IVC and SVC flows to only LPA and RPA respectively caused several complications 
when one of the pulmonary tracks became obstructed. Additionally, such a configuration 
directed the hepatic blood to flow only to the LPA, which was demonstrated to be 
strongly correlated with pulmonary venous malformation in SV patients [Justino, 2001; 








                                                   [Fontan and Baudet, 1971] 
Figure 2.9: Schematic of the original Fontan repair for tricuspid atresia.  The 5 steps in 
the surgical repair were marked using black arrows: (1) end-to-side anastomosis of the 
distal end of the RPA to the SVC; (2) end-to-end anastomosis of the right atrial 
appendage to the proximal end of the RPA by means of an aortic homograft; (3) closure 
of the atrial septal defect; (4) insertion of a pulmonary valve homograft into the IVC; and 
(5) ligation of the MPA.  
 
 
Shortly after the first successful Fontan repair in 1971, Kreutzer et al. [Kreutzer, 
1973] described a modified Fontan procedure without using a valve in the IVC. This was 






directly to the pulmonary arteries (Figure 2.10). The tricuspid valve was also sutured to 
separate the pulmonary and systemic circulation. This procedure had the advantages of 
providing the pulsatile action of the atrium and redistributing the hepatic fluid to both 
lungs. Though the valve-less AP connection proved as a reliable technique patients had 
to suffer from complications like supra-ventricular arrhythmias, right atrial thrombus, 
exercise intolerance and other symptoms of low cardiac output [Dobell, 1986; Driscoll, 
1992; Fontan, 1990; Mair, 1992]. These complications were usually related to a 
markedly dilated right atrium appendage, which was suspected to be due to the 




Figure 2.10: Schematic of an atrio-pulmonary connection with the right atrial appendage 
shown using the red arrow.  
 
2.4.1.3 The Total Cavo-pulmonary Connection (TCPC) 
The atrio-pulmonary connection mentioned above was one of the many surgical 






used method, the benefits of the AP connection were questionable as the associated 
complications significantly affected the long-term outcome. In 1988, De Leval et al. 
proposed the total cavopulmonary connection (TCPC) as a logical alternative to the 
Fontan procedure [de Leval, 1988]. The TCPC was characterized as an anastomosis of 
the SVC directly (end-to-side) to the superior wall of the RPA, followed by creation of an 
intra-atrial channel through the right atrium to connect the IVC to the inferior wall of the 
RPA (Figure 2.13). De Leval hypothesized that such geometry would lead to more 
streamlined flow patterns with less turbulence and fluid energy loss. Several studies 
have showed that the TCPC is accompanied by a lower mortality rate, improved 
outcomes and a more favorable course during the postoperative period when compared 
to AP connection [Pearl, 1991; Podzolkov, 1997; Be’eri, 1998; Marcelletti, 2000]. 
 
2.4.2 Different Stages of Fontan 
Fontan operation is usually performed in three stages during the earlier ages of 
childhood. This staging has significantly improved the success of the Fontan procedure. 
The objectives of the stage I procedure (Norwood), which is performed normally within 
the first 2 weeks of life, are to provide an unobstructed pulmonary venous return, a 
permanent systemic outflow from the right ventricle, and a temporary pulmonary blood 
supply to allow the pulmonary vasculature to develop and mature. The stage II 
procedureis usually performed by 6 months of age [Khairy, 2007] and consists of a bi-
directional Glenn shunt or hemi-Fontan connection. Between around 18 months and 3 
years of age [Khairy, 2007], the stage III procedure completes the total cavo-pulmonary 







2.4.2.1 Stage I: Norwood Procedure 
The goals of the Norwood procedure [Norwood, 1993] are to allow the right 
ventricle to provide systemic circulation and to create a stable, balanced systemic and 
pulmonary circulation. The main pulmonary artery is opened and a homograft patch is 
placed in the area where the MPA branches into the RPA and LPA (Figure 2.11). In case 
of infants with a stenosed aorta, the narrowed aorta is opened, and a homograft patch is 
used to enlarge the aorta. The MPA is sutured to the aorta to allow the right ventricle to 
provide systemic circulation. A Blalock-Taussig shunt (BT shunt) is used to connect the 
right subclavian artery and the right pulmonary artery. At the completion of the stage I 
procedure the patient will have a mixture of oxygenated and de-oxygenated blood in the 
atria and right ventricle, providing blood both to the lungs (via the modified BT shunt|) 
and to the body (via the newly constructed aorta). During the next 6 months, the patient 
will grow out of the BT shunt and will be scheduled for the stage II surgery. 
 
2.4.2.2 Stage II: Bi directional Glenn (Glenn) or Hemi-Fontan Procedure 
Within a few months after the stage I, treated infants outgrow their shunts and 
become increasingly cyanotic. The second stage of the surgery, which consists of either 
a hemi-Fontan procedure [Norwood, 1993] or a bi-directional Glenn [Tanoue, 2001], is 
performed at this time. The principles in both are similar and involve an SVC to 
pulmonary artery anastomosis (Figure 2.12). The hemi-Fontan consists of an end-to-side 
anastomosis between the SVC and the RPA near the bifurcation. These results in blood 
flow from the SVC into both the pulmonary arteries. The cardiac end of the SVC is 
ligated. In the hemi-Fontan, both the cranial and cardiac ends of the SVC are sutured to 
















     (a)                              (b)      [Khairy, 2007] 
Figure 2.11:  The Norwood Stage 1 procedure (a) The classic Blalock-Taussig shunt 
consists of an end-to-side anastomosis of the subclavian and pulmonary artery (b) The 
modified Blalock-Taussig shunt consists of an interposition tube graft that connects the 
subclavian artery to the ipsilateral pulmonary artery. 
 
 
. The purpose of the second stage surgery is to begin the separation of the pulmonary 
and systemic circulation. Once the anastomosis is complete, the BT shunt can be 
removed. At the completion of the stage II, blood flows from the IVC into the right atrium 
and blood from the SVC flows into the pulmonary artery. As a result, there is a reduction 
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Figure 2.12:  The bi-directional Glenn procedure showing the SVC-RPA anastomosis. 
The modified BT shunt, shown in white, was taken down and over sewn  
 
 
2.4.2.3 Stage III: Total Cavo-Pulmonary Connection (TCPC) 
The third stage operation completes the separation of pulmonary and systemic 
circulation. The venous blood goes directly into the pulmonary arteries and then to the 
lungs. The oxygenated blood returns to the heart from the pulmonary veins and is 
pumped out to the body by the single right ventricle. The two widely used TCPC 
procedures are the lateral intra-atrial tunnel and the extra-cardiac conduit connection. 
 
2.4.2.3.1 Intra atrial TCPC 
De Leval et al [de leval, 1988] performed the first intra atrial TCPC operation in 
1988. In that procedure, the right atrium is first connected to the RPA using the right 
atrial appendage. Then, a baffle of synthetic graft is placed inside the right atrium to 
SVC RPA 
anastomosis






allow the systemic venous blood to flow along the right side of the baffle towards the 
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Figure 2.13:  Schematic of an intra atrial TCPC. The baffle connecting the IVC and 
pulmonary artery is marked using a black arrow.  
 
 
2.4.2.3.2 Extra cardiac TCPC 
Marcelleti [Marcelleti, 1990] and Laschinger et al [Laschinger, 1993] described 
the extra-cardiac conduit modification in the early 1990’s. Here, rather than going 
through the right atrium, the systemic venous return from the IVC is routed around the 
heart (Figure 2.14). The IVC is disconnected from the right atrium and anastomosed to a 
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Figure 2.14:  Schematic of an extra cardiac TCPC. The baffle connecting the IVC and 
pulmonary artery is shown as white colored conduit.  
 
 
2.4.2.3.3 Choice of the TCPC Procedure 
The choice of connection type at every stage seems to be dictated by surgeon 
preference. Numerous studies have focused on finding out which method is the optimum 
choice, mainly focusing on the 3rd and last stage of the procedure and leading to 
balanced pros and cons for both intra-atrial and extra-cardiac connections. The pumping 
action of the right atrium, which provides limited pulsatility to the IVC flow, is pointed as 
an advantage of the intra atrial option. However, this involves the risk of sinus-node 
damage and resulting arrhythmias. Extra-cardiac conduits, on the other hand, provide 
numerous advantages including smoother geometries, less atrial damage, and less or 
no time on the heart-lung machine. On the other hand they provide no growth potential 
and may lead to conduit stenosis and throboembolism [Haas, 2000; Petrossian, 1999; 
Tam, 1999]. Although long-term follow-ups are not yet available, early- and mid-term 
results for extra-cardiac conduits are favorable [Laschinger, 1996; Amodeo, 1997; 






2.5 Previous Studies on TCPC 
After the first Fontan surgery in 1971, numerous modifications have been 
suggested and implemented, aiming at improving long-term surgical outcomes and 
patients’ quality of life. In addition to the major surgical suggestions discussed in the 
previous sections, which resulted in the current form of Fontan operation the TCPC 
procedure, studies have been going on to further improve the TCPC design with the 
hope of further minimizing post operative complications. 
 
2.5.1 In vivo studies 
Understanding the TCPC hemodynamics and geometrical features using in vivo 
modalities like echocardiography and MRI has become more and more common with the 
new innovations in medical industry. To name a few, Shiota et al reported the use of 
high-resolution echocardiography for studies the intra cardiac structures of CHD patients 
[Shiota, 1999]. In 1995 Fogel et al. [Fogel, 1996] performed a detailed study on SV 
patients after the Fontan operation using MRI tagging to understand the effect of this 
surgery on the myocardial functioning of the patients. They found significant differences 
in the myocardial strain of the patients between the three Fontan stages. In another 
study, Fogel et al. [Fogel, 1999] were able to characterize the contribution of each vena 
cava to each one of the pulmonary arteries in 10 Fontan patients with intra-atrial tunnels. 
In agreement with previous findings [Salim, 1995], they found that at an average age of 
1.8+0.3 year-old most of the caval flow from the SVC, 60±6% went to the RPA, and 
67±12% of the IVC blood went to the LPA. Be’eri et al [Be’eri 1998] used phase-contrast 
MRI to demonstrate the advantages of TCPC over an AP connection. Sharma et al 
[Sharma, 2001] analyzed the flow characteristics seen in intra atrial TCPC using MRI. 






lateral tunnel and 5 five with an extra-cardiac conduit. MRI velocity mapping combined 
with the use of adequate interpolation methods is capable of producing three-
dimensional in vivo velocity data [Frakes, 2004], which can in turn be used to compute 
energy dissipation [Healy, 2001] or other parameters to characterize the efficiency of a 
given TCPC geometry. 
 
2.5.2 In vitro studies 
Since the first in vitro experiment done by de Leval et al. that demonstrated the 
superiority of the TCPC over AP connection [de Leval, 1988], researchers use in vitro 
studies to better understand the TCPC hemodynamics and come up with optimized 
TCPC designs. Sharma et al. [Sharma, 1996] studied the effects of varying caval offsets 
at various RPA/LPA flow ratios to determine the optimal combination for minimizing 
energy losses across the TCPC using glass models. They showed that offsetting the IVC 
and SVC by 1.0 or 1.5 caval diameters could significantly reduce the power dissipated 
across the connection. DeGroff et al [DeGroff, 2002] supported these findings by 
comparing the results obtained using two different sets of models with the typical vessel 
dimensions of 3-year old and 15- year-old patients, respectively. They demonstrated that 
the improvement in the efficiency produced by a caval offset decreased with larger 
vessels. More importantly they pointed out that the improvement brought in by a caval 
offset was not comparable to that of bigger vessels and thus questioned the trend of 
performing the Fontan on increasingly younger patients. 
Caval offset decreases the fluid energy dissipation by avoiding direct collision of 
the caval flows. Another option is to curve the venae cavae and direct the caval flows 
such that they do not collide. Gerdes et al [Gerdes, 1999] demonstrated that this option 






[Ensley, 1999] further demonstrated that curving the venae cavae was only optimal 
under specific flow conditions and instead recommended flaring the vessels towards the 
connection site. This method was shown to lower the power loss as well as allow for 
caval blood mixing. Using digital particle image velocimetry (DPIV) Grigioni et al 
[Grigioni, 2000] confirmed the observations made by Ensley et al [Ensley, 1999]. They 
identified a vortex at the confluence of the venae cavae and demonstrated its role in the 
regulation of pulmonary blood flow. Walker et al [Walker, 2001] proposed another 
modification suggesting that there will be poor hepatic fluid distribution in a zero offset 
flared model. They suggested that the optimal geometry would be the zero offset “cowl” 
geometry whereby an enlargement was made on one side of the IVC and of the SVC. As 
long as the cowl was directed toward the pulmonary artery of lowest flow rate, low power 
loss and relatively good distribution of hepatic flow could be obtained. De Zelicourt et al 
[De Zelicourt, 2005] created intra-atrial models reconstructed from patient MR images 
using transparent stereolithographic technique to look into the details of flow features of 
true anatomic configurations. They have reported complex, unsteady, and highly three-
dimensional flow structures within the anatomic model, leading to high-pressure drops 
and power losses. 
The latest among the series of optimum design for TCPC model is an optiflow 
model recommended by Soerensen et al [Soerensen, 2007]. This design featured a 
bifurcated vena cava, so as to lower the fluid mechanical power losses in the connection 
and to ensure proper hepatic blood perfusion to both lungs. They used rapid prototype 
modeling to investigate the flow patterns in the model, which were compared with those 







2.5.3 Numerical simulations 
Application of numerical simulations for the assessment of flow features in TCPC 
models has been popular in the Fontan research area for more than a decade now. 
Computational fluid dynamics (CFD) were used by de Leval et al. to investigate their 
intuition about the impact of caval diameter and IVC anastomosis size on the 
competition of IVC and SVC flows [de Leval, 1996] in intra-atrial model. This numerical 
study was the first of a series. The major advantages of CFD simulations include a full 
3D representation of the flow field and a high degree of freedom regarding the geometry 
to be simulated. Knowledge of the whole flow field helps in the assessment of 
parameters such as flow distribution, pressure gradients and power losses that are 
otherwise more complex to quantify. Also the cost efficiency of the CFD simulations 
compared to the experimental set-ups attracts more people into this area.  
Following the path of de Leval [de Leval, 1996], Migliavacca et al [Migliavacca, 
1999] looked at the flow structures of extra-cardiac conduits. This design was shown to 
have superior hemodynamics [Hsia, 2004], which was in agreement with previous in vivo 
observations [Lardo, 1999]. Parametric studies have focused on the design of the IVC 
anastomosis site [Migliavacca, 2003]; the influence of varying caval flow ratios on 
dissipation, flow structures, and shear stress [Khunatorn, 2003], and the effect of 
pulmonary after-load [Guadagni, 2001]. The geometry of the TCPC has been modeled 
with increasing accuracy, from angular parametric models based on average anatomical 
measurements [de Leval, 1996] to realistic models directly reconstructed from patient 
MRI data [Guadagni, 2001; Ryu K, 2001; Migliavacca, 2003; Pekkan, 2004; De Zelicourt, 
2006]. CFD also becomes an inevitable part in designing optimum TCPC geometries 






modeling to compare the flow structures seen in their hemodynamically optimized TCPC 
configuration with other TCPC configurations.  
For better understanding of the hemodynamics of complex physiological 
geometries such as Fontan, numerical simulation tools like CFD are becoming an 
essential part of the entire Bioengineering research area.  
 
2.5.4 Summary of Fontan Geometrical Studies 
Because the limited lung perfusion in the TCPC and increased central venous 
pressures impair the clinical outcome [Fontan, 1990], efforts have been made to 
evaluate optimized, surgically practicable TCPCs. In this context several modifications of 
the TCPC have been studied. As mentioned in section 2.5.2, the suggestion of adding 
an offset between the venae cavae [Sharma, 1996] received a lot of attention [DeGroff, 
2002]. Including a curvature in the IVC and/or SVC at the TCPC junction was another 
popular suggestion [Gerdes, 1999; Ensley, 1999; Grigioni, 2000; Walker, 2001]. The 
latest among these studies is an optimized Fontan connection [Sorenson, 2007], which 
can provide good mixing of the hepatic blood and also can avoid the dissipative inflow 
collision.  
In addition to the improvements suggested in TCPC design, certain studies 
pointed out that the geometrical parameters of the TCPC, especially the vessel 
dimensions also plays an important role in determining the overall efficiency of the TCPC 
[Hosein, 2007]. Among all the vessels that are part of the TCPC i.e, the IVC, SVC, LPA 
and RPA, it is the narrowing of the pulmonary arteries, which is commonly seen pre-
operatively in Fontan patients, that is the major risk factor [Hosein, 2007]. Kerem et al. 
[Pekkan, 2005] conducted a CFD study on an LPA-stenosed TCPC model, in which they 






in an LPA stenosed model compared to the same model after removing the stenosis. 
The power loss was increasing exponentially with the increase in LPA flow split. It has 
been reported by Morgan et al [Morgan, 1998] that a reduction in the pulmonary artery 
diameter causes a significant reduction in the pulmonary artery flow as well. This finding 
has been concreted by the latest studies published by Ordovas et al. [Ordovas, 2007], 
that showed an exponential relation between the ratios of the narrowest diameters of the 
right to left pulmonary arteries (RPA/LPA size) and right to left pulmonary arterial flow 
(RPA/LPA flow) in patients with pulmonary artery stenosis. 
All these above mentioned studies points to the fact that the dimensions of the 
TCPC vessels may have a higher impact on the overall TCPC efficiency than other 
design parameters, but no strong conclusion has yet been established. Over the past 
decades, experimental and numerical models have incorporated increasing levels of 
geometrical complexity in an effort to more accurately model the in vivo conditions. 
However, these have failed to establish the general conclusions due to the complexity 
and number of the geometrical features that needs to be taken into account.There is 
now a need for  systematic analysis methodology that will allow for the identification of 
crucial geometrical parameters (such as vessel diameter) and their correlation with the 
TCPC performances.  
 
2.6 Centerline Approximations of 3D Geometries 
Taking advantage of the techniques for 3D reconstruction of anatomies using MR 
images [Frakes, 2003], a method to obtain the geometrical parameters of TCPC models 
has been developed in this study. An approach of central line estimation of the 3D 
geometrical models has been used to achieve this goal. This technique of centerline 






applications in both computer and biomedical area. A description about the approach of 
centerline approximation has been detailed in this section. 
 
2.6.1 The Skeletonization Technique – An Overview 
 Skeletonization is the method used to obtain the centerline representation of 
geometries, which provides information about the shape features of the geometry. In 
1967 Blum [Blum, 1967] explained, a mathematical definition of the “skeleton” of a 
model. His definition was that, in the 3D Euclidean space (a plane that is defined using a 
set of points that can be defined in terms of angles and distance between the points is 
called a Euclidean plane), the skeleton or the centerline of geometry is the locus of the 
centers of all the maximal inscribed spheres.  
There are several approaches to get centerline of geometry. A concept of 
boundary peeling is the frequently used technique for generating an approximation to the 
‘‘true’’ Euclidean skeleton [Kong and Rosenfeld, 1989]. Also this is one of the intial 
approaches used to get geometry skeletons. In this technique border points of the object 
that satisfy certain topological and geometric constraints are deleted in iteration steps 
(figure 2.15). The entire process is repeated until only the ‘‘skeleton’’ of the geometry is 
left [Palagyi, 1998]. Different types of techniques have been developed over the time for 
skeletonization based on the efficiency of the process, ease of implementation and field 
of application of the technique. Some of these techniques are explained in detail in the 
section 2.5.2. The choice of a method depends on the application and also on the 
accuracy of the skeleton for the application. Combination of the two more techniques 














Figure 2.15: (a) A 3D picture containing the character ‘‘A’’ and (b) its central line 
obtained by the deletion of surface points are shown here. Each cube represents the 
surface points of the geometry that are deleted during the iterations. 
 
2.6.3 Different approaches to the Skeletonization Technique 
2.6.3.1 Iterative Thinning Algorithms 
 Among all the available algorithms for skeletonization, one of the first reported 
methods is the “Thinning Algorithm”. This technique is based on the iterative deletion of 
geometric surfaces based on topological and geometric constraints. Rosenfield was first 
one to define a parallel thinning procedure (Rosenfield, 1975), in which different object 
elements in the object boundary are removed simultaneously.  Later, in 1981 
Morgenthaler  [Morgenthaler, 1981] defined a deletion criterion for the thinning 
technique. His idea was to delete the “simple” or “deletable points” on the geometric 
surface and he defined a simple point as the point whose deletion does not change the 
topology of the geometry. Finally, Kong and Rosenfeld [Kong and Rosenfeld, 1989] put 
together a set of criteria that is now considered as the gold standard for topology 
preservations in the thinning algorithms.  
Over the years a number of advancements have been suggested in parallel thinning 
algorithms, which improved the efficiency and processing time of the whole process 
[Palvidis, 1982; Hong 1995; Palagyi 1998]. The centerlines determined by this method 






determination of which points to be removed, known as simple point criteria, can be 
complex and computationally expensive [Paik, 1998]. 
 
2.6.3.2 Distance Mapping  
 
Distance mapping, is a technique commonly used in robotics applications. Here a 
final point of the centerline is defined within the geometry and a distance to this goal 
point is computed for each point within the structure of interest [Kaufman, 1993; 
Lorensen, 1995]. The distance assigned is the shortest distance along a path to the goal 
point through the structure. Once the distance map is generated, a path from any 
starting point to final point can be determined by descending through the gradient of the 
distance map. An advantage of this technique is that it is computationally inexpensive 
[Paik, 1998]. For large structures, however, the distance map requires substantial 
computer memory. Additionally, the shortest distance approach has a tendency to 
produce paths that hug the wall of the organ rather than follow the central axis. 
2.6.3.3 Iterative adjustment of the centerline  
 This technique divides the geometry into a number of frames. Then a 
starting frame is defined first and subsequent frames are determined based on the 2D 
center of mass calculation in the plane perpendicular to the center obtained at the 
previous point. This method is one of the simplest skeletonization techniques. Though 
this technique tends to keep the path centralized, since the center of mass in a 2D slice 
may not lie along the central axis of the 3D structure the centerline approximation may 
not be accurate all the time. Additionally, this method does not guarantee that the path 






 In this study, we are using a modified form of this iterative approach. Here 
the accuracy of the centerline computed using the initial frames are substantially 
improved by further iterations, in which the frames are defined in directions 
perpendicular to the axis of the geometry. By doing so, all the disadvantages of the 
iterative method mentioned in the above paragraph will be corrected. 
 
2.6.3.4 Harmonic Skeletonization 
 Yang and Zhu [Yang, 2005; Zhu, 2005] defined a different approach for 
skeletonization, in which they used the solution of a harmonic equation on the tubular 
geometric surface to evaluate the centerline. They called it a “harmonic skeleton.” 
Solution of a Laplace equation defined based on the surface temperature distribution of 
the geometry is obtained by providing appropriate boundary conditions. This solution is 
then used to extract the centerline of the geometry. This technique guarantees 
smoothness and connectivity of the central line. 
 
2.6.4 Applications of skeletonization in Bio Engineering 
 Even though the skeletonization technique was commonly used in computer 
animations and robotics for a long time, it started to get a lot of interest in the bio 
engineering area from the beginning of 1990 onwards. Some of the areas that use the 
skeletonization of geometries in large extent include endoscopy (mainly for the path 
planning applications in virtual endoscopy), stenosis evaluation of the tracheal tree, and 
modeling of the blood vessels.  
It was for the development of virtual endoscopy that the skeletonization was first 






et al [Vining, 1996], in which the organ of interest was reconstructed using CT images 
and these images were then used for non-invasive screening of the tubular structured 
organs like bronchial trees and colon in the body. Soon this concept became a popular 
screening technique because of its low cost and non-invasive approach. Also this 
method requires fewer user interactions and less computation time compared to the 
invasive screening techniques.  
In order to guide the virtual camera through the lumen of the organ, it is 
necessary to define a centerline of the geometry. The boundary thinning method was the 
commonly used approach. Later, Paik et al [Paik, 1998] developed a modified thinning 
algorithm for virtual endoscopic application. They have used a combination of the 
thinning algorithm and the distance mapping method, which reduced the computation 
time substantially.  
Later, Wang et al [Wang, 1999] used the modified thinning algorithm for another 
application, where they used this technique for modeling and segmentation of blood 
vessels. To develop a 1D model for the finite element modeling applications in 
cardiovascular area, Steele et al [Steele, 2003] also used the same algorithm of 
skeletonization. Yushkevich et al [Yushkevich, 2006] proposed a similar application of 
skeletonization called inverse skeletonization, where the skeleton of an object is defined 
first and the object’s boundary is derived analytically from the skeleton. They suggest 
that is method is provides the boundaries of three-dimensional objects as continuous 
parametric manifolds, while maintaining the proper geometric relationship between these 
manifolds. 
Another rapidly growing application of skeletonization techniques is the modeling 
of blood vessels and the evaluation of stenosis in blood vessels. Yang et al [Yang, 2005] 
used harmonic skeletonization for quantifying coronary artery stenosis. They showed 






accurately. Another application for this harmonic skeletonization was proposed by Zhu et 
al [Zhu, 2005], in which they used this approach to obtain the flattened visualization of 
branched physiological structures like blood vessels. This method could also be used for 
accurate modeling of the vascular structure.  
A different approach of skeletonization for modeling of the bifurcating vessels 
uses centroid estimation of the inscribed spheres of the blood vessel model, proposed 
by Antiga et al [Antiga, 2004]. They use this automatic technique for the objective 
comparison of distributions of geometric and hemodynamic quantities over the surface of 
bifurcating vessels.  Kiesler et al [Kiesler, 2006] reported successful implementation of 
the thinning algorithm for quantifying the laryngo-tracheal stenosis in the larynx as 
another application of the skeletonization method.  
 
2.6.5 Summary  
Because of the tubular structure of the participating vessels, the method of 
skeletonization can be easily applied to the TCPC geometry to calculate the parameters 
associated with this anatomy. In this study, we have used the method of Iterative 
adjustment of the centerline for obtaining the TCPC skeleton.  The simplicity of the 
algorithm was the main attraction. The disadvantageous associated with the approach 
was overcome using an additional iterative procedure which approximates the centerline 
towards the “true” skeleton after each iteration.  
Following chapters of this thesis will give a detailed idea about the method 











HYPOTHESIS AND SPECIFIC AIMS 
 
 
As described in the previous chapter, previous studies have shown that certain 
geometric characteristics of the TCPC and the associated vessels, mainly the pulmonary 
arteries (PA), play an important role in determining short-term and long-term patient 
outcomes. Factors such as PA stenosis degrade flow efficiency and increase the risk 
factor for Fontan failure [Hosein, 2007; Pekkan, 2005]. In-vitro studies have highlighted 
the importance of curvature of the inferior vena cava (IVC) and its offset relative to the 
superior vena cava (SVC) in minimizing the energy dissipation at idealized TCPC 
junctions. Despite these studies, no quantitative data exists that characterizes the 
complex TCPC geometries of patients and correlate their hemodynamic 
efficiency/inefficiency with geometrical parameters. The lack of quantitative geometric 
characterization of these complex vascular anatomies hinders the analysis necessary to 
correlate the overall hemodynamic performance of the TCPC with certain surgical 
techniques and/or anatomical features. Such correlation would help design future 
surgeries so as to minimize power losses and, in doing so, improve long-term patient 
quality of life. 
 
3.1 Hypothesis 
The guiding hypothesis of this study is that: 
The geometric characteristics of TCPC anatomies differ significantly and may be 







Following are three specific aims of this study designed to test the hypothesis: 
 
3.2 Specific Aim 1 
Develop a methodology to obtain geometric characteristics of the TCPC. 
 
In order to obtain the geometrical parameters associated with the TCPC 
anatomies, a centerline approximation of the 3D representation of the models named as 
the “skeletonization” approach will be used. Developing a technique for this purpose is a 
critical step that will then allow us to compute critical geometric parameters such as, 
vessel dimensions, caval offset and vessel curvature. 
 
3.3 Specific Aim 2 
• Use the above developed skeletalization approach to compute the 
geometric parameters associated with different TCPC anatomies and: 
o Compare extra cardiac and intra atrial geometries 
 Impact on HLHS vs. Non HLHS patients 
o Compare pre and post Fontan geometries 
o Analyze bi-lateral SVC geometries 
 
3.4 Specific Aim 3 







In this specific aim, the correlation between the computed geometric parameters and 
the hemodynamic efficiency of the TCPC geometries will be analyzed. Power loss, a 
commonly accepted measure of the overall efficiency of a given TCPC design will be 
used as the hemodynamic efficiency parameter in this study. Experimental power 
loss measurements across six different TCPC geometries obtained from previous in 
vitro experimental studies and CFD power loss measurements for nine TCPC 
geometries will be used for this purpose. In addition, these power losses will be 
contrasted to the ventricular power output calculated from in vivo PCMRI for each 




















MATERIALS AND METHODS 
 
4.1 Overview 
The first six sections of this Chapter (4.2 through 4.6) detail the methodology 
developed to break down patient-specific Fontan anatomies into a series of quantifiable 
parameters. This is accomplished by skeletonizing the geometry and obtaining a 
centerline representation of the 3D geometry [Paik, 1998]. These data reduction steps 
allow for the easy extraction and quantification of geometrical characteristics, such as 
vessel cross sectional area, area variation across the vessel length, vessel curvature, 
caval offset etc. These parameters can also be used to find out if there is any correlation 
between the anatomic and hemodynamic data of the TCPC. The details of the study 


















Figure 4.1: Flow chart representation of the overall procedure of TCPC geometric 
characterization starting with the patient MR Images.  
 
 
4.2 Reconstruction of Patient-Specific 3D Anatomic Models 
The methodology followed in our laboratory to generate patient specific 3D 
anatomical models from raw anatomic magnetic resonance (MR) images use a semi-
automated in-house code [Frakes, 2003] and commercial software Mimics (Materialise 
Inc. Ann Arbor, MI). A stack of MR images of the thoracic region of the patient is 
acquired as the first step.   
The MRI scanning protocol to obtain the stack of anatomic images is as follows. 
A steady state free precession (SSFP) sequence is used to obtain axial slices of 3-5 mm 
in thickness with approximately 1 x 1 mm in-plane resolution. This is achieved with a 256 






examination at the Children’s Healthcare of Atlanta (CHOA), the Children’s Hospital of 
Philadelphia (CHOP), and the University of North Carolina (UNC).  
Data from CHOA are acquired on a Signa (General Electric Healthcare, Chalfont 
St. Giles, United Kingdom) 1.5 Tesla scanner, where a repetition time (TR) of 5-8 ms 
and an echo time (TE) of 1.5-3 ms are used. At CHOP, a Sonata or an Avanto (Siemens 
Medical Solutions, Erlangen, Germany) 1.5 Tesla scanner is used with a TR of 150-250 
ms and a TE of 1.1-1.5 ms. Signals are averaged over two acquisitions and 25-45 slices 
are acquired, depending on the size of the patient. Magnetic resonance (MR) 
angiographic methods are not employed because younger patients are not 
systematically administered gadolinium contrast. 
The pixel sizes of these images are typically anisotropic, with the through plane 
resolution being higher than the in plane resolution. Isotropic voxel sizes are obtained 
using an adaptive control grid interpolation technique, a method based on a hybrid 
technique of optical flow and block matching as described by Frakes et al [Frakes, 
2003]. The vessels of interest, the superior vena cava (SVC), inferior vena cava (IVC), 
left pulmonary artery (LPA), and right pulmonary artery (RPA), are then segmented out 
from the interpolated stack of anatomic MR images using a previously developed 
inhouse semi-automatic methodology [Frakes, 2003]. Each image is thresholded by 
intensity and spherical element of voxels is randomly moved throughout a selected 
region for several iterations to segment the vasculature. Raw, thresholded, and 
segmented sample vessels in one axial slice are shown in Figure 4.2. Segmented 
results are saved as binary images, containing only pixels that define the vessels of 
interest.  
 
The final step is to reconstruct the segmented vessel cross-section into a 3D 






(Materialise Inc. Ann Arbor, MI). This is a reverse engineering tool designed to interface 
between MR imaging and computer aided design (CAD), rapid prototyping, or finite 
element analysis. 
 
Figure 4.2: (a) Raw, (b) thresholded, and (c) segmented images of the pulmonary 
arteries shown from the axial perspective. 
 
4.3 Skeletonization Method 
4.3.1 Overview 
To characterize the complex 3D geometries of the TCPCs, a skeletonization 
approach, which is commonly used for shape analysis applications, is employed. A 
modification of the commonly used skeletonization technique, iterative adjustment of the 
centerline method [Paik, 1998], is used in this study. The basic principle of this method is 
to “slice” the geometry of interest into a series of frames and then define the geometric 
centerline as the line that connects the center of mass of each frame.  
As explained in section 4.2, 3D TCPC anatomies are reconstructed from patient 
MR images. These 3D reconstructions are represented as triangulated 3D surface 
geometries, from which a skeletalized representation will be obtained by reducing the 






4.3.2 Geometry “Slicing” and Centroid Calculation 
The first step of the skeletonization process is to “slice” the geometry so as to 
represent it as a series of cross-sections rather than a full 3D surface. Thus, the 3D 
TCPC surface is sliced at ~1 mm spacing along the direction of vessel length.  These 
initial geometry slicing performed on a TCPC vessel can be seen in the flowchart 
representation of skeletonization shown in Figure 4.3. A macro written for the software 
Tecplot (Tecplot Inc., Bellevue, WA) is used to create the initial slices and this macro is 
provided in Appendix C. 
The slice centroids, for building the geometric centerline, are then computed from 
these initial slices as follows. (1) A point that is approximately at the center of the slice is 
selected as shown in Figure 4.4 a.  (2) Each slice cross sectional area is divided into 
triangles using the approximate center as the common vertex for all triangles. The 
triangulation starts from a point on the slice that is closest (shortest distance) to the slice 
center. The program then finds the next point on the slice that is closest to the initial one 
and forms a triangle. This process goes on until it comes back to the starting point.  A 
schematic of this process is shown in Figure 4.4 b. (3) The area and centroid of each 
triangle is computed using the following basic geometric equations: let ABC be a triangle 




Then, the area of the triangle ABC can be written as follows: 
 A = )()()(( csbsass −×−×−×   (4.1) 



































Figure 4.3: Flow chart representation of the skeletonization procedure. Starting with the 
3D reconstructed anatomical model, the flow chart shows pictures of initial and final 
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The centroid of the triangle ABC is given by 
where,  x i and y i are the triangle vertices. 
 










 Figure 4.4: Schematic showing the centroid calculation of geometry slices (a) a sample 
geometry slice is shown along with the slice center (b) this sample slice is then divided 
into triangles with the slice center as their common vertex. The triangulation starts from 
the point that is of shortest distance from the slice center and completes a triangle using 
its immediate neighbor (c) one triangle from this slice is zoomed in to shown the triangle 
sides and vertices. 
 
 
Once the area and centroid of the triangles have been computed, the center of 
each vessel cross-section can be obtained by the equation:  





                             (4.3) 
The vessel centerline is then built by connecting the centers of adjacent vessel 
cross-sections or slices. 
4.3.3 Iteration Procedure 
The accuracy with which the centerline is captured after the first iteration is highly 
dependent upon the initial slicing direction and the orientation of the slices. Figure 4.3 
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between the initial and final slicing directions. If the vessel slicing is not truly 
perpendicular to the centerline, the estimated skeleton will not be accurate. An iterative 
procedure is thus defined to correct simultaneously both the slicing direction and 
associated centerline (see figure 4.3). The iterative centerline refinement proceeds as 
follows: An initial guess is first made and the associated centerline S0 is computed. 
Then, in each subsequent iteration N, the 3D vessel geometry is re-sliced in a direction 
perpendicular to the tangent of the centerline curve SN-1 computed in the previous 
iteration (i.e, in the N-1th iteration). The centroids are recomputed for the new set of 
slices and the curve through the newly computed centroids provides a better estimate SN 
of the true centerline, S0. The process is repeated until centerlines SN-1 and SN from two 
consecutive iterations converge. An in- house code developed using ‘C’ language 
(Microsoft Visual studio 6.0, Microsoft Corporation) is used to perform the slice centroid 
computation and the skeletonization   process. A protocol for the entire skeletonization 
process is provided in Appendix A. 
 
4.3.4 Application to the TCPC 
 
In this study all four vessels of the TCPC – IVC, SVC, LPA and RPA were 
skeletonized separately so that the geometric characteristics of each vessel could be 
compared independently. The landmarks used to define the beginning and end of each 
of the four vessels are as follows: the region of confluence of the four vessels on one 
end, and the region of bifurcation on the other end (figure 4.5). 
The first slicing direction is chosen to be in the left-right direction for the 
pulmonary arteries (LPA and RPA) and the superior-inferior direction for the inferior and 






method, the centroid curve was found to converge to the true vessel centerline within 







Figure 4.5:  3D reconstructed TCPC anatomy marked with the points of vessel 




In order to validate the skeletonization method, the procedure explained in 
section 4.3 was applied to an idealized TCPC model, whose vessel dimensions are 
known a-priori. The geometry retained for this purpose was the zero-offset TCPC model. 
In order to assess the sensitivity of the developed approach to the initial slicing direction, 
the model was run twice through the skeletonization process. First, vessel axes were 
aligned with the coordinate axis (Figure 4.6a), so that the original slicing was actually 
performed normal to the vessel axis. In this orientation, it is expected to get slices 






an angle (300) with respect to its original co-ordinates (Figure 4.6b), so that the initial 
slicing resulted in oblique slices of the model. Here also, all the four vessels of the TCPC 




Figure 4.6:  Idealized zero offset TCPC model used for the validation studies with (a) 
vessel axes aligned to the coordinate axes (b) model rotated by 300 with respect to the 
original co-ordinate axes. 
 
 




Once the skeletalized representation of the TCPC is obtained, geometric 
parameters such as vessel area, vessel orientation, vessel curvature and offset are 









4.5.2 Vessel Area  
 
The final iteration of the skeletonization provides the cross-sectional area along 
each vessel centerline at ~1mm intervals. Since different TCPC templates (intra atrial, 
extra cardiac, bi-lateral SVC and pre Fontan) are analyzed in this study, in order to 
quantify their vessel cross-sectional area, mean cross-sectional area across the vessel 
length and its standard deviation are computed. Narrowing of the vessel dimensions are 
quantified using minimum vessel cross-sectional area. For comparison purposes 
maximum cross-sectional area was also computed. The procedures used to compute 
each of these parameters are listed below.  
Mean vessel area and standard deviation: The cross-sectional areas computed along 
the entire length of a vessel centerline are averaged yielding the mean vessel area and 
standard deviation. This standard deviation is used as a measure of the geometric in-
homogeneities along the vessel length.  
Minimum and maximum vessel area: Minimum and maximum vessel cross-sectional 
areas are computed from the area curve. The minimum vessel area can be used to 
quantify vessel stenosis especially in case of pulmonary arteries. 
4.5.3 Vessel Orientation and Curvature 
 
4.5.3.1 Vessel Curvature 
 
Vessel curvature quantifies the curvature of the vessel (IVC, SVC, LPA and RPA) 
at the TCPC junction. To compute this parameter, the first step is to calculate the 
tangent of the vessel centerline, denoted as T , at the TCPC junction. Suppose s(t) is a 
curve in the Euclidean space (Figure 4.7), the tangent vector T  of this curve is given by 
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dtdsT =          (4.4) 
Then the derivative T&  is numerically calculated with second order accuracy.  The 
curvature of the vessel centerlines at the TCPC junction can then be calculated as:  
 







Figure 4.7: Sample TCPC geometry with the skeleton of the venae cavae is shown in the 
figure. Part of the IVC centerline is zoomed in to show the tangent vector T (black arrow) 
at the TCPC junction. The red arrow indicates the direction of the space curve s(t), which 
is the IVC centerline in this scenario. 
 
 
4.5.3.2 Vessel Collinearity 
 
Using the tangent vectors of the IVC and SVC at the TCPC junction (figure 4.8), 
a parameter is defined that can be used as an indication of collision of flows coming 
through these vessels. In this study, this parameter is called “vessel collinearity” and is 
computed as:  











where T̂  is the unit vector of the tangent T and r̂  is the unit displacement vector 
between the points where the IVC and SVC meet the junction.  By definition, 10 ≤φ≤ . 
0=φ  corresponds to a head-on colliding orientation between the great veins, and 
1=φ corresponds to a configuration where the SVC and IVC flows are anastomosed in 








Figure 4.8: Schematic explaining the terms used for collinearity calculation. Sample 
TCPC geometry with the skeleton of the venae cavae is shown on the left. TCPC 
junction is enlarged on the right (black box) to show the unit tangent vectors T̂ svc and 
T̂ ivc (black arrows). The unit displacement vector r̂  is shown in blue arrow. 
 
 
4.5.4 Vessel Offset  
 
Three vessel offsets are defined: (1) anterior-posterior (AP) offset between IVC 
and SVC; (2) right-left (RL) offset between IVC and SVC; and (3) PA-VC offset between 
pulmonary arteries (PA) and the venae cavae (VC). The first two were computed by 
projecting the displacement vector r  along the AP and RL directions, respectively, while 
the PA-VC offset was computed as the shortest distance between the line connecting 
RPA to LPA and the line connecting SVC to IVCs, respectively. In the case of a zero PA-














4.6 Fontan Hemodynamic Characterization 
 
The primary purpose of quantitative geometric characterization is to correlate the 
geometric features with its hemodynamic performance. This section describes the three 
hemodynamic parameters taken into consideration: (1) power loss within the TCPC, (2) 
ventricular power output, and (3) cardiac index.  
 




Power loss across the TCPC is a critical parameter that quantifies the overall 
efficiency of the connection. Control volume power loss quantification requires the 
simultaneous knowledge of velocity and pressures. These cannot be computed based 
on in vivo measurements (unless catheterization data are acquired in all four vessels), 
but can be obtained by conducting in vitro experiments or CFD simulations on 
anatomically accurate TCPC geometries. Two modalities are used in this study to 
acquire the power loss, CFD simulations and in vitro experiments. In vitro experiments 
previously conducted in our laboratory [Kitajima, 2007], provided with power loss data for 
six patients and CFD studies performed by Whitehead et al [Whitehead, 2007] provided 
power loss for nine patients from our anatomic database. The subsequent sections 
provide an overview of the experimental and CFD protocols followed for data acquisition 







4.6.1.2 Experimental Studies  
 
Anatomically accurate in-vitro models are fabricated using stereolithography [De 
Zelicourt, 2005], based on the reconstructed 3D anatomies obtained in Section 4.2. The 
in vitro model is then inserted in a flow loop, which allows for the control of total cardiac 
output (CO) as well as IVC/SVC and LPA/RPA flow splits. Global flow rates and static 
pressures measurements are acquired at each inlet and outlet. These static pressures 
are corrected for pressure head bias introduced by small changes in the model elevation 
and then used to compute power losses (
•
E loss) across the connection using an 






iloss QPQPE                   (4.7) 
where Pi and Qi, are the corrected static pressure and volumetric flow rate respectively.  
  Flow conditions used for the study are shown in Table 4.1 and are based 
on the phase contrast MRI acquired at the time of the MRI scan. The average flows are 
then computed through the vessels of interest, which are prescribed at the time of the 
experiment. The lowest tested flow rates thus corresponded to the resting PC-MRI flow 
































4.6.1.3 CFD Simulation 
 
The 3D anatomical reconstructions described in section 4.2 are used for grid 
generation in which vessel volumes are divided into computational elements (meshes).  
The number of elements varies depending on geometry size and complexity, but ranges 
from 548,842 to 1,674,440 for the models studied [Whitehead, 2007].  At each element, 
the governing Navier-Stokes conservation equations of mass and momentum for laminar 
fluid flow are solved. The CFD computations were performed using the commercial 
software FIDAP 8.7.4 (Ansys Inc. Canonsburg, PA). Each patient geometry is simulated 
at MRI flow condition obtained from the PCMRI data averaged over the cardiac cycle.   
Power loss through the TCPC is calculated using the control volume method, 
derived from the macroscopic energy balance equation [Liu, 2004]: 
Patient Flow Conditions (L/min) 
CHOA007 2*, 3,4 
CHOA008 2 *, 3,4 
CHOP013 2,3 *, 4 
CHOA009 2 *, 3,4 
CHOA011 4*, 5,6,7 
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1 ρρ&    (4.8) 
where, P is the static pressure, ui is the velocity component and Q is the 
volumetric  flow rate. 
In practical terms, net power loss is calculated by subtracting outlet power from 
inlet power: 
rpalpaIVCSVCloss EEEEE &&&&& −−+=          (4.9) 
where, (
.
IVCSVC EE +& ) is the outlet power and (
.
RPALPA EE −& ) is the inlet power. 
lossE&  is the power loss in the control volume. 
 
4.6.2 Ventricular Power Output and Cardiac Index 
 
The mechanical energy of blood flow in the ascending aorta in the single 
ventricle patients is the total energy available to drive blood through both the systemic 
and the pulmonary beds. This ventricular power output may thus be used as a 
representation of the work done by the single ventricles of these Fontan patients.  
From the PC MRI of the ascending aorta, the ascending aorta is segmented 
using an in house scheme [Sorenson, 2006 MS thesis], and cardiac output is calculated 
by integrating the velocities over the entire cardiac cycle. The cardiac output is then 
normalized by patient body surface area (called Cardiac Index) to facilitate comparison. 
The cardiac output, mean velocities and the cuff blood pressure measurements are then 
used in the modified Bernoulli equation to obtain the ventricular power output 







  ( ) systolesystole QPVE  +ρ= 221&      (4.10)  
where, ρ=1060 kg/m3 is the density of blood, systoleV  is the mean systolic velocity 
in the ascending aorta, P is the mean arterial pressure , and systoleQ  is the  mean systolic 
flow rate.  
4.6.4 Non-dimentionalization 
In order to compare geometric ad hemodynamic features for different patients,  
the power loss needs to be appropriately indexed or non-dimensionalized. Vessel areas 
are normalized with patient body surface area (BSA).  
Since the TCPC power loss, denoted as lossE&  depends on the physical and 
geometrical characteristics, its functional dependence may be broadly characterized as 
a function of the blood flow rate (Q), density (ρ ), viscosity (µ ), BSA, flow split (α ) and 
the specific parameters that describe the geometry completely (mainly, vessel 
dimensions, angles, orientation, etc). The following equation describes this complex 
relationship: 
 
Note that geometry is denoted with subscript i, signifying that it may be a vector 
quantity with several components corresponding to each geometric detail.  
All the six variables mentioned in equation 4.11 have any one of the following 3 
dimensions – length, mass and time. That means, this relationship could be reduced to a 
relationship between three dimensionless quantities, expressed in terms of the 
dimensions length (L), mass  (M) and time (T) as explained below [Bukhingham, 1914].  








By fluids law, Reynolds number (Re), which lumps flow rate, density, viscosity 
and characteristics length defined by BSA is one of the non-dimensional variables. Flow 
split α is already non dimensional and is thus the second non-dimensional variable. The 
geometry can be non-dimensionalized by the patients BSA that forms the third non-
dimensional variable. Finally, lossE&  can be non-dimensionalized using BSA, density and 
cardiac output. i.e. 
 
In terms of their respective dimensions, each of these quantities can be 
expressed as Power loss in Kgm2/sec3 (Work done/Time), cardiac output in L/min, BSA 
in m2, density in Kg/m3.  Expressing these quantities in terms of length (L), mass (M) and 
time (T), we get   
  
cba MLLTLTML ][][][ 321332 −−− =  
Simplifying the above equation and equating dimensionalities for M, L, and T we 
get the following three equations: 
3;2323;1 ==−+= acbac  
Solving the above equations give, a = 3, b = -2, and c = 1.  Thus is has been 
shown that lossE&  scales with 2
3
BSA
Qρ , where ρ is the density of blood in Kg/m3, Q is the 
CO in L/min and BSA is the patient body surface area in m2.  So the power losses, lossE& , 
are thus normalized by 0E , defined as: 0E  = 2
3
BSA
Qρ       (4.15) 
and the non dimensional relationship reduces to: 
cba
















4.7 Patient Population 
4.7.1 Overview 
In our laboratory, a database of over 200 patients has been created as part of an 
ongoing study seeking to better understand the Fontan hemodynamics and improve the 
TCPC design. This database contains anatomical PC MRI and necessary clinical 
information from 3 major hospitals in the United States - Egleston Hospital, Atlanta 
(CHOA), Children’s Hospital of Philadelphia (CHOP) and University of North Carolina 
(UNC). Informed consent was obtained from all patients and all study protocols complied 
with the Institutional Review Boards of participating hospitals and the Georgia Institute of 
Technology.  
 
4.7.2 Details on the database 
The database includes details of all the three stages of Fontan surgery and the 
different templates available for each of these stages. Table 4.2 summarizes the number 
of patients in each category. 
4.7.3 Inclusion criteria for the study 
The work described in this thesis is a retrospective study designed to (i) compare 
the geometrical features of different TCPC templates and (ii) to assess the correlation 
between these geometrical parameters and the associated hemodynamic performances. 
The main focus is on EC and IA templates as these are the most widely represented 
anatomical types in the database. Accordingly, the inclusion criteria for this study are: (1) 
availability of experimental and CFD power loss data (2) availability of clinical 






with no visible artifacts (some geometries have loss of MRI signal due to the presence of  
“clips” in the vessels that surgeons attach to the vessel during surgery). 
Table 4.2: Summary of patients in each Fontan category present in the database  
(as of March, 2007) 
 
Fontan Category Number of patients 





- Hemi Fontan 10 
Stage 3 
- Intra atrial 
 
85 
- Extra cardiac 29 
- Bi-lateral SVC 8 




- Interrupted IVC 3 
 
 
In addition the EC and IA TCPCs, there are some marginal groups that are also 






for this group are similar to that of EC and IA with one addition, presence of two superior 
venae cavae. 
In order to see how the geometrical characteristics of Fontan patients evolve with 
time the geometrical characteristics of pr and post Fontan surgical pairs are also 
included in the study. For this group, the criterion addition to that of EC and IA is the 
presence of pre Fontan PCMRI data. 
Based on these criteria 34 patients were selected from the database for this 
study. Among these 34 patients, there are 13 intra atrials, 13 extra cardiacs, 5 bi-lateral 
SVC and 3 pre Fontan anatomies.  A tabulated form of patients chosen in each category 
is shown in table 4.4. Details of the study groups are provided in the following sections. 
 
 
Table 4.3: Summary of patients in each Fontan category studied in this work (The 3 pre-
Fontan models are not included in this list) 
 
 
Fontan type  Post-Fontan Total 
Intra atrial 12 1 13 
Extra cardiac 12 1 13 
Bi-lateral SVC 4 1 5 
 
 
4.7.4 Extra cardiac vs. Intra atrial 
At the time of patient selection (November 2006), there were about 75 intra atrial 
and 23 extra cardiac geometries in the database. Among these 26 patients, 13 each of 
extra cardiac (EC) and intra atrial (IA) were chosen based on the criteria defined in 






Among the 13 EC patients, 2 are from CHOA and 11 from CHOP, while among 
the IA patients, 4 are from CHOA and 9 from CHOP.  Details of the studied EC and IA 
patient populations are provided in Tables 4.5 and 4.6, respectively. 4 EC patients and 6 
IA patients within the study group had an initial diagnosis of HLHS.  Also, 16 of the 26 
patients had bi-directional Glenn (BDG) as their 2nd stage Fontan and remaining 10 had 
a hemi-Fontan. 
For all 26 patients, geometric characterization of the TCPC was performed to 
quantitatively differentiate EC and IA. Since there was a clear distinction about the 
diagnosis of the patients as HLHS and non-HLHS, a detailed analysis of these two 
categories are also performed where necessary. In-vitro power loss quantification for a 
range of cardiac outputs (CO) representing rest through exercise conditions and PA flow 
splits is available for 6 of 26 patients as well as CFD power loss data is available for nine 
of 26 patients. PCMRI data for the ascending aorta are available for 13 of 26 patients, 
which enabled estimation of the ventricular power output of the heart (Table 4.4). These 
parameters along with the cardiac index are used to analyze the hemodynamic 


































CHOP006 135 65 89.50 20.96 1.64 
CHOP007 119 62 81.95 50.63 1.90 
CHOP013 123 61 85.80 31.94 1.22 
CHOP067 103 64 78.18 26.16 1.51 
CHOP089 110 54 66.44 27.12 1.62 
CHOP090 126 69 83.78 25.85 2.78 
CHOP091 98 62 72.80 19.66 1.47 
CHOP095 96 67 79.61 18.86 1.61 
CHOP008 137 69 123.40 1.62 0.58 
CHOP018 123 65 82.40 23.27 1.95 
CHOP030 116 74 82.40 59.95 2.79 
CHOP068 107 54 66.72 21.88 0.82 



















EC – extra cardiac; Hemi - hemi-Fontan; BDG - bidirectional glenn; HRHS - hypoplastic 
right heart syndrome; HLHS - hypoplastic left heart syndrome; TA - tricuspid atresia; 
ASD - atrial septal defect; VSD - ventricular septal defect; SV - single ventricle; LV - left 
ventricle; RV - right ventricle; DI - double inlet; DO - Double Outlet; TGA - transposition 
of great arteries; DX – dextrocardia; AA - aortic arch; PA - pulmonary atresia; DSK - 







Patient Diagnosis Fontan Type Hemi/BDG BSA (m2) Age (Yrs) 
CHOA007 HLHS  EC BDG 0.79 6 
CHOA008 HRHS,TA EC BDG 0.69 5 
CHOP006 HLHS EC Hemi 1.05 10 
CHOP007 HRHS, Ebstein’s anomaly 
EC,DSK-ASD 
repair BDG 1.02 8 
CHOP013 HLHS,ASD EC Hemi 0.83 6 
CHOP067 SV-DI LV,VPS-TGA EC BDG 1.064 9 







EC-Fenestrated BDG 0.544 3 
CHOP089 TA,VSD EC-Fenestrated BDG 0.872 7 
CHOP090 PA,IVS,                   RV-Hypertrophy EC-Fenestrated BDG 1.152 8 
CHOP091 DO-RV,IVS,MA,PA EC-Fenestrated BDG 0.994 8 
CHOP095 DI LV,PA EC-Fenestrated BDG 1.253 8 










IA -intra atrial; Hemi - hemi-Fontan; BDG - bidirectional glenn; HRHS - hypoplastic right 
heart syndrome; HLHS - hypoplastic left heart syndrome; TA - tricuspid atresia; ASD - 
atrial septal defect; VSD - ventricular septal defect; SV - single ventricleAV - 
atrioventricular; DI - double inlet; TGA - transposition of great arteries; DX – 
dextrocardia; AA - aortic arch; PA - pulmonary atresia; PS - pulmonary stenosis; DSK - 
Damus-Stansel-Kaye procedure 
 





IA BDG 0.56 3 
CHOA009 SV-DI AV connection IA,DSK BDG 0.58 2 
CHOA011 HLHS IA-Fenestrated BDG 1.21 11 
CHOA027 
HRHS, TGA, 
TA, VSD, LPA 
hypoplasia 
IA, DSK, 
fenestrated BDG 0.58 2 
CHOP008 HLHS IA Hemi 1.94 16 
CHOP018 HLHS,ASD IA Hemi 1.23 12 
CHOP030 TA,VSD IA Hemi 1.32 10 
CHOP034 HRHS,SV,DX, TA,VSD,PS IA Hemi 1.19 11 
CHOP037 PA,HRHS IA Hemi 1.49 15 
CHOP068 HLHS IA Hemi 0.94 6 





IA-Fenestrated Hemi 0.495 1 






4.7.5 Pre vs. post Fontan 
Among the 34 patients MR images were available before and after the TCPC 
surgery for 3 pairs (i.e. images acquired at the 2nd stage and 3rd stage of the surgery). 
This allowed us to analyze the evolution of the vessel geometric characteristics between 
the Glenn and TCPC stages. Table 4.5 summarizes the information of these 3 surgical 
pairs. 
 
Table 4.7:  Clinical diagnosis of patients before and after Fontan surgery 
 
 
BDG - bidirectional glenn; HRHS - hypoplastic right heart syndrome; HLHS - hypoplastic 
left heart syndrome; TA - tricuspid atresia; VSD - ventricular septal defect;  RV - right 
ventricle; LA - left atrium; RA - right atrium; AV - atrioventricular; TGA - transposition of 
great arteries; DX – dextrocardia; PA - pulmonary atresia; PVS – pulmonary valve 
stenosis; DSK - Damus-Stansel-Kaye procedure; VPS – valvular pulmonary stenosis; 
AVC - Atrio-ventricular Canal 
 





CHOA014 TGA, AVV atresia, HRHS, VSD - BDG 0.53 1 
Pair 1 
CHOA027 HRHS, TGA, TA, VSD, LPA hypoplasia 
IA, DSK, 




to the RV, RV aorta 
with PA, hepatic 
veins and IVC to RA, 
PV to LA 





to the RV, RV aorta 
with PA, hepatic 
veins and IVC to RA, 
PV to LA 
EC, bi-
lateral SVC - 0.63 4 
CHOP057 HLHS - BDG 0.43 2 
Pair 3 






2 patients in the pre-post pair, CHOA027 and CHOP085 also comes under the 
category of IA and EC groups respectively, and are used for the comparison of EC vs. IA 
study. Also CHOP055, the post pair of CHOP053 is included in the bi-lateral SVC 
analyses also. 
 
4.7.6 Bilateral SVC 
Because of their unique characteristics of having 2 SVCs, one connected to the 
right side (RSVC) and one to the left side (LSVC) of the pulmonary arteries, patients with 
bilateral SVCs stand out as a separate template in the database. Geometric 
characterization is thus performed on this TCPC type as well. For this purpose, 5 TCPCs 
with bilateral SVCs are analyzed in this study. The selection criteria are defined in 



































Table 4.8: Clinical diagnosis of Bilateral SVC patients 
 
 
HLHS - hypoplastic left heart syndrome; TA - tricuspid atresia; VSD - ventricular septal 
defect; SV – single ventricle;  RV - right ventricle; LA - left atrium; RA - right atrium; AV - 
atrioventricular; TGA - transposition of great arteries; DX – dextrocardia; DO- double 
outlet; PA - pulmonary atresia; PVS – pulmonary valve stenosis; DSK - Damus-Stansel-
Kaye procedure; VPS – valvular pulmonary stenosis; AVC - Atrio-ventricular Canal 
 
 
4.8 Statistical Analysis 
To perform the statistics on the analyzed data, the first task is to test the 
normality of the data.  The normality test showed that all comparative data are non-
normal and correspond to a two-sample population (EC vs. IA). Hence the non-
Patient Diagnosis Fontan Type Hemi/BDG BSA (m
2) Age (Yrs) 
CHOA039 HLHS EC --- 0.575 3 
CHOP019 HLHS EC --- 0.91 7 
CHOP022 
DX, SV-DO RV, 
PA, Heterotaxy, 
AVC 










unbalanced to the 
RV, RV aorta with 
PA, hepatic veins 
and IVC to RA, 
PV to LA 






parametric Mann-Whitney test is used to examine statistical significance among the 
various geometric parameters evaluated. All statistics are performed using the software 
Minitab (Minitab Inc, PA).   
The Mann-Whitney test is a non-parametric test used for assessing two samples 
of observation coming from the same distribution. In this study, the two samples extra 
cardiac and intra atrial are coming from the same distribution – Fontan surgical group. 
Here the null hypothesis is that the two samples are drawn from a single population, and 
therefore that probability distributions are equal.  
Because of the low sample size of 3 patients for pre-post Fontan pair and 5 bi-
lateral SVCs no  statstical analysis could be performed on these study groups. 
 Factors are considered statistically significant for p values <0.05. To examine 
the association between anatomic and hemodynamic parameters, a regression analysis 
for two variables was performed using Microsoft Excel (Microsoft Office 2000, Microsoft). 
P values <0.05 are considered statistically significant. P values slightly higher than 0.05 


















 CHAPTER 5 
   RESULTS 
 
5.1 Overview 
This chapter presents the results of the geometric analyses starting with the 
validation studies conducted in idealized TCPC geometries. The following section then 
moves on to the patient-specific anatomies selected from the database, detailing the 
results obtained for the different study subsets of the Fontan geometries, namely extra 
cardiac vs. intra atrial, pre vs. post Fontan and bi-lateral SVC. Finally the third and last 
section provides the hemodynamic correlates of the TCPC anatomies, using the power 
losses computed using CFD simulations and in vitro experiments and the ventricular 
power output when they are available.  
 
5.2 Skeletonization Results – Specific Aim1 
The skeletonization method described in Chapter 4 was successfully 
implemented. However, prior to applying it to patient-specific anatomies and drawing any 
clinical conclusions from our findings, a critical step was to validate it on geometries with 
known geometrical parameters. Accordingly, this section first goes over the validation 








5.2.1 Validation Studies 
In order to validate the skeletonization approach, the method was tested on 
idealized TCPC models whose details are provided in Chapter 4. The two validation 
models along with their corresponding centerline representations are shown in figure 




      
(a) (b) 
Figure 5.1: Results of method validations on idealized TCPC models are shown here. (a) 
Idealized Fontan geometry with zero offset between the venae cavae. (b) The same zero 
offset model as in figure (a) rotated at 300 with respect to its original co-ordinates. The 
blue lines are the centerline representation of the models and v1, v2, v3 and v4 
represents the vessels of the TCPC geometry. 
 
 
For the representation of the centerline to be accurate, the vessel slicing in the 
final iteration should be done in directions perpendicular to the vessel axis. This is 















                                 
 
Figure 5.2: Slices obtained after the (a) first and (b) second iteration on vessel v1 of the 











Figure 5.3: Slices obtained after the (a) first and (b) second iteration on vessel v1 of the 
300 rotated zero-offset model. Note the over estimation of slice area and extension of 
slices onto vessel v2 in figure (a). 
 
Figure 5.2 shows the results of vessel slicing on vessel v1 of the idealized model 
after the first and second iterations, respectively. A perfect match is obtained for both 










However in Figure 5.3 the same geometry is rotated at a fixed angle with respect to the 
center so that the vessel axis is now off from the initial slicing direction. Over estimation 
of the slice area as well as the fact that slicing is extended to vessels that are not of 
interest (vessel v2 in this example) are clearly visible in Figure 5.3a. However, as shown 
in Figure 5.3b, the slices are back to a orientation perpendicular to the vessel axis, 
resulting in an accurate centerline of the geometry, as soon as in the 2nd iteration 
 
Figure 5.4 shows the area plots obtained for the validation models. These plots 
provide quantitative details of the cross-sectional area variations along the vessel length 
for the different tested configurations. For the1st configuration with no rotation (Figure 
5.4a, the vessel area starts at the value ~225 mm2 and then decreases to ~150 mm2. 
The initial increase in area is because the region where the vessel connects to the 
TCPC is also included in the picture. The good agreement between the first and second 
iteration curves show that the respective centerlines are also converging with one 
another, which was expected since, with no rotation, the initial slicing direction was 
exactly perpendicular to the vessel axes. Now looking at the rotated configuration 
(Figure 5.4b), it is very clear that the initial slices shown using the curve 1 (shown in 
blue) yielded inaccurate area estimations (see Figure 5.3a). Despite such inaccuracy in 
the initial estimates, the accurate slices were obtained after the second iteration, which 


















(a)       (b) 
Figure 5.4:  Area plot showing the cross sectional area of vessel v1 for the zero offset 
model (a) with no rotation and (b) with rotation. Note the good match between the first 
and second iteration curves in figure (a) and the area overestimation shown in figure (b).  
 
 
Since both test cases employed the exact geometry, both plots are expected to 
be identical and equal to the design specifications. The zero-offset model was designed 
with vessel diameters of 14mm. Accordingly, the expected cross-sectional area was of 
153.86mm2. Figure 5.5 compares this theoretical value to the output of the 
skeletonization approach to both configurations. It should be noticed that (1) the 
skeletonization method yielded identical results irrespective of the initial slicing 
orientation for both configurations; and (2) the cross-sectional areas computed in both 
cases were of about 148mm2 (diameter of 13.7mm), which was in close agreement with 
the theoretical value of 153.86mm2. Both observations are critical features that validated 
the ease of use of the developed method (with minimum constraints on the initial model 
orientation) as well as for its reliability and accuracy. An excel spreadsheet of all the 
computed parameters for the validation studies is provided in Appendix B. 
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Figure 5.5: Comparison of the cross-sectional area plots obtained for the zero-offset 
model after 2nd iteration with and without rotation (pink and blue, respectively) against 
the theoretical value (gray). 
 
 
5.2.2 Application of skeletonization – Centerline of TCPC geometries 
TCPC geometries that have been analyzed using the skeletonization approach in 
each study category are shown in figures 5.6 to 5.9. Figure 5.6 shows the 3 pairs of pre 
and post Fontan groups that have been used in this study along with their centerline 
representation and figure 5.7 shows the same for the four bilateral SVC models. Figure 
5.8 and 5.9 presents the skeletonization and geometries of the 12 EC and 12 IA patient 
groups, respectively, underscoring their large geometric variability and complexity. In all 
these Figures, the geometries are oriented such that the vessel pointing to the top of the 
page is the SVC, towards the bottom is the IVC, to the left is the RPA and to the right is 
the LPA. 
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Figure 5.6: 3D reconstructed TCPC anatomies with centerline curves for the three pairs 
of pre and post Fontan models. Pre Fontan models are shown on the left side while post 
Fontan models are shown on the left. Since CHOP055 is a bi-lateral SVC it is included in 
the analysis of bi-lateral SVC also. Similarly, CHOA027 (IA geometry) and CHOP085 














         
                                          
 
 
                                         
Figure 5.7: 3D reconstructed TCPC geometry along with the centerline curves for the 4 
Bilateral SVC models. SVC seen on the right hand side is called LSVC and the one on 
the left hand side is the RSVC. The fifth bi-lateral SVC in this category is CHOP055, and 


























Figure 5.8: 3D reconstructed TCPC anatomies with centerline curves for extra cardiac 
geometries; the special characters shows the subgroups within each category -  * HLHS, 
† hemi, ‡ - BDG. 
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Figure 5.9: 3D reconstructed TCPC anatomies with centerline curves for intra atrial 
geometries; the special characters shows the subgroups within each category - * HLHS, 
† hemi, ‡ - BDG. 
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5.3 Geometrical Characteristics of the TCPC – Specific Aim 2 
This section focuses on the quantification and analysis of the parameters 
retained to characterize the TCPC geometry, namely the vessel area, the vessel 
orientation and curvature and the vessel offsets. This analysis was performed on the 
following study subgroups - extra cardiac vs. intra atria; pre vs. post Fontan; and 
Bilateral SVC.  
 
5.3.1 Extra cardiac vs. Intra atrial TCPC 
Results of the geometric characterization performed in 13 extra-cardiac (EC) and 
13 intra-atrial (IA) models are shown here. In order to isolate factors others than the 
procedure used for the 3rd stage alone, these two study groups are further subdivided 
into (1) HLHS vs. non-HLHS (2) IA-HLHS, IA – non-HLHS, EC – HLHS, EC – non-HLHS 
and (3) Glenn vs. hemi-Fontan, wherever it is necessary. A summary of all the computed 
















Table 5.1: Summary of the computed values of geometric characteristics for 13 EC and 
13 IA geometries. 
 
Computed Variables Extra Cardiac Intra Atrial P Value 
    
Mean Vessel Cross-
Sectional Area / BSA    
IVC 3.67x10-4± 1.83 x10-4 4.03 x10-4± 1.71 x10-4 0.2917 
SVC 1.65 x10-4± 0.67 x10-4 1.34 x10-4± 0.63 x10-4 0.0874 
RPA 1.18 x10-4± 0.70 x10-4 1.19 x10-4± 0.62 x10-4 0.2917 
LPA 1.12 x10-4± 0.59 x10-4 0.95 x10-4± 0.41 x10-4 0.1704 
    
Vessel Cross-Sectional 
Area Ratio    
LPA/IVC 0.32± 0.19 0.27± 0.15 0.2534 
LPA/SVC 0.69± 0.34 0.79± 0.42 0.1427 
RPA/IVC 0.34± 0.15 0.31± 0.12 0.1562 
RPA/SVC 0.72± 0.28 0.89± 0.26 0.0443 
    
Vessel Area Standard 
deviation / BSA    
IVC 3.42 x10-5 ±  1.96 x10-5 9.17 x10-5 ±  4.55 x10-5 0.0006 
SVC 4.17 x10-5 ±  1.29 x10-5   3.23 x10-5 ±  1.7 x10-5 0.0970 
RPA 2.38 x10-5 ±  1.39 x10-5 2.95 x10-5 ±  2.13 x10-5 0.4426 
LPA 3.51 x10-5 ±  2.22 x10-5 3.89 x10-5 ±  1.80 x10-5 0.2722 
    
Minimum Vessel Cross-
Sectional Area / BSA    
RPA 7.99 x10-5± 5.97 x10-5 7.71 x10-5± 4.64 x10-5 0.3537 
LPA 6.57 x10-5± 4.64 x10-5 4.71 x10-5± 2.92 x10-5 0.1183 
    
Vessel Curvature at the 
TCPC junction    
IVC 0.19± 0.11 0.26± 0.19 0.2179 
SVC 0.22± 0.19 0.18± 0.16 0.4199 
RPA 0.34± 0.43 0.22± 0.26 0.0705 
LPA 0.21± 0.17 0.16± 0.11 0.3537 
    
IVC-SVC Collinearity 0.54± 0.11 0.48± 0.28 0.0562 
    
IVC-SVC AP offset / BSA1/2 3.44 x10-3± 3.4 x10-3 2.36 x10-3± 1.81 x10-3 0.1704 
    
IVC-SVC RL offset / BSA1/2 4.6 x10-3± 3.01 x10-3 4.47 x10-3± 4.33 x10-3 0.2917 
    







5.3.1.1 Vessel Area Characteristics:  
The mean and standard deviation of vessel areas computed for the EC and IA 
patient groups are shown in Figure 5.10. Although the mean cross-sectional areas are 
larger for the SVC, LPA and RPA in case of EC compared to the IA connections, there 
was no statistically significant difference for any of them (Figure 5.10a). Standard 
deviations of the cross sectional area computed along the vessel length on the other 
hand did reveal statistically significant differences between the two groups with regard to 
the IVC area variation with p = 0.0006 (Figure 5.10b). Another statistically significant 
difference (p = 0.0443) was observed in the ratios of mean cross-sectional areas of RPA 








 (a) (b) 
Figure 5.10: Vessel area characteristics with (a) mean and (b) standard deviation of   
each vessel in the vicinity of the TCPC compared between EC and IA patient groups 
(N=13 each).  
 















































































Figure 5.11: Vessel area ratios between the venae cavae and pulmonary arteries for EC 
and IA patient groups (N=13 each). 
 
 
There was no statistically significant difference in minimum PA cross-sectional 
areas (i.e. smallest cross-section along the length of the skeletonized PA) between the 
EC and IA patient groups. However, as shown in Figure 5.12a, the minimum LPA cross-
sectional area was found to be significantly lower (p = 0.016) than the RPA among the 
IA population. A potential explanation for the minimum LPA cross-sectional area to be 
smaller than the minimum RPA cross-sectional area is the presence of LPA stenosis 
after aortic reconstruction, which is typically associated with the surgical repairs of HLHS 
patients. In order to test for this hypothesis, the study groups were reorganized as HLHS 
and non-HLHS patients (Figure 5.12b). There was no statistical difference between 
minimum LPA and RPA cross-sectional areas for non-HLHS patients, while the minimum 
LPA cross-sectional area was significantly smaller than the minimum RPA cross-
sectional area (p = 0.0106) among HLHS patients. Furthermore, the minimum LPA 
cross-sectional area was found to be significantly smaller for HLHS than for non-HLHS 
patients (p = 0.0163). Investigating the question a little further, the two-subgroup 







































HLHS and EC-non HLHS. Here again minimum PA cross-sectional areas are compared 
across all four subgroups (Figure 5.12c). Among HLHS patients, the LPA had a 
significantly smaller (p = 0.0227) minimum cross-sectional area than the RPA for the 
patients with IA connection. Also, for non-HLHS patients, the minimum LPA cross-
sectional area was smaller for patients with an IA TCPC than for those with an EC TCPC 
(p = 0.0533). 
 
  


































Figure 5.12: Minimum vessel area for the pulmonary arteries – LPA and RPA for 
population groups: (a) EC and IA (N=13 each) (b) HLHS (N=10) and non-HLHS (N=16), 































































P = 0.0227      






























*P = 0.0106          









5.3.1.2 Vessel Orientation and Curvature: 
Figures 5.13 and 5.14 show the results related to vessel curvature and 
orientation. Figure 5.13 compares the averaged vessel curvatures observed in the IA 
and EC connections. The RPA curvature for the EC group was found to have larger 
patient-to-patient variation. As depicted in Figure 5.14a, the IA collinearity was 
significantly smaller than EC collinearity (p = 0.0562). Since the second stage surgery of 
these patients can significantly influence collinearity, we compared the collinearity 
between hemi-Fontans and BDG and report that hemi-Fontans had significantly smaller 
collinearity (p = 0.0467; Figure 5.14b).  
 
         
























Figure 5.13: TCPC orientation depicted by mean vessel curvature between the EC and 
IA patient groups (N=13 each).  
 










(a)             (b) 
Figure 5.14: TCPC orientation depicted by (a) mean collinearity for EC and IA (N=13 
each) (b) mean collinearity for hemi-Fontan (N =10) and BDG (N=16)  
 
 
5.3.1.3 Vessel Offset: 
Comparison between the three types of vessel offsets - (1) right-left (RL) offset 
between IVC and SVC, (2) anterior-posterior (AP) offset between IVC and SVC, and (3) 
PA-VC offset between pulmonary arteries and the venae cavae - showed no statistical 
significance. All the offset values are divided with square root of BSA, so as to provide 
proper normalization. Each of these results is shown independently in Figures 5.15, 5.16 
and 5.17. Since these offsets largely depend on the second stage of the Fontan, the 
same comparison between Glenn and hemi Fontan is also provided in these figures. The 
PA-VC offset showed a smaller p value of 0.15 when the comparison was made 



































































Figure 5.15: RL offset between the IVC and SVC of the TCPC for (a) EC and IA (N=13 









































































Figure 5.16: AP offset between the IVC and SVC of the TCPC for (a) EC and IA (N=13 



























































































Figure 5.17: Offset between the venae cavae and pulmonary arteries TCPC for (a) EC 






























































5.3.2 Pre Fontan vs. Post Fontan 
Geometric characteristics of three pairs of pre and post Fontan models are 
quantified in this section. Each computed parameter is averaged over the 3 models and 
its values before and after the 3rd stage surgery are compared. Since the sample size 
was three and one of the models was a bilateral SVC no statistical analysis could be 
performed on the data. In addition, since bilateral SVC has both RSVC and LSVC, 
RSVC is used for comparing with normal SVC of other models. The LSVC value is also 
plotted in all the graphs. The pre Fontan stage does not include an IVC, hence only the 
post-Fontan characteristics of the IVC are included in the analysis. A summary of the 




















































Computed Variables Pre Fontan Post Fontan 
   
Mean Vessel Cross-
Sectional Area / BSA   
IVC - 5.61 x10-4± 0.81 x10-4 
SVC 2.43 x10-4± 1.46 x10-4 1.73 x10-4± 0.82 x10-4 
LSVC 1.64 x10-4 1.53 x10-4 
RPA 2.25 x10-4± 1.36 x10-4 2.25 x10-4± 0.43 x10-4 
LPA 1.95 x10-4± 1.36 x10-4 1.81 x10-4± 0.41 x10-4 
   
Vessel Cross-Sectional 
Area Ratio   
LPA/IVC - 0.32± 0.06 
LPA/SVC 0.90± 0.62 1.16± 0.42 
LPA/LSVC 1.10 0.92 
RPA/IVC - 0.40± 0.04 
RPA/SVC 1.05± 0.64 1.44± 0.49 
RPA/RSVC 1.24 1.31 
   
Vessel Area Standard 
deviation / BSA.   
IVC - 8.26 x10-5 ±  6.64 x10-5 
SVC 2.26 x10-5 ±  1.64 x10-5 2.16 x10-5 ±  1.71 x10-5 
LSVC 1.76 x10-5 7.97 x10-5 
RPA 4.16 x10-5 ±  2.99 x10-5 4.58 x10-5 ±  2.54 x10-5 
LPA 6.03 x10-5 ±  1.36 x10-5 4.56 x10-5 ±  1.16 x10-5 
   
Minimum Vessel Cross-
Sectional Area / BSA   
RPA 1.62 x10-4 ± 1.02 x10-4 1.51 x10-4± 0.37 x10-4 
LPA 1.24 x10-4± 1.16 x10-4 1.22 x10-4± 0.43 x10-4 
   
Vessel Curvature at the 
TCPC junction   
IVC - 0.10± 0.10 
SVC 0.12± 0.09 0.06± 0.03 
LSVC 0.03 0.01 
RPA 0.26± 0.15 0.38± 0.56 
LPA 0.21± 0.08 0.27± 0.27 
   
PA-VC Offset / BSA1/2 4.88 x10-3± 2.63 x10-3 7.12 x10-3± 4.12 x10-3 






5.3.2.1 Vessel Area Characteristics:  
Four parameters of the TCPC geometry are quantified in this section. These 
include vessel cross sectional areas, area standard deviations, ratios of the LPA and 
RPA cross-sectional areas over the IVC and SVC areas, and minimum PA areas. 
Counter intuitively, the SVC and LPA cross-sectional areas averaged over the entire 
vessel length were slightly less after the surgery than before (Figure 5.18).  Investigating 
whether this could be attributed to the appearance of new LPA stenosis, minimum 
vessel cross-sectional areas were compared but no difference was observed between 
the pre and post values (Figure 5.19). In order to quantify the area variation across the 
vessel length, the standard deviation of the cross sectional area is plotted for each of the 
vessels in the vicinity of the TCPC, revealing higher variations in LPA cross-sectional 












Figure 5.18: Mean vessel cross sectional area depicted for pre and post Fontan 

















































Figure 5.19: Minimum vessel areas of the pulmonary arteries depicted for pre and post 














Figure 5.20: Area standard deviation of the TCPC vessels depicted for pre and post 
































































5.3.2.2 Vessel Curvature: 
Figure 5.21 shows the vessel curvature at the junction of the TCPC for all the 
connecting vessels for the pre and post Fontan pairs. Curvature of both the PAs showed 
smaller values before the surgery. Also the RPA curvature for the post Fontan group 
was found to have larger patient-to-patient variation. Curvature of the SVC was slightly 
higher for the pre-Fontan group than for the post-Fontan geometry. 
 
5.3.2.3 Vessel Offset Characteristics: 
Since pre-Fontan connections do not include the IVC, the AP, RL and PA-VC 
offsets were not computed on 2nd stage anatomies.  
 

























Figure 5.21: Vessel curvature depicted for pre and post Fontan groups for all the vessels 






5.3.3 Bilateral SVC TCPC models 
 Bilateral SVC models are a special category of Fontan patients with two 
SVCs named as right SVC (RSVC) and left SVC (LSVC) as shown in Figure 5.6. This 
section quantifies the geometric features of five bilateral SVC models. The results of 
calculated parameters for all the models are presented in tabulated format for each 
category.  
 
5.3.3.1 Vessel Area Characteristics:  
Mean vessel cross-sectional area, area standard deviation and the minimum 
vessel area for the PAs are computed in this analysis (Table 5.3).  To see how the 
vessel dimensions of bilateral SVCs compared to that of common Fontan geometries, 
the mean vessel cross sectional area of all the vessels, except the LSVC, of bi-lateral 
SVCs where compared to that of EC TCPC (Figure 5.22). The reason to choose EC 
TCPC is because, all the five bi-lateral SVCs have extra cardiac TCPC.  
There was no significant difference between the cross sectional areas of RSVC 
and LSVC (Figure 5.23). Also sum of RSVC and LSVC of the bi-lateral SVCs are used 
for comparing with the SVC of normal Fontans. However, the vessel area standard 














Table 5.3: Vessel area characteristics computed for the 5 bilateral SVC models along 











Bilateral SVC Computed 
Variables 
CHOA039 CHOP019 CHOP022 CHOP032 CHOP055 Mean 
       
Mean Vessel 
Area / BSA  
     
IVC 4.08X10-4 1.96X10-4 1.20X10-4 2.58X10-4 4.79X10-4 2.92X10-4 
RSVC 1.8X10-4 0.69X10-4 0.61X10--4 0.62X10-4 1.00X10-4 0.95X10-4 
LSVC 1.5X10-4 0.46X10-4 1.02X10-4 0.75X10-4 1.53X10-4 1.07X10-4 
RPA 1.61X10-4 0.69X10-4 1.0X10-4 0.73X10-4 2.00X10-4 1.21X10-4 
LPA 2.34X10-4 0.75X10-4 0.69X10-4 1.08X10-4 1.41X10-4 1.27X10-4 
       
Vessel Area 
Stdev./ BSA  
     
IVC 11.06X10-5  1.05X10-5 1.24X10-5 6.82X10-5 4.64X10-5 4.96X10-5 
SVC 1.85X10-5 1.64X10-5 7.81X10-5 6.75X10-5 9.82X10-5 1.19X10-5 
LSVC 2.46X10-5 1.34X10-5 6.93X10-5 8.16X10-5 7.97X10-5 2.47X10-5 
RPA 3.23X10-5 1.57X10-5 3.206X10-5 1.60X10-5 4.02X10-5 2.73X10-5 
LPA 8.19X10-5 1.92X10-5 6.34X10-5 3.5X10-5 4.73X10-5 3.79X10-5 
       
Min. Vessel 
Area / BSA  
     
RPA 9.45X10-5 4.19X10-5 4.89X10-5 4.95X10-5 12.1X10-5 7.11X10-5 











































Figure 5.22: Mean vessel cross sectional area of bilateral SVC (N=5) compared to that 
of EC Fontan (N=13). Note that the sum of RSVC and LSVC of the bi-lateral Fontans are 













Figure 5.23: Mean vessel cross sectional area of the left and right SVC of bi-lateral SVC 













































Figure 5.24: Vessel area standard of the left and right SVC of bi-lateral SVC Fontans 
(N=5). Area variation of LSVC is almost twice as compared to RSVC. 
  
 
5.3.3.2 Vessel Curvature: 
Curvature of all the vessels for the five bilateral SVC models is shown in table 
5.4. No comparison between the curvature of the EC Fontans and bi-lateral SVCs could 
be made case because the SVCs of the bi-lateral Fontans are connected to the PAs 
directly in certain geometries (CHOP019 and CHOA039 of Figure 5.6). 
 
5.3.3.3 Vessel Offset Characteristics: 
Offset between the PA and VC is computed for all the five bilateral SVCs are 



































Table 5.4: Vessel curvature computed for the 5 bilateral SVC models 
Vessels 
analyzed CHOA039 CHOP019 CHOP022 CHOP032 CHOP055
IVC 0.13 0.23 0.18 0.04 0.21 
RSVC 0.17 0.23 1.94 0.34 0.09 
LSVC 0.03 0.27 0.60 0.46 0.006 
RPA 0.13 0.23 0.58 0.62 0.13 





Table 5.5: PA-VC offset computed for the 5 bilateral SVC models 
Bilateral SVC Models PA-VC Offset / BSA1/2 
CHOA039 7.54X10-3 
















5.4 Anatomy vs. Hemodynamic correlates of the TCPC – Aim 3 
Some of the geometric parameters computed using the skeletonization method 
might be correlated with the TCPC hemodynamics, mainly the TCPC power loss, 
Cardiac Index and the ventricular power output. This correlation between the TCPC 
geometry and the hemodynamic parameters are explained in this section of the chapter.   
Previous experimental and numerical studies have all underscored the tight 
relationship between the TCPC design and its efficiency [Pekkan, 2005; De Zelicourt, 
2005]. Though these studies have led to some suppositions as to what features could 
play an important role in dictating the overall connection efficiency of TCPC, no study 
has yet been able to correlate TCPC hemodynamics to simple geometric parameters.    
The skeletonization approach, developed in this study is a strong tool that can be 
used to demonstrate such correlation. Accordingly, this last section of the Chapter seeks 
to take advantage of the geometric features analyzed in the previous sections and 
correlate them with the following hemodynamic parameters: experimental and CFD 
control volume power losses, cardiac index and ventricular power output. 
 
5.4.1 TCPC Geometry and Experimental Power Loss 
 
Figure 5.25 depicts the non dimensionalized in-vitro power loss ( lossE& / 0E ) for six 
patients, as a function of the minimum vessel sizes normalized with the BSA at 50-50 
pulmonary flow split at MRI cardiac outputs.  From Figure 5.25, the relationship between 
power losses within the TCPC and minimum LPA cross-sectional area appears to be the 
most coherent. Power loss is found to scale as a power law with respect to the minimum 
LPA area with an R2 of 0.96 (Figure 5.25c). The R2 values with respect to IVC, SVC, and 






To further investigate the effect of minimum vessel cross-sectional area on power 
loss, non-dimensionalized in-vitro power loss ( lossE& / 0E ) at equal pulmonary resistance 
(refer appendix D for the details about computing the equal pulmonary resistance) and at 
MRI flow split condition (both calculated at MRI cardiac output) are also plotted on 
Figures 5.26 and 5.27, respectively.  However, the R2 values are not significant for the 
minimum LPA area (and all other vessels) in these plots. Table 5.6 summarizes the 
power-losses computed at 50-50 pulmonary flow split, MRI flow split and equal 
pulmonary resistance conditions for experimental condition. The non-dimensionalized 






















                    




































































Figure 5.25: Non-dimensionalized experimental power loss ( lossE& / 0E ) at 50-50 
pulmonary flow split and at MRI cardiac outputs for six TCPC geometries plotted against 
the minimum vessel cross-sectional area of: (a) IVC and (b) SVC (c) LPA and (d) RPA. 















                    





































































Figure 5.26: Non-dimensionalized experimental power loss ( lossE& / 0E ) at equal 
pulmonary resistance flow split and at MRI cardiac outputs for six TCPC geometries 
plotted against the minimum vessel cross-sectional area of: (a) IVC and (b) SVC (c) LPA 















                    





































































Figure 5.27: Non-dimensionalized experimental power loss ( lossE& / 0E ) at MRI flow split 
condition and at MRI cardiac outputs for six TCPC geometries plotted against the 















Table 5.6: Summary of experimental power loss (PL) values computed at MRI cardiac 
output for the flow conditions – 50-50 pulmonary artery flow split, MRI flow condition and 
at equal pulmonary resistance (eq.PR) 
 
Model PL at 50% flow split (mW) 
PL at MRI flow 
split (mW) 
PL at eq.PR 
(mW) 
CHOA007 19.03 19.03 13.80 
CHOA008 4.60 6.72 5.44 
CHOP013 135.99 11.50 8.65 
CHOA009 11.94 11.94 9.70 
CHOA011 13.26 21.42 13.76 
CHOP034 12.56 14.59 13.24 
 
5.4.2 TCPC Geometry and CFD Power Loss 
Power losses computed using CFD simulations for nine patients are also plotted 
against the minimum vessel diameters to see the strength of the correlation. Figures 
5.28, 5.29 and 5.30 shows these plots for non-dimensionalized CFD power losses 
( lossE& / 0E ) computed at the flow conditions: 50-50 pulmonary artery flow split, MRI flow 
condition and at equal pulmonary resistance (eq.PR), respectively.  Refer table 5.7 for 
the summary of the computed power loss values. 
These power losses are computed at MRI flow conditions using PCMRI data and 
are plotted against minimum vessel cross-sectional areas of IVC, SVC, LPA and RPA 
similar to section 5.4.1. However, with the CFD power loss it is the RPA that shows more 
correlation than that of LPA.  This means that it the minimum vessel area of the outlet 









                    





































































Figure 5.28: Non-dimensionalized CFD power loss ( lossE& / 0E ) at 50-50 pulmonary flow 
split condition and at MRI cardiac outputs for nine TCPC geometries plotted against the 















                    




































































Figure 5.29: Non-dimensionalized CFD power loss ( lossE& / 0E ) calculated at equal 
pulmonary flow split condition and at MRI cardiac outputs for nine TCPC geometries 
plotted against the minimum vessel cross-sectional area of: (a) IVC and (b) SVC (c) LPA 















                    




































































Figure 5.30: Non-dimensionalized CFD power loss ( lossE& / 0E ) calculated at MRI flow 
split condition and at MRI cardiac outputs for nine TCPC geometries plotted against the 
















Table 5.7: Summary of CFD power loss (PL) values computed at MRI cardiac output for 
the flow conditions – 50-50 pulmonary artery flow split, MRI flow condition and at equal 
pulmonary resistance (eq.PR) 
 
Model PL at 50% flow split (mW) 
PL at MRI flow 
split (mW) 
PL at eq. PR 
(mW) 
CHOP018 31.56 18.56 7.79 
CHOP022 5.83 7.53 4.85 
CHOP034 34.53 43.57 23.51 
CHOP037 25.61 18.83 13.56 
CHOP055 0.68 0.94 0.67 
CHOP067 61.87 61.53 63.12 
CHOP088 0.83 1.77 0.97 
CHOP089 2.84 2.84 2.84 
CHOP090 1.37 3.47 1.21 
 
The non-dimensionalized power loss values along with the normalized minimum 
vessel areas are provided in Appendix B. 
 
5.4.3 TCPC Geometry and Cardiac Index 
Figure 5.31 depicts the impact of TCPC geometry on the patient’s cardiac output 
(CO) by showing both the in-vitro power loss data and CFD power loss data at MRI 
conditions plotted against the in-vivo cardiac indices obtained from the clinical 
information. As shown in Figure 5.31a, a significant association between the patients’ 
cardiac index and the experimental power loss was observed with an R2 value of 0.84. 
However, there was no statistically significant association between the in-vivo cardiac 






given in Figure 5.32. The results show similar trend as that of the MRI condition with no 
significant correlation seen for CFD simulations. 
               
 
 
   


















                                (a) CI vs. Experimental power loss at MRI flow split 
               


















                                       (b) CI vs. CFD power loss at MRI flow split  
 
Figure 5.31: Cardiac index plotted against (a) normalized in-vitro power loss ( lossE& / 0E ) 
and (b) normalized CFD power loss ( lossE& / 0E ) at MRI flow split condition. 
R2=0.84 


























(a) CI vs. Experimental power loss at eq. PR 


















     (b) CI vs. CFD power loss at eq. PR 
 
Figure 5.32: Cardiac index plotted against (a) normalized in-vitro power loss ( lossE& / 0E ), 




Since we have previously shown that the normalized minimum LPA cross-
sectional area correlated with increased experimental power loss, cardiac index and 
power losses were plotted together testing if they could be correlated as well. It can be 
seen from Figure 5.33, that cardiac index drops when the vessel area of LPA decreases, 
however there was no statistical significance. 
R2=0.70 
P = 0.07 
R2=0.11 


























5.4.4 Ventricular Power Output 
The circulatory power (or available mechanical energy) in the ascending aorta 
normalized by 0E is a measure of ventricular power output (
.
E ) relative to the patient’s 
TCPC power loss. Regression between this quantity, 0EE& (normalized ventricular 
power output), and the normalized minimum LPA cross-sectional area (N=13) also 
showed a negative correlation (P = 0.04) as shown in Figure 5.34. Figure 5.35a shows 
the statistical comparison of the ventricular power output between the EC and IA 
patients. The two populations had a statistically significant difference (p = 0.0336), with 
the ventricular power output relative to the TCPC power loss being higher for the IA 
population than for the EC population. Also note that the standard deviation among the 
IA population is higher. When comparing the same data between HLHS and non-HLHS 
patient groups there was no statistical significance (p = 0.4715) as seen in figure 5.35b. 
However a higher standard deviation in ventricular power output relative to the TCPC 
power loss was seen in HLHS patients as compared to non-HLHS patients. Figure 5.35c 
R2=0.38 






shows that among the HLHS patients, IA patients are associated with higher ventricular 
power output (p = 0.0558) and relatively higher patient-to-patient variability. 











Figure 5.34: Normalized Ventricular power output ( 0EE& ) plotted against minimum LPA 



































Figure 5.35: Power in the ascending aorta normalized with the TCPC dissipation scale, 
0εE&  compared between (a) EC (N=8) and IA (N=5) and (b) HLHS (N=6) and non-
HLHS group (N=7) (c) EC - HLHS (N=2), IA - HLHS (N=4), EC - non-HLHS (N=6) and IA 



































































































































Literature reviews show that, so far there exists no quantification of the geometric 
characteristics of the complex Fontan geometries. This motivated us to design the 
present study, whose main objectives were i) to develop a methodology to obtain the 
skeletalized representation of the TCPC ii) utilize this method to obtain the geometric 
characteristics of the Fontan models iii) correlate the Fontan geometries with their 
hemodynamics. 
As detailed in the previous chapters, we have developed a method to obtain the 
centerline approximations of the complex TCPC anatomies. This method was used to 
obtain the geometrical characteristics associated with the TCPC models. Quantifying the 
geometrical parameters of Fontan anatomies are useful to get a better insight of the 
geometrical characteristics of different Fontan templates. This information will come in 
handy for the surgical planning of Fontan surgeries, which is one of the overall 
objectives of the multi-center Fontan research program. In addition, this method also 
correlates some of the important geometrical parameters of TCPC like the vessel 
dimensions with the TCPC hemodynamics, especially the power loss. 
 The skeletonization methodology and its application to analyze the Fontan 










Skeletonization, a commonly used technique in pattern recognition and shape 
analysis applications is now finding more and more opportunities in the medical field. Its 
ability to provide accurate geometrical information of complex shapes is the main 
attraction of this approach. Among the various techniques available to obtain the 
centerline representation of geometries, we chose the technique that iteratively adjusts a 
path toward the central axis. The simplicity of the algorithm and ease of implementation 
of the program are the major reasons for selecting this approach. 
The basic principle of this method, as detailed in section 4.3, is to “slice” the 
geometry of interest into a series of frames and then define the geometric centerline as 
the line that connects the center of mass of each frame. However, such an approach is 
highly sensitive to the chosen slicing direction and may in some cases yield completely 
erroneous estimates of the geometry skeleton. Two major concerns are 1) though this 
technique tends to keep the path centralized the center of mass in a 2D slice may not lie 
along the central axis of the 3D structure and 2) this method does not guarantee that the 
path will stay within the geometry. In addition, when using the cross-sections obtained 
with the initial arbitrary slicing to perform further geometrical analysis, a commonly 
encountered problem was that the computed cross-sections did not actually correspond 
to the true vessel cross-sections. So to rectify these issues, an iterative procedure was 
added to the existing approach. The first iteration proceeds exactly as explained above, 
based on an arbitrary slicing direction prescribed by the user. In all subsequent 
iterations, however, the geometry is re-sliced in a direction perpendicular to the 






studies performed to test the accuracy and sensitivity of this method to obtain the 
geometric centerlines are discussed in the following section 
6.2.1 Validation Studies 
 
The validation studies were performed on idealized Fontan models. These 
models have uniform vessel diameters for all four vessels. In addition, the model was 
positioned such that in the non-rotated configuration, the vessel axes were exactly 
aligned with the Z coordinate axis for the IVC and SVC and the X coordinate axis for the 
LPA and RPA.  
Accordingly, the outputs expected from the skeletonization when applied to the 
non-rotated configuration were that: (i) the cross-sectional area plots of all four vessels 
should fall right on top of each other; (ii) the computed cross-sectional areas should be 
constant and equal to the design specification; and finally (iii) the computed center line 
should be parallel to the coordinate axis. The results shown in Chapter 5, demonstrate 
an excellent agreement between the theoretical and computed results in all respects.    
The motivation for testing the two orientations was to assess the effect of the 
initial slicing direction and also to measure the extent to which the subsequent iterations 
where able to correct the erroneous start.  Indeed, due to the 30 degrees rotation with 
respect to the center of the model, the vessel axes were no longer parallel to x or z – 
coordinate axes, which resulted in over estimated cross-sections after the first iteration. 
The main output of the skeletonization process when applied to the test-case was that 
the cross-sectional area plots obtained on the rotated configuration should be exactly 
identical to those obtained with the non-rotated one, As mentioned before, this aspect 







Since the computation of geometric skeleton is an automated process, the only section 
that needs user interaction in the entire procedure is where the user has to define the 
meeting point of each vessel at the TCPC junction. The variability in this judgment 
affects the length of the computed skeleton. Intra observer error in determining each 
vessel’s meeting point at the junction was calculated using 5 different users and the 
difference in the x, y and z co-ordinates of the point at the junction was quantified. The 
errors for all the four vessels were less than 5%.  A detailed table used for the 
calculation of intra observer error is added in Appendix B 
 
6.3 Geometrical Analysis 
 As mentioned earlier, quantifying the geometrical characteristics of various types 
of Fontan models was the main motivation of this study. We analyzed 26 TCPC models 
among which 13 were extra cardiac and 13 were intra atrial TCPCs. Among them, there 
was a subcategory of patients based on their clinical diagnosis as HLHS and non-HLHS, 
as shown in Tables 2.2 and 2.3. Another category was the group of patients with bi-
lateral SVCs and five models were studied in this section.  Finally, the last group was the 
patients whose MRIs were taken before and after the Fontan surgery, which included 3 
patients. Among these 3 patients, two were from the extra cardiac vs. intra atrial group 
(one each) and one was from the bi-lateral SVC group. Results of the geometrical 







6.3.1 Extra Cardiac Vs. Intra Atrial  
EC and IA anatomies result from different approaches to the surgical reconstruction 
of the Fontan baffle as described in the section 2.4.2. However, our results show that 
there is no significant difference in their baffle sizes. Instead the difference appears to be 
a higher standard deviation of the baffle cross-sectional area along its length in IA 
TCPCs when compared to EC TCPCs (Figure 5.10). Thus, it may be concluded that the 
IA baffle always has larger cross-sectional fluctuations than the EC conduit, which is to 
be expected as the former is constructed using part of the right atrium while a smooth 
and uniform graft conduit is used for the latter. The large standard deviation of the IVC 
cross-sectional areas observed in the IA TCPCs could also be the reason why there was 
no statistical significance between the IVC dimensions in IAs and ECs. No trends in the 
standard deviations of LPA and RPA could be detected. 
 IA patients showed significantly higher values in the ratio of mean cross-sectional 
areas of RPA to SVC, which is possibly because the TCPC junction for the IA and EC 
are not located at the same point on the native RPA. The native RPA anatomically 
decreases in diameter toward the right side, and the location on the RPA where the 
TCPC is constructed for the IA is possibly slightly shifted toward the left side compared 
to the EC TCPC. From a hemodynamic standpoint, the closer the TCPC is to the main 
pulmonary artery (MPA), the larger the PA sizes will be and thus the lesser the overall 
constriction in the flow transport. 
There was no statistical significance in the curvature of the vessels at the meeting 
point of the TCPC junction. The reason for the large standard deviation in the curvature 
of the RPA may be attributed to a particular geometry, CHOP013 shown in Figure 5.8, in 






As depicted in Figure 5.14.a, the IA Fontans have lower collinearity (nearly 
significant) value than their EC counter parts. As defined in section 4.5.3.2, collinearity 
values approaching zero can be interpreted as their IVC and SVC are oriented in a head 
on collinear manner. So IA Fontans have an increased chance of flow stagnation and a 
highly unsteady and dissipative interaction between the colliding flows, compared to that 
in ECs. Since most of the ECs analyzed in this study have bi-directional Glenn (BDG) as 
their 2nd stage and IA have hemi-Fontan as their 2nd stage (Tables 4.5 and 4.6, 
respectively) it could be attributed that the difference between BDG and hemi-Fontan 
procedures are most likely the reason for the observed difference in collinearity. As 
shown in Figure 5.14.b, hemi-Fontans had smaller collinearity (p = 0.0467), than their 
BDG counterparts. This is counter-intuitive since hemi Fontans have the SVC 
anastomosed posteriorly as compared to the BDG. Therefore, we expected more 
collinearity for Fontans with the BDGs as their 2nd stage.   
 
6.3.1.1 HLHS vs. non-HLHS Patients: 
Results in Figure 5.12 show that the minimum LPA diameter (region of smallest 
cross-sectional area) depends on both the patient’s single ventricle pathology (HLHS or 
non-HLHS) and also the surgical protocol (EC or IA).  
Figure 5.12c shows all possible combinations of the EC/IA and HLHS/non-HLHS 
categories (EC HLHS, EC non-HLHS, IA HLHS and IA non-HLHS) and the important 
conclusion is that, for HLHS patients who underwent IA surgery, the minimum LPA size 
is significantly smaller than their minimum RPA size (p = 0.0227). The trend is the same 
for HLHS patients who underwent EC surgery too but there is no statistical significance 
(p = 0.1562). The lack of significance may be due to the fact that the minimum RPA is 






previous section, makes the RPA area also small and thus reduces the relative 
difference between LPA and RPA cross-sectional areas. From these data, it is clear that 
the HLHS patients have a significantly constricted LPA, which, could be attributed to the 
aortic reconstruction procedure, where the reconstructed aorta appears to compress the 
LPA.  
Interestingly, for non-HLHS patients, results show that the minimum LPA size of the 
patients who underwent IA surgery was near-significantly smaller than the minimum LPA 
size of patients with EC surgery. The trend is the same for minimum RPA size but with 
no statistical significance. Precise reason for this observation cannot be distinguished 
from these data. 
6.3.1.2 Discrete and diffuse stenosis: 
There are two types of anatomically observed stenosis morphologies: (1) a discrete 
stenosis in which the vessel is constricted for a smaller vessel length and will be 
expanded after the constriction region (2) a diffuse stenosis in which the vessel 
constriction is observed for a longer length compared to the discrete stenosis. Figure 6.1 
shows the discrete and diffuse stenosis seen in two TCPC reconstructions used in this 
study.  
Among the 26 patients analyzed in the EC vs. IA study population, severe LPA 
stenosis was observed in 13 patients by visual inspection of their 3D reconstructions. 
Table 6.1 groups the stenosis seen in these patients as the discrete and diffuse 
categories. Among the six discrete stenosis cases, except CHOA009 all other patients 
have HLHS. Among the seven diffused stenosis patients 3 have HLHS (CHOA007, 
CHOP008 and CHOP092) and CHOP088 have a hyplostatic aortic arch that needs an 


























       (a) CHOP013            (b) CHOP092 
 
Figure 6.1: Two types of LPA stenosis: (a) discrete and (b) diffuse stenosis are shown 





Table 6.1: Patients having discrete and diffused LPA stenosis 
 






















6.3.2 Pre vs. post Fontan 
Pre Fontan patients have only their SVC attached to the pulmonary arteries, while 
the IVC still drains to the right atrium. Since the Fontan operation is performed after 12 
months to a couple of years after the second stage surgery, notable variations in the 
geometric characteristics were expected. However, the mean vessel cross-sectional 
area of the geometries showed surprising behavior after the surgery. For the SVC and 
LPA there was a small reduction in vessel area (Figure 5.18). These reductions in cross 
sectional area after the TCPC surgery could be due to acute post surgical trauma of the 
vessels. However, this could only be proved using the long-term follow up data on these 
patients, which were not available during the time of this study.  
Since there were only 3 pairs of patients in this study no statistical analysis could be 
performed. Also the patient distribution was in consistent; two were from the same 
hospital (CHOP) and the third one from CHOA, and one of the two datasets from CHOP 
had a bilateral SVC connection.  
Figure 6.2 shows the vessel cross-sectional areas for the 3 pre and post Fontan 
pairs. From this figure, it is clear that this reduction in area after the surgery was noted 
only for the two patients from CHOP, while the third pair from CHOA had an increase in 















Figure 6.2: Vessel cross-sectional area for all the vessels in the vicinity of TCPC for the 
three patient pairs before and after the Fontan operation is shown here. Note the 



































































































 The standard deviation of the cross-sectional areas along the vessel length did 
not vary significantly between the pre and post geometries for all vessels. This was 
expected, as the surgery does not involve any PA or VC vessel reconstructions. 
Similarly, the minimum vessel cross-sectional areas were approximately the same 
before and after the surgery for both of the pulmonary arteries. This re-confirms the 
previous observation (seen in Figure 5.12) that narrowing of the LPA could be due to the 
aortic reconstruction performed in HLHS patients during the 1st stage of the Fontan 
surgery and that 2nd or 3rd stage do not contribute to this phenomenon.   
 The larger standard deviation in the RPA curvature of post Fontans may be due 
to the higher curvature of the RPA of CHOP085 as seen in Figure 5.6. An increase in the 
vessel curvatures were observed for the right and left PAs of post-operative anatomies 
as compared to the pre-operative ones (Figure 5.21). Potential reason for such an 
observation could the addition of flaring and offset to the TCPC structure during the 
connection of IVC baffle onto the 2nd stage anatomy. 
 
6.3.3 Bilateral SVC 
 It is the presence of an additional SVC that differentiates bilateral SVCs from 
other Fontans. The TCPC connection aspects of bilateral SVCs are similar to other 
Fontans except the location of the IVC with respect to the two SVCs and the vessel 
dimensions of the two SVCs. As shown in Figure 5.7, for some cases the IVC was 
connected in between the two SVCs (CHOP032 and CHOP022), while for others the 
IVC was connected facing the RSVC (CHOA039 and CHOP019).  
Comparison between the mean vessel cross sectional areas of right and left SVC 
for the 5 bi-lateral geometries, showed that both the vessels have a similar cross 






lateral SVCs with their Fontan counterparts. As explained in the results section 5.3.3.1, 
all five bi-laterals in this study had an extra cardiac connection for their TCPC. So we 
decided to choose EC TCPC for comparison purposes. Also RSVC of the bi-lateral 
model was used to compare with the SVC of EC Fontan. This is because, in most of the 
bi-lateral SVC’s it is the RSVC that is connected near to the IVC and the LSVC is located 
more towards the left lung.   
There was no difference between the vessel areas of the pulmonary arteries. 
However, RSVC of the bi-lateral model showed smaller cross sectional area when 
compared to the SVC of the EC TCPC. Table 5.3 shows that LSVC also had the same 
trend (Mean vessel cross sectional areas for each of these vessels are: RSVC = 
0.95X10-4, LSVC = 1.07 X10-4, and EC SVC = 1.34 X10-4). IVC cross sectional area of 
the bi-lateral model was also less than the EC IVC area. Area variation across the vessel 
length for RSVC and LSVC showed a higher variation on the LSVC. 
 Because some of the models have their IVC connected directly to the PAs, no 
intra group comparison seems fair for the vessel curvature and offset analysis as the 
computation of these parameters involve the meeting points of the vessels at the 
connection site. For bi-lateral SVCs it was hard to define a TCPC junction point for the 











6.4 Anatomy vs. Hemodynamics 
As discussed in the previous section, comparison of the extra cardiac and intra 
atrial geometries showed that minimum LPA diameter is the most distinguishing 
geometric feature and is intimately related to both the underlying pathology (HLHS or 
non-HLHS) and surgery type (EC or IA). In this section, we examine the influence of 
geometric factors on the patient’s in-vitro and in-vivo hemodynamics, with a specific 
emphasis on the minimum PA diameter. Essentially, this section tries to answer the 
following questions: “Do the anatomic characteristics of the TCPC impact its 
hydrodynamic efficiency?”, and “Does this affect the functioning of the single functioning 
ventricle?” What is shown in the following subsections is that the minimum PA diameter 
is the most important geometrical parameter that has the highest impact on TCPC 
hemodynamics and that it does  in turn significantly impacts patient cardiac output and 
ventricular loading. 
 
6.4.1 TCPC Power Loss: 
From the experimental power loss plot shown in Figures 5.25, it is clear that 
minimum LPA size, which is a measure of the geometric bottleneck of the TCPC, is the 
primary influencing factor in determining the TCPC efficiency, with lossE& / 0E scaling 
inversely with minimum LPA area. This correlation was stronger in the 50-50 pulmonary 
flow split condition. However, no significant correlation between the minimum vessel 
area and power loss was seen with MRI flow split condition or at equal pulmonary 
resistance (Figures 5.26 and 5.27). However, when looking at the values of the 






with unbalanced PA dimensions lead to unbalanced flow splits and lung perfusion (Ex: 
CHOA008 with an RPA stenosis, CHOP013 with an LPA stenosis). 
This re-confirms the fact that, in the actual Fontan physiologic condition, the flow 
splits are naturally adjusted to incorporate any vessel narrowing like an LPA stenosis. In 
order to shed further light on this phenomenon, let us consider a simple Poiseuille flow in 
a rigid straight pipe. The relationship between pressure drop, P∆ , across the pipe and 







−=∆  (6.1) 
where R is the pipe radius, L is the pipe length and υ  is the dynamic fluid viscosity. 
Based on this simple example, we can see that in a straight pipe the resistance opposed 
by the pipe to the flow scales as 4−R . Given the choice between two pipes with radii R1 
and R2 such that 21 RR < , the pressure drop required to force a flow rate Q through pipe 
1 will be higher than through pipe 2, which in terms of power losses translates into 
higher power loss in pipe 1 than pipe 2 for a given flow rate. Accordingly, if one of the 
PAs is constricted, decreasing (up to a certain point) the share of the flow going through 
the constricted vessel will decrease the overall power losses. This is basically what 
comes out of the MRI flow splits listed in Table 6.1. Given a constriction along the 
vasculature, the body tends to redistribute the flow to minimize energy losses along the 
way. Thus when more flow is imposed on the constricted vessels, this results in higher 
power losses within the TCPC. For example, as shown in Table 5.6, the CHOP013 
geometry results in a larger power loss at 50-50flow split compared to the MRI condition 
(PL 50%lpa = 135.99mW vs. PL MRI = 11.50mW) and this geometry has a severe LPA 







Table 6.2: MRI flow split conditions for the six experimental models computed using the 


















      
CHOA007 1.01 1.03 1.04 0.929 50-50 
CHOA008 0.93 1.37 0.57 1.28 70-30 
CHOP013 1.85 1.42 1.37 0.83 60-40 
CHOA009 0.82 1.15 1.03 1.08 50-50 
CHOA011 2.56 1.48 0.72 2.47 80-20 
CHOP034 3.31 1.93 1.85 2.27 55-45 
  
 
When evaluating the power loss values obtained from the CFD simulations, (as 
shown in Figures 5.28-5.30), it was the minimum RPA area that exhibited the highest 
correlation. This suggests that efficiency of TCPC depends highly on the outlet vessel 
diameter (i.e., either LPA or RPA).  To further confirm this observation, the minimum PA 
values were plotted against the power loss obtained from both CFD and experimental 
studies as shown in Figure 6.3.   A combined plot showing the power loss from the two 



























(a) CFD power loss 
 
 

















(b) Experimental power loss 
Figure 6.3: Minimum PA values of RPA and LPA plotted against the normalized power 
loss  ( lossE
&
/ 0E ) at MRI flow split condition obtained from (a) CFD; (N=9) and (b) 
experimental (N=6) studies. The CHOA008 model with a severely stenosed RPA is 























Figure 6.4: Minimum PA values of RPA and LPA vs. the power loss obtained from both 
CFD (blue) and experimental (red) studies at MRI flow split condition (N=15). The 













 Good correlation between the minimum vessel areas of the PAs and the power 
loss are seen in these figures except for Figure 6.3b, which is the experimental power 
loss condition. Further investigation showed that the low correlation was due to one 
particular data set used in experimental power loss, CHOA008. The anatomic 
reconstruction of this data showed a severely stenosed RPA (Figure 6.5 a). However, 
when the model was used for experimental analyses, the stl file used to create stereo- 
lithographic model of CHOA008 was sliced before the stenosis site (see Figure 6.5b). 
When the plot shown in Figure 6.3b is redrawn without CHOA008, the R2 value jumps to 
0.96 indicating a very strong correlation (see Figure 6.6a). Similarly for the combined 
plot of CFD and experimental vs. min PA area, the correlation coefficient increased to R2 
= 0.91 (see Figure 6.6b). This again confirms the fact that any narrowing of the 
pulmonary arteries could result in a larger power loss within the TCPC. 
                    (a)        (b) 
Figure 6.5: (a) 3D anatomic reconstruction of CHOA008. Red bar shows the point where 
the RPA was sliced for making stl model and the black arrows shows the severe RPA 
stenosis. (b) The stl model of CHOA008 used for experimental study. The end of the 







        


































    
(b) 
Figure 6.6: Minimum PA values of RPA and LPA plotted against the normalized power 
loss ( lossE
&
/ 0E ) at MRI flow split condition obtained from; (a) experimental (N=5) studies 
alone and (b) experimental and CFD studies combined (N=14), after removing the 
CHOA008 point, which was used for experimental studies.  
 
The highest correlation coefficient (R2-value) of 0.96 for the power loss vs. 
minimum LPA area (see Figure 5.25c) for the experimental studies shows that all other 
relevant geometric parameters have second order effects in relation to the minimum LPA 
area. From a fluid mechanics standpoint, the relationship between lossE& / 0E  and the 
geometry is multivariate with possible varying non-linearities associated with each 
R2=0.96 
P = 0.04 
R2= 0.91 






parameter. Given the extent of correlation observed in Figure 5.25c, the trends observed 
in Figure 5.25a, b, and d cannot be the true trends with respect to the corresponding 
variables (minimum vessel areas of IVC, SVC and RPA). Due to the small sample size a 
multivariate analysis was not possible in this study. As a result, the dominating influence 
of the minimum LPA area could mask out the real trend of other geometric parameters. 
For example, the increasing trend for lossE& / 0E with minimum RPA area does not make 
physical sense, as clearly a reduction in RPA diameter (e.g. RPA stenosis) must 
increase the power loss. By plotting the ratio of lossE& / 0E  with the power-law fit from 
Figure 5.25c, i.e. further indexing the data with respect to minimum LPA area, it was 
found that the trend reversed thus showing that lossE& / 0E  does increase with decreasing 
RPA minimum area when accounted for the confounding minimum LPA area. Figure 6.7 
shows the power loss plots for the experimental studies after indexing with the power-
law fit from the LPA plot (Figure 5.25c) for minimum vessel areas of IVC, SVC and RPA. 
Note that, the IVC plot, which showed a decreasing power loss with increasing IVC area, 
also had a less significant trend after removing the effect of the LPA. 
While our data cannot provide the complex functional relationship between 
lossE& / 0E and all the geometric parameters, it is however sufficient to show that minimum 
PA area is the most important factor in determining TCPC power loss rate when 










       
Figure 6.7: Normalized experimental power loss ( lossE
&
/ 0E ) at 50-50 flow splits and all 
the cardiac output indexed with the power-law fit of LPA plotted against the minimum 
cross-sectional areas of: (a) IVC and (b) SVC and (c) RPA.  
 
 
In addition to the pulmonary arteries, the IVC also showed a strongest correlation 
with power loss, (with R2 values around 0.5). This was observed in both experimental 






































































cases. This strong correlation between power loss and minimum IVC area could be due 
to the fact that, an input flow split of 60-40 is assigned between IVC and SVC for both 
experimental and CFD studies. Especially, in case of 50-50 flow split, it is the IVC that 
carries the highest flow rate (IVC – 60%, SVC – 40% and LPA and RPA – 50% each). 
This relation was clearly seen in the figures 5.25 and 5.28 that plotted 50-50 flow split 
condition for both experimental and CFD studies (with R2 values of 0.50 and 0.61, 
respectively). Also because of this high flow rate in the IVC, when there is a vessel 
constriction in IVC, it will show a power loss. As seen in figures 5.6 and 5.7, some of the 
IVC vessels show severe constriction in the vessel cross-sectional areas (Eg; CHOP 
018, CHOP034, CHOP037).  This could also impact the power loss.  
 
Given the statistical significance of the standard deviation of IVC area, we 
examined if this geometric parameter correlated with lossE& / 0E . Since the ratio of the 
standard deviation to the mean is a measure of in homogeneity, higher losses for larger 
values of this ratio are expected, analogous to the effect of wall unevenness in simple 
pipe flows. However, there was no significant correlation (Figure 6.8).  To further 
investigate the correlation between IVC area variance and power loss, power loss from 
both CFD and experiments were plotted separately for EC and IA TCPCs. However, no 
significant correlation was seen for both the categories at MRI condition and at 50% flow 
















































   
   (a)      (b) 
Figure 6.8: Normalized experimental power loss ( lossE
&
/ 0E ) at 50-50 flow splits and all 
the cardiac outputs plotted against IVC area standard deviation (a) with and (b) without 


































(a) MRI flow split for EC TCPC                  (b) MRI flow split for IA TCPC 






























(a)   50-50 flow split for EC TCPC                  (b) 50-50 flow split for IA TCPC 
 
Figure 6.9: Cardiac index plotted against the normalized power loss ( lossE
&
/ 0E ) from 
CFD and experimental studies combined at MRI flow split for (a) extra cardiac TCPC (b) 
intra atrial TCPC and at 50-50 flow splits for (c) extra cardiac TCPC (d) intra atrial TCPC. 













This once again points out that the primary confounding variable is the minimum 
PA diameter (in this case the LPA), and the notion that a large “fluctuating” IVC 
morphology produces higher power loss appears to be a second order effect. The 
dominance of size vs. shape with respect to power loss is in fact classical. Even in 
simple pipe junction flows, the pipe diameter plays a more dominant effect on power loss 
than surface roughness or other geometric shape factors (angle, curvature etc). Similar 
to standard deviation of IVC area, we have seen that there was no significant correlation 
for any of the other parameters calculated, namely collinearity and offset. The correlation 
of power loss vs. these parameters with and without the LPA effect is shown in Figures 









































   (a)      (b) 
Figure 6.10: Normalized experimental power loss ( lossE
&
/ 0E ) at 50-50 flow splits and all 

















                (a)           (b) 
Figure 6.11: Normalized experimental power loss ( lossE
&
/ 0E ) at 50-50 flow splits and all 




6.4.2 Cardiac Index: 
The Result section extensively investigates the relationship of power losses to 
different geometrical features of the TCPC. However, this approach only provides a local 
measure and does not grant that the local TCPC hemodynamics truly impact the whole 
cardiovascular system. Cardiac index was thus brought into the picture as a metrics that 
is representative of the performance of the whole cardiovascular circuit. Results show 
that minimum LPA diameter is inversely correlated with power loss (Figures 5.25c) and 
positively with cardiac index (Figure 5.33). The direct translation of these correlations is 
that a stronger vessel constriction (smaller minimum LPA diameter) corresponded to 
higher energy dissipation in the TCPC (higher power loss) as well as to a lower cardiac 
index. To more quantitatively assess the relationship between those three parameters, 
Figures 5.25c and 5.33 are collapsed into a single one in Figure 6.12. The black data 
points and trend-line represent the cardiac index data, while the red trend-line 













































the in-vitro experimental power loss shown in Figure 5.25c, leading to the following 
























QEloss ρ  (Watts)                             (6.2) 
The display retained for Figure 6.12 shows the impact of minimum LPA area on 
both power loss within the TCPC itself and on the cardiac index on the same graph. For 
a given minimum LPA area, the corresponding cardiac index can be read by taking the 
point on the cardiac index curve (shown in black in the figure 6.12) and reading its 
coordinate on the left axis. Similarly, the corresponding normalized power loss through 
the TCPC can be read using the red curve along with the right axis. It can thus be seen 
that (Figure 6.13 shows the details of this calculation), a normalized minimum LPA area 
of 3 X 10-5 corresponds to a normalized power loss of 1.3 X 108 and a cardiac index of 
2.75L/min/m2, while a normalized minimum LPA area of 9 X 10-5 corresponds to a 
normalized power loss and cardiac index of 0.4 X 108 and 3.25 L/min/m2, respectively. 
By plotting these three variables together, it is thus evident that energy dissipation 
across the TCPC and cardiac performance (via the cardiac index) are intimately related, 
and a variation in the TCPC power loss can impact the resting cardiac index by up to 
50%. 
Finally, it should be noticed that the power loss relation given in Equation 6.2 has 
an exponential relationship to both minimum LPA area, LPAmin, and flow rate, Q. 
Accordingly, if a small variation in LPAmin was shown to have a strong impact on power 




























Figure 6.12: Cardiac index plotted against normalized LPA minimum area. Also depicted 
is Equation 6.2 in red color, which shows the relation between TCPC power loss and the 
minimum LPA area.  
 
Figure 6.13: Cardiac index plotted against normalized LPA minimum area along with the 
TCPC power loss (shown in red).  For ease of reading the graph, readings correspond to 
two LPA areas 3 X 10-5 and 9 X 10-5 is explained here. PL1 and PL2 (shown in green) 
correspond to the power loss for the LPA areas 3 X 10-5 and 9 X 10-5 respectively, 
while CI 1 and CI2 (shown in blue) are their respective cardiac indices.   
 
Even though a statistically significant correlation was seen between the minimum 
LPA area and cardiac index, no significant relationship could be identified when the 










                   














Figure 6.14: Cardiac index plotted against normalized minimum PA area. No significant 
correlation was seen in this case. 
 
 
6.4.3 Ventricular power output: 
The high regression and low P value (0.04) betweenE& / 0E and the normalized 
minimum LPA diameter confirm that the ventricular power output increases with 
decreasing PA diameter (increasing resistance), especially with the minimum LPA which 
showed the highest correlation. In other words, the single ventricle pump has to increase 
its power if there is an increase in the resistance. However, considering that the cardiac 
index decreased with decrease in minimum LPA diameter, the heart is not only pumping 
harder (at increased resistance) but also fails to compensate by providing sufficient 
cardiac output. The statistical significance (p = 0.04) of this result underscores that the 
TCPC geometry (in particular the minimum PA size) is extremely important since it does 
impact ventricular function and loading. Furthermore, the data shown in Figure 5.34 only 
correspond to resting conditions, which means that if the single ventricle fails to 
compensate under resting conditions, exercise conditions will be extremely challenging.  
Given that the minimum LPA diameter is intimately related to both TCPC 
geometry (i.e. EC or IA) and pathology (i.e. HLHS or non-HLHS) as shown in Figure 
5.12, the study Group 1 (IA vs. EC) was further subdivided according to patients’ 
R2=0.06 






diagnosis for a deeper examination of ventricular power output as a function of these 
variables. While Figure 5.35a shows that the ventricular power output for IA TCPCs is 
higher, the impact of the TCPC on the non-HLHS patients clearly seems less severe 
with a lower workload than in HLHS patients. This finding, juxtaposed with previous 
results on the performance of HLHS and non-HLHS patients [Sundareswaran, 2006], 
reveals a clear message: i.e, hypoplastic left ventricles, which are poor pumps to begin 
with, unfortunately need to work harder than their non-HLHS counterparts. Figure 5.35c 
shows all possible combinations and shows that among the HLHS patients, IA TCPCs 
are associated with higher workloads than EC TCPCs. The figure also shows that the 
ventricular power output for EC TCPCs is about the same for both HLHS and non-HLHS 
patients. Therefore, it may be concluded that EC surgery is beneficial to the ventricle 
irrespective of whether the patient has HLHS or not. However, the precise reason for this 
finding needs further research and understanding of the Fontan physiology.  
As discussed earlier, it has been shown that the lower minimum LPA sizes in 
HLHS patients is due to their aorta reconstruction, in which the aorta anatomically rests 
on the LPA, causing LPA stenosis. In order to support this finding a reconstruction of 
one of the non-HLHS patient anatomy is presented here and compared to an HLHS 
patient anatomy (Figure 6.15). We would like to emphasize that the LPA, which passes 
under the aorta is extremely susceptible to physical contact forces. An enlarged aorta as 
seen in HLHS patients easily constricts space available for LPA and may limit growth of 







   
 
Figure 6.15: Reconstructed anatomy of the heart and TCPC of a non-HLHS patient 
depicted by (a) coronal perspective and (b) sagittal perspective compared against 




Another important factor about the aortic reconstruction is that, though all the 
patients diagnosed with HLHS need aortic reconstruction, not all patients with aortic 
reconstructions have HLHS.  For example, among the patients analyzed in this study, 
CHOP088 (see Table 6.3) is a patient with no HLHS. But, the clinical data shows that 
this patient has hypoplasia of the aortic arch, which needs an aortic reconstruction 
similar to the HLHS patients.  The narrowing of the LPA is seen for this patient as in the 






patients (both EC and IA) along with their clinical diagnosis and points out that among 
these patients who all needed an aortic reconstruction. 
 




















EC – extra cardiac; Hemi - hemi-Fontan; BDG - bidirectional glenn; HRHS - hypoplastic 
right heart syndrome; HLHS - hypoplastic left heart syndrome; TA - tricuspid atresia; 
ASD - atrial septal defect; VSD - ventricular septal defect; SV - single ventricle; LV - left 
ventricle; RV - right ventricle; DI - double inlet; DO - Double Outlet; TGA - transposition 
of great arteries; DX – dextrocardia; AA - aortic arch; PA - pulmonary atresia; MA -Mitral 






CHOA007 HLHS Yes 
CHOA008 HRHS,TA No 
CHOP006 HLHS Yes 
CHOP007 HRHS, Ebstein’s anomaly Yes 
CHOP013 HLHS, ASD Yes 
CHOP067 SV-DI LV,VPS-TGA Yes 








CHOP089 TA,VSD No 
CHOP090 PA,IVS,           RV-Hypertrophy No 
CHOP091 DO-RV,IVS,MA,PA No 
CHOP095 DI LV,PA No 



































IA -intra atrial; Hemi - hemi-Fontan; BDG - bidirectional glenn; HRHS - hypoplastic right 
heart syndrome; HLHS - hypoplastic left heart syndrome; TA - tricuspid atresia; ASD - 
atrial septal defect; VSD - ventricular septal defect; SV - single ventricleAV - 
atrioventricular; DI - double inlet; TGA - transposition of great arteries; DX – 








CHOA004 HRHS,TA, VSD, PS No 
CHOA009 SV-DI AV connection No 
CHOA011 HLHS Yes 
CHOA027 
HRHS, TGA, 
TA, VSD, LPA 
hypoplasia 
Yes 
CHOP008 HLHS Yes 
CHOP018 HLHS, ASD Yes 
CHOP030 TA, VSD No 
CHOP034 HRHS,SV,DX, TA,VSD,PS No 
CHOP037 PA, HRHS No 
CHOP068 HLHS Yes 












6.4.4 Pulmonary Vascular Resistance: 
 Systemic and pulmonary vascular resistance (SVR and PVR, respectively), 
based on catheter measurements was available for five of the twenty-six patients 
analyzed in this study. Figure 6.16 shows the SVR and PVR for the five patients plotted 
against their respective power loss.  From this figure it is clear that, though the 
correlation coefficient R2 was small, when the resistance increase, the power loss also 
increase for both SVR and PVR.  
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Figure 6.16: Normalized power loss ( lossE
&
/ 0E ) at the MRI flow split condition plotted 
against (a) pulmonary vascular resistance, PVR normalized with BSA and (b) systemic 













6.5 Clinical Significance 
In this study, we showed that vessel diameter; especially pulmonary artery 
diameter, is the most influential among all the TCPC geometric parameters. Among the 
pulmonary arteries, LPA diameter was observed to have the highest correlation with 
power loss within the TCPC, while all other geometric characteristics had only secondary 
effects. The IVC curvature and IVC-SVC offsets did not impact the power loss as much 
as the PA diameter but are possibly beneficial in reducing the PA vessel narrowing by 
allowing enough blood flow through these vessels. However, orienting the IVC towards a 
stenosed PA causes higher power losses and lower the cardiac output from the 
ventricle. Hence a right balance between the two competing factors is necessary. 
The geometrical comparison between the two commonly used TCPC templates, 
extra cardiac and intra atrial TCPCs, showed that of among all the geometric 
parameters, it is the minimum PA diameter that impacts the TCPC efficiency 
significantly. Hence, it is apparent that a critical step for the hemodynamic improvement 
of the TCPC hemodynamics is to correct the stenosis of pulmonary arteries. Indeed the 
presence or absence of stenosis was shown to have a much more drastic effect than the 
type of TCPC template retained. Such observation concurred with previous studies by 
Ryu et al. [Ryu, 2001] and De Zelicourt et al (De Zelicourt, 2005], which state that most 
of the power loss measured in the TCPC may be attributed to wall friction (which for a 
given flow rate will drastically increase with decreasing vessel diameter) rather than to 
the connection design. 
In this study, the majority of the patients had LPA stenosis than RPA stenosis and 
among them a majority had also been diagnosed with hypoplastic left heart syndrome. 
As mentioned in the discussion section, the relation between those two symptoms may 






From the clinical data available for the patients in the Fontan database, 29 out of 56 
HLHS patients were reported to have significant LPA stenosis (data as of March 2007). 
Thus surgeons should either optimize the aortic reconstructions providing ample space 
for LPA growth or use effective and permanent methods to repair the stenosis to make 
an efficient TCPC. 
With respect to the impact of the TCPC on the ventricle, we have shown that the 
TCPC indeed makes a significant impact on ventricular function. LPA narrowing which 
only causes a few hundred milliwatts of power loss can in fact reduce the resting cardiac 
output by 50%. This will have a huge impact on the exercise capacities of these younger 
patients and thus significantly affect their quality of life. Also, hearts with a single 
functioning right ventricle (HLHS) need to work harder than hearts with a single 
functioning left ventricle (non-HLHS).  So the impact of the TCPC could be greater in 
HLHS patients than their non-HLHA counterparts. This could also leads to low exercise 
tolerance in HLHS patients.  
Since the geometrical characteristics of bi-lateral SVC models are similar to the 
other Fontans, the focus should be on where to connect the IVC with respect to the 
SVC. Previous findings show that that IVC should be connected in between the two 
SVC’s for better lung perfusion [de Zelicourt 2006]. 
Breaking down the TCPC into a simpler set of geometrical parameters may be 
difficult as one could potentially neglect some of the most important factors. Correlation 
of geometric features and hemodynamic factors is thus a critical safe guard that 
assesses whether the parameter retained plays a significant role and whether an 
important parameter has been left out. Such an approach is very valuable to the growing 
surgical planning field. The basic idea behind the current surgical planning approach is 






them to envision and test the efficiency of different possible configurations for the 3rd 
stage. Ideally, the geometric optimization of the 3rd stage could even be completely 
automated, with the surgeon only checking for the feasibility of the outputted solutions. 
However, given the complexity of the geometries considered and the range of possible 
surgical methods, optimization may be a very tedious process. By pinpointing which 
parameters should be initially optimized, this study may significantly ease the process. 
The geometrical parameters obtained in the pre and post pairs and their evolution 
through time, may also be very valuable when trying to model more realistic TCPCs and 
their evolution with time. Finally, the skeletonization tool described in this study may be 
used as a diagnostic tool, helping the clinicians quantify variations in the Fontan 






















LIMITATIONS OF THE STUDY 
 
Though the method of skeletonization proved to be useful in estimating the 
geometrical characteristics of complex TCPC anatomies, this method has certain 




 The key methodology that has been developed and implemented as a part of this 
study, “the skeletonization” technique is capable of estimating the centerline of the 
geometry and extracts its geometric characteristics. However this method has certain 
limitations that are described below. 
 
7.1.1 Semi automatic Program 
 In its present form, this method is a semi-automatic program. User intervention is 
required to do the slicing, which is one of the key steps in performing the centerline 
calculation. Visualization software Tecplot (Tecplot Inc., Bellevue, WA) has to be used 
along with the execution of the ‘C’ program for two purposes: (1) to input the starting and 
end frames of the vessel for centerline computation; and (2) to make sure that no slice 
overlapping occurs and only appropriate slices are inputted to the program for iteration.   
Another limitation is that batch processing of multiple input files is not feasible at 






each iteration. Though the processing time of the program is less than a minute, user 
intervention makes the over all processing time longer. 
 
7.1.2 Vessel Branching 
 The design of this program is such that a starting frame and an ending frame of 
the geometry have to be defined by the user for the centerline estimation. For a normal 
TCPC this is not a problem as we are interested in one vessel at a time for better 
comparison. However, estimating the centerline at the connecting point is still a problem 
with this method as it involves at least three vessels at a time. Also, this program is not 
efficient in estimating the centerlines of branched vessels like coronary arteries due to 
the same reason. So each vessel centerline has to be computed separately and merge 
together using Tecplot (or similar visualization software). 
 
7.1.3 Accuracy 
Though the accuracy of this method has been validated using idealized TCPC 
models, it depends heavily on the input slices. Hence it is necessary to make sure that 
no slice overlapping occurs during the geometric slicing. The overlapping occurs in 
cases where the vessel is curved or has a sudden change in its curvature. During such 
situations the user has to manually remove the overlapping slices to obtain a smooth 
centerline curve. 
7.2 Geometric Analysis    
 The small sample size was an issue during the geometrical analysis, especially 
when comparing the geometric characteristics of the pre and post Fontan surgical pairs. 






performed. This prevented us from drawing any clinical correlations. Similar was the 
case of bi-lateral SVC models in which only five models were available for analysis. 
 
7.3 Hemodynamic Efficiency Analysis  
 Since this work was a retrospective study that uses the existing Fontan data 
base rather than a prospective study, not all the models selected for the geometrical 
analysis had all the hemodynamic parameters needed for specific aim 3, which was to 
correlate Fontan geometry with its hemodynamics. This resulted in uneven sample sizes 
for comparison of power loss (N = 15), cardiac index (N=26) and ventricular power 
output (N = 13) with the geometric parameters. 
The relatively low sample size of the in-vitro energy loss experiments, ruled out a 
multivariate statistical analysis. However, we do show that the data are sufficient to show 
that the LPA size is the dominant variable, while all the other geometric parameters have 
second order effects. But with nine datasets, the CFD power loss showed that RPA 
vessel dimension is significantly correlated with the power loss. This points out that it is 
the minimum PA vessel dimension that is the main bottleneck. Addition of few more 


















In this study, details about the geometric parameters associated with Fontan 
anatomies, specifically the vessel cross-sectional areas, vessel offset and curvature are 
analyzed. These parameters help to us quantify the geometric features of the commonly 
used Fontan templates – extra cardiac TCPC, intra arial TCPC, pre Fontan anatomies 
and bi-lateral SVC. Also some of the important anatomic correlates of the TCPC 
efficiency are extracted out as a part of the analysis. 
 
8.1 Skeletonization Method – Specific Aim 1 
 A method to compute the geometrical characteristics of complex TCPC 
anatomies such as vessel dimensions, vessel offset and curvature has been developed 
and successfully implemented as a part of this study. This technique uses the centerline 
approximation of geometries for computing the geometrical details. By pre-selecting the 
vessels that need to be processed, all the different Fontan templates irrespective of the 
number of vessels can be processed by this technique. 
 
8.2 Characterization of Fontan Geometries – Specific Aim 2 
 Geometric characteristics of three types of Fontan templates were analyzed in 
this study. They are: 
o Extra cardiac and intra atrial geometries 






o Pre and post Fontan geometries 
o Bi-lateral SVC geometries 
Since two types of TCPC anatomies, extra cardiacs and intra atrials, 
mainly dominate our database, these anatomies were analyzed in-depth. Comparison 
between the TCPC geometries of these two models showed that it is not the vessel 
cross-sectional area of the IVC baffle but the area variation across the vessel length is 
the significantly different parameter. Interpretation of the collinearity values suggests that 
the orientation of the IVC and SVC for intra atrials is in a more head on colliding manner 
than the extra cardiacs. Another major observation is the narrowing of the LPA 
compared to the RPA irrespective of their TCPC surgical type. Further investigation 
showed that this difference is more predominant in patients diagnosed with hypoplastic 
left heart syndrome (HLHS). This suggests that the narrowing of the LPA could be due to 
the aortic reconstruction performed during the 1st stage of the Fontan surgery in HLHS 
patients, which causes compression on the LPA. 
From the three pre-post surgical pairs studied, a small reduction in the 
vessel cross sectional areas is noted for SVC and LPA. However, this could be due to 
the acute surgical trauma as detailed in the discussion section. No narrowing of the 
pulmonary arteries are observed before and after the TCPC surgery, which confirms the 
fact that LPA narrowing could be due to the aortic reconstruction performed in the 1st 
stage of Fontan. 
The analysis of vessel cross sectional areas of bi-lateral SVC anatomies 
showed that the both RSVC and LSVC have same vessel areas. However, LSVC shows 






8.3 TCPC Geometry vs. Hemodynamics – Specific Aim 3 
Among the various geometrical parameters analyzed, it was the minimum PA 
diameter of the TCPC that had the highest impact on TCPC efficiency. Both LPA and 
RPA when plotted against the experimental and CFD power losses respectively, showed 
significant correlation values (R2=0.88 for LPA and R2=0.78 for RPA). Further 
investigation using the minimum LPA diameters showed that, in addition to the TCPC 
efficiency, this vessel narrowing in fact also impacted the patient cardiac index and the 
ventricular power output. Since the results in this study correspond to resting cardiac 
output, the effect is expected to be even higher under exercise conditions. Another 
important observation is that for patients with HLHS the ventricular power out was 
greater than their non-HLHS counter parts. In conclusion, more attention should be 
given to the pulmonary artery sizes during the first stage of Fontan surgery so as to 























RECOMMENDATIONS FOR FUTURE WORK 
 
In this study, we developed and implemented a skeletonization method to extract 
the geometric characteristics of complex TCPC anatomies. This methodology was 
applied to 34 Fontan patients selected from our patient database. Breaking down the 
complex patient-specific anatomies into a set of geometric parameters allowed us to 
quantitatively compare the different anatomies and pinpoint recurrent geometric 
features. These parameters were also correlated with a metrics for TCPC efficiency 
(power losses) thus isolating critical parameters for the improvement of the TCPC 
procedure. The first application demonstrated the strength and relevance of our 
approach for the hemodynamic analysis and optimization of the TCPC. This leads the 
way for future endeavors both technical, in order to improve the program’s efficiency, 
and clinical, to further explore the intricacies of the TCPC anatomy. Both aspects are 
detailed in this chapter, starting with the technical development and then moving into 
future studies of the Fontan anatomies.  
 
9.1 Technical Improvements to the Skeletonization Approach 
9.1.1 Program Automation 
The skeletonization program in its present form needs regular user intervention. 
The user has to manually enter the input and output file names for all iterations. Also, 
user intervention is needed to visually inspect the convergence of the centerlines 






less than 30 seconds, these user interventions increase the overall processing time. In 
order to further improve the efficiency of the over all procedure, this program can be fully 
automated using additional coding.  
By modifying the existing program, input file names can be automatically plugged 
in to the code. By automatically updating the file names after each iteration, the need for 
manual data entry can be fully removed from the skeletonization protocol. Appropriate 
convergence criteria, like distance between the centroids of two consecutive iterations 
approaching zero, could be used to test the convergence of the centerline rather than 
visual inspection. 
 Thus, by fully automating the entire skeletonization (1) manual data entry can be 
avoided and (2) overall processing time can be substantially reduced (3) In addition, a 
fully automated code will enable batch processing applications, which will be a critical 
feature for large scale analysis of our anatomical database. 
 
9.1.2 Processing multi branch vessels 
 The algorithm implemented in this study considers the geometry of interest as a 
stack of contiguous “slices” and computes the centerline as the line going through the 
center of mass of the vessel cross-section in each one of the “slices”. That approach 
works well in most cases, but problems may arise if the geometry has multiple branches. 
Indeed, the “slices” required for the computations are obtained by intersecting the 3D 
anatomy with a plane. In certain cases, this plane may intersect two or more vessels, so 
that the corresponding “slice” will actually contain two or more vessel cross-sections. In 
the current implementation, the program does not have the ability to distinguish among 
these and will retain all cross-sections present for the subsequent centerline 






centerline, which may even fall outside of the geometry. A potential solution may be to 
add selection criteria into the program that will allow the code to first detect that there are 
multiple distinct cross-sections present in the “slice” and then choose which one is the 
one that corresponds to the vessel of interest. Such procedure should overcome the 
issue of processing branched vessels thus yielding a more general code formulation and 
application as well as reducing the processing time by reducing the amount of user 
intervention and control.  
 
9.2 Future Studies of the Fontan Anatomy 
9.2.1 Evaluate Geometric Changes Over Time  
The Fontan surgery is usually performed during the patients’ early childhood. It 
will thus be interesting to look at the changes in the vessel dimensions and other related 
parameters like power loss and flow characteristics over the years as the child grows. In 
this study, an effort has been made to look into the pre- and post-Fontan stages of the 
same patient. This gave a first insight into how vessel dimensions evolve with time. 
However, since there were only 3 patient pairs available for the analysis, no strong 
conclusion could be made. It would thus be interesting to scan the same patients at 
multiple points in time so as to perform a detailed study on the evolution of the Fontan 
geometry. Time-points of interest could be (1) right before and right after the 3rd stage of 
the TCPC (pre/post pairs), (2) shortly after the surgery and a few month later to try and 
assess the impact of the magnitude of the acute response to the surgery and its impact 
on the hemodynamics, and/or (3) two time points after the surgery that would be 






as the patient grows and assess how much control the surgeon truly has over the final 
TCPC geometry.  
This study could be helpful in the development of the surgical planning tool, 
which is one of the major focuses of Fontan research, so as to make the tool more 
realistic by including the surgeon’s preferences. This data can also be used for validating 
the surgical planning tool so as to see how the tool predicted a post Fontan using the pre 
Fontan model and see how well the prediction compared to that of the actual surgery 
performed by the surgeons.  
 
 
9.2.2 TCPC Volume estimation 
 For majority of the geometric parameters of TCPC, especially for vessel 
dimensions, patient body surface area is used as the normalization factor. Though this 
parameter has been clinically accepted as the best available normalization quantity, a 
more appropriate choice will be the TCPC volume. Computational complications of this 
measurement are the major barrier. Since we are computing the vessel cross sectional 
areas as a part of the skeletonization process, obtaining the TCPC volume will not be a 
tedious task.  Care should be given to keep uniform vessel length for all the geometries, 
which will otherwise affect the analysis. By specifying landmarks at fixed distance from 
the TCPC junction the uniformity in computation can be preserved. 
 
9.2.3 Geometrical Analysis of Glenn vs. Hemi Fontan 
 One major study population that had to be left out from this analysis is the two 






limitation at the time of our study was the small number of 2nd stage patients that had 
been scanned and included in our database, and as a consequence the absence of 
efficiency metrics for these patients. With a database that has grown up to more than 10 
patients in each category and the recent availability of experimental and CFD power 
losses for 2nd stage anatomies, an analysis similar to what was done in this thesis for 
intra-atrial and extra-cardiac TCPCs could now be conducted focusing on the 2nd stage 
rather than on the final one. This will be of great value, especially since the long-term 
objective of Fontan research revolves around surgical optimization and planning at each 

























PROTOCOL FOR SKELETONIZATION 
 
 
Entire process of skeletonization procedure that needs to be performed in order 
to obtain the centerline of TCPC geometries is described in this section. For clarity the 
whole process is defined in five separate sections (AA1 through AA5). The protocol for 
this procedure is described in the same order in which all the data has been processed 
for this work. 
A1.  Obtain Tecplot compatible 3D reconstructed anatomy 
The method used for this skeletonization process involves slicing the geometry into 
thin frames. This slicing is performed in Tecplot using a macro. So the first step is to 
import the 3D TCPC geometry into the Tecplot.  
 Tecplot 360 is compatible with the .stl file (commonly used format for saving 3D 
reconstructed data). For all older versions of Tecplot, follow the given steps to create a 
.dat file, which can be opened in Tecplot. An executable program stl2dat.exe performs 
the stl to dat conversion. 
1. Save the stl2dat.exe program and the input ASCII stl file in the same folder. 
2. Go to the command mode of the machine 
a. Go to Run in the Start prompt and type “cmd ” 
b. Go to the working directory using change directory command “cd” 
3. Perform the format conversion by typing   “stl2dat     stlfilename.stl” 







A2.  Geometry Slicing 
Once the Tecplot compatible input files are ready, open them in the Tecplot to perform 
the slicing. Given below are the instructions for initial slicing. 
 
1. There is a Tecplot macro written to perform the initial slicing. For convenience 
there are two separate macros for venae cavae (macro_for_SI_slicing) and 
pulmonary arteries (macro_for_RL_slicing). The two macros differ only in their 
slicing direction and their logic is the same. 
2. Open the macro using Notepad and type in the input file name 
3. The skeletonization program needs the user to input the starting and end frame 
of the geometry. An easy way to do this with TCPC models is, to find out the min 
and max ranges of z co-ordinate for the venae cavae, which is roughly parallel to 
the z axis and x co-ordinate for the pulmonary arteries, which is roughly parallel 
to the x axis using Tecplot.   
4. Enter these minimum and maximum values for the slicing position in the 
appropriate macro depending on the vessel of interest.  An example for slicing 
the pulmonary artery is shown below: 
VarSet |position| = “minimum” 
$!GLOBALSLICE SLICESURFACE = XPLANES 
$!GLOBALSLICE POSITION1{X = |position|} 
$!GLOBALTHREED SLICE{NORMAL{Z = 0}} 
$!GLOBALTHREED SLICE{NORMAL{X = 1}} 
$!GLOBALTHREED SLICE{NORMAL{y = 0}} 






5. Run the macro in Tecplot. The slices will be automatically saved in the out folder 




A3.  Skeleton and Area Computation - First Iteration 
For the sake of clarity and simplicity, two programs are created for initial centroid 
computation and for further iterations. Please note that the logic of both programs is 
exactly same and the only   reason for having two separate programs is to avoid any 
confusion. Also this way it will be easy to keep track of the initial processing and 
subsequent iterations 
1. Open the program for initial computation in Microsoft Visual Studio. The program 
is written in Microsoft Visual Studio 6.0 
2. Enter the input filename, which is the file containing the slices generated in 
section AA2. 
a. User needs to enter the complete path for the input file  
3. Similarly enter the output file names also. Since the program computes vessel 
cross sectional areas also, user can specify the type of output file (Ex:  xls for 
Excel, txt for text etc) to store the area. An example of the input and output lines 
from the program is shown below: 
Input Slices: char *path_inputslices = 
{"C:\\Skeltonization\\Model1\\Model1_input_slices_iteration1.dat"}; 
Output Centroid: char *path_outputslices = 
{"C:\\Skeltonization\\Model1\\Model1_output_centroid_iteration1.dat"}; 







A4.  Iterative Slicing 
Because the vessel axes are not always perpendicular to the co-ordinate axes, re-slicing 
of the geometry is needed to improve the accuracy of computation. This section explains 
the steps involved in doing this process. 
1. The C program “generate macro for normal slicing” can create another Tecplot 
macro to improve the accuracy of geometry slicing. These slices will be in 
directions perpendicular to the centerline obtained from the first iteration. 
2. User needs to enter the input file name, which will be the previously computed 
centerline and output file, which will be the Tecplot macro. An example is shown 
below: 
Input Centroid: char *centroid_in = 
{"C:\\Skeltonization\\Model1\\Model1_output_centroid_iteration_n-1.dat"}; 
Output Tecplot Macro: char *macro_out =  
{"C:\\Skeltonization\\Model1\\Model1_output_macro_iteration_n.mcr"}; 
3. Run this program to get the Tecplot macro for normal slicing. 
4. In Tecplot run the macro obtained in step 3 of this section AA4.  
6. This creates slices that are roughly normal to the vessel of interest. User will be 
able to visualize these slices in Tecplot. However, in this step user has to save 
the slices manually. By doing so, user can make sure that any overlapping slices 








A5.  Iterative Computation of Skeleton and Area  
To improve the accuracy of computed centerline and cross-sectional area repeat the 
iterations until they converge as described below. 
1. Obtain slices normal to the vessel axes as described in section AA4. 
2. For centroid computation use the program for iteration. 
3. Input the file names as explained in step 3 of section AA3.  
4. Once the skeleton is obtained, visually compare it with the skeleton obtained 
from the previous iteration. If they are on top of each other, the process can be 
stopped. Other wise repeat section AA4 and AA5 until results from two iterations 
converge. 





















RESULTS FOR FONTAN GEOMETRICAL ANALYSIS  
  
The values corresponding to each model, which were used to compute different 
geometric parameters of the Fontan templates analyzed in this study, are provided in 
this appendix. 

















1.00 0.00 230.54 0.00 223.77 
2.00 0.89 212.55 0.93 208.83 
3.00 1.85 200.10 1.90 196.30 
4.00 2.84 185.89 2.89 182.19 
5.00 3.84 170.56 3.89 166.97 
6.00 4.83 164.47 4.89 160.93 
7.00 5.83 161.63 5.89 158.11 
8.00 6.83 158.69 6.89 155.17 
9.00 7.83 156.26 7.89 152.78 
10.00 8.83 154.98 8.89 151.50 
11.00 9.83 154.86 9.89 151.39 
12.00 10.83 154.75 10.89 151.28 
13.00 11.83 154.64 11.89 151.17 
14.00 12.83 154.53 12.89 151.06 
15.00 13.83 154.42 13.89 150.95 
16.00 14.83 154.31 14.89 150.85 
17.00 15.83 154.20 15.89 150.74 
18.00 16.83 154.10 16.89 150.63 
19.00 17.83 153.99 17.89 150.53 
20.00 18.83 153.89 18.89 150.42 
21.00 19.83 153.78 19.89 150.32 
22.00 20.83 153.68 20.89 150.21 
23.00 21.83 153.57 21.89 150.11 
24.00 22.83 153.47 22.89 150.01 
25.00 23.83 153.37 23.89 149.91 
26.00 24.83 153.27 24.89 149.81 
27.00 25.83 153.17 25.89 149.71 






29.00 27.83 152.97 27.89 149.51 
30.00 28.83 152.87 28.89 149.41 
31.00 29.83 152.78 29.89 149.31 
32.00 30.83 152.68 30.89 149.22 
33.00 31.83 152.58 31.89 149.12 
34.00 32.83 152.49 32.89 149.02 
35.00 33.83 152.39 33.89 148.93 
36.00 34.83 152.30 34.89 148.83 
37.00 35.83 152.21 35.89 148.74 
38.00 36.83 152.11 36.89 148.65 
39.00 37.83 152.02 37.89 148.55 
40.00 38.83 151.93 38.89 148.46 
41.00 39.83 151.84 39.89 148.37 
42.00 40.83 151.75 40.89 148.28 
43.00 41.83 151.66 41.89 148.19 
44.00 42.83 151.58 42.89 148.10 
45.00 43.83 151.49 43.89 148.01 
46.00 44.83 151.40 44.89 147.92 
47.00 45.83 151.32 45.89 147.83 
48.00 46.83 151.23 46.89 147.74 
49.00 47.83 151.15 47.89 147.65 
50.00 48.83 151.06 48.89 147.57 
51.00 49.83 150.98 49.89 147.48 
52.00 50.83 150.90 50.89 147.40 
53.00 51.83 150.82 51.89 147.31 
54.00 52.83 150.73 52.89 147.23 
55.00 53.83 150.65 53.89 147.14 
56.00 54.83 150.57 54.89 147.06 
57.00 55.83 150.50 55.89 146.98 
58.00 56.83 150.42 56.89 146.90 
59.00 57.83 150.34 57.89 146.83 
60.00 58.83 150.26 58.89 146.75 
61.00 59.83 150.19 59.89 146.68 
62.00 60.83 150.11 60.89 146.61 
63.00 61.83 150.04 61.89 146.54 
64.00 62.83 149.97 62.89 146.47 
65.00 63.83 149.89 63.89 146.40 
66.00 64.83 149.82 64.89 146.33 
67.00 65.83 149.75 65.89 146.26 
68.00 66.83 149.68 66.89 146.19 
69.00 67.83 149.61 67.89 146.12 
70.00 68.83 149.54 68.89 146.05 
71.00 69.83 149.47 69.89 145.98 
72.00 70.83 149.40 70.89 145.91 
73.00 71.83 149.34 71.89 145.84 
74.00 72.83 149.27 72.89 145.77 
75.00 73.83 149.20 73.89 145.70 
76.00 74.83 149.14 74.89 145.64 
77.00 75.83 149.07 75.89 145.57 






79.00 77.83 148.95 77.89 145.43 
80.00 78.83 148.89 78.89 145.36 
81.00 79.83 148.82 79.89 145.29 
82.00 80.83 148.76 80.89 145.22 
83.00 81.83 148.70 81.89 145.15 
84.00 82.83 148.64 82.89 145.08 
85.00 83.83 148.59 83.89 145.01 
86.00 84.83 148.53 84.89 144.94 
87.00 85.83 148.47 85.89 144.88 
88.00 86.83 148.41 86.89 144.81 
89.00 87.83 148.36 87.89 144.74 
90.00 88.83 148.30 88.89 144.67 
91.00 89.83 148.25 89.89 144.60 
92.00 90.83 148.20 90.89 144.53 
93.00 91.83 148.14 91.89 144.47 
94.00 92.83 148.09 92.89 144.40 
95.00 93.83 148.04 93.89 144.33 
 
 

















1.00 0.00 518.02 0.00 144.31 
2.00 1.15 524.71 1.15 144.47 
3.00 2.31 547.27 2.31 144.55 
4.00 3.46 302.12 3.46 144.63 
5.00 4.62 299.94 4.62 144.71 
6.00 5.77 299.59 5.77 144.79 
7.00 6.93 299.24 6.93 144.87 
8.00 8.08 298.90 8.08 144.95 
9.00 9.24 298.56 9.24 145.03 
10.00 10.39 298.22 10.39 145.11 
11.00 11.55 297.88 11.55 145.19 
12.00 12.70 297.54 12.70 145.27 
13.00 13.86 297.21 13.86 145.35 
14.00 15.01 296.88 15.01 145.43 
15.00 16.17 296.55 16.17 145.51 
16.00 17.32 296.22 17.32 145.59 
17.00 18.48 295.90 18.48 145.67 
18.00 19.63 295.57 19.63 145.75 
19.00 20.79 295.25 20.79 145.83 
20.00 21.94 294.93 21.94 145.91 
21.00 23.10 294.62 23.10 145.99 
22.00 24.25 294.30 24.25 146.07 
23.00 25.41 293.99 25.41 146.15 






25.00 27.71 293.37 27.71 146.31 
26.00 28.87 293.07 28.87 146.39 
27.00 30.02 292.76 30.02 146.47 
28.00 31.18 292.46 31.18 146.55 
29.00 32.33 292.16 32.33 146.63 
30.00 33.49 291.86 33.49 146.72 
31.00 34.64 291.57 34.64 146.80 
32.00 35.80 291.28 35.80 146.88 
33.00 36.95 290.99 36.95 146.97 
34.00 38.11 290.70 38.11 147.07 
35.00 39.26 290.41 39.26 147.16 
36.00 40.42 290.13 40.42 147.26 
37.00 41.57 289.84 41.57 147.36 
38.00 42.73 286.96 42.73 147.46 
39.00 43.88 270.26 43.88 147.55 
40.00 45.04 247.52 45.04 147.65 
41.00 46.19 220.92 46.19 147.76 
42.00 47.35 190.72 47.35 147.86 
43.00 48.50 159.80 48.50 147.96 
44.00 49.66 128.91 49.66 148.06 
45.00 50.81 98.06 50.81 148.17 
46.00 51.96 67.98 51.96 148.27 
47.00 53.12 41.55 53.12 148.38 
48.00 54.27 19.04 54.27 148.48 
49.00 55.43 2.60 55.43 148.59 
51.00 57.74 586.29 56.58 148.70 
52.00 58.89 216.09 57.74 148.81 
53.00 60.05 168.78 58.89 148.92 
54.00 61.20 168.68 60.05 149.03 
55.00 62.36 168.58 61.20 149.14 
56.00 63.51 168.48 62.36 149.25 
57.00 64.67 168.38 63.51 149.36 
58.00 65.82 168.29 64.67 149.47 
59.00 66.98 168.19 65.82 149.59 
60.00 68.13 168.10 66.98 149.70 
61.00 69.29 168.01 68.13 149.82 
62.00 70.44 167.92 69.29 149.93 
63.00 71.60 167.83 70.44 150.05 
64.00 72.75 167.74 71.60 150.17 
65.00 73.91 167.65 72.75 150.29 
66.00 75.06 167.56 73.91 150.41 
67.00 76.22 167.48 75.06 150.53 
68.00 77.37 167.39 76.22 150.65 
69.00 78.52 167.31 77.37 150.77 
70.00 79.68 167.23 78.52 150.90 
71.00 80.84 167.14 79.68 151.02 
72.00 82.02 167.06 80.85 151.27 
73.00 83.22 166.98 82.04 151.55 










B3. IVC Area Characteristics for EC and IA Models 
 
 











      
Extra Cardiac      
CHOA007 51.13 141.55 12.58 110.69 161.23 
CHOA008 42.81 370.99 19.03 296.77 391.81 
CHOP006 57.76 202.57 42.03 145.92 281.00 
CHOP007 68.82 410.43 16.37 361.61 427.40 
CHOP013 54.33 229.92 35.17 166.27 288.58 
CHOP067 33.63 182.22 30.90 143.87 251.43 
CHOP088 43.94 402.08 35.69 319.98 451.96 
CHOP089 34.28 316.91 19.47 284.60 349.58 
CHOP090 40.65 314.66 31.45 278.82 399.94 
CHOP091 37.56 367.33 78.48 162.49 459.31 
CHOP095 48.00 200.99 18.18 176.11 266.77 
CHOP116 54.11 435.13 17.70 409.96 459.19 
CHOP085 34.62 330.89 24.78 273.26 372.06 
      
Intra Atrial      
CHOA004 57.87 188.36 64.86 70.89 290.82 
CHOA009 54.30 349.06 104.13 181.27 520.91 
CHOA011 57.04 558.70 130.10 264.64 694.76 
CHOP008 87.78 596.06 220.92 280.70 1005.91 
CHOP018 58.23 275.38 53.06 186.47 360.62 
CHOP030 71.43 335.15 74.13 222.19 430.57 
CHOP034 48.77 335.40 132.23 147.29 546.14 
CHOP037 60.88 356.33 139.32 163.46 580.43 
CHOP068 38.93 337.05 57.08 234.54 419.72 
CHOP073 49.93 602.95 74.74 464.73 760.22 
CHOP092 46.68 325.66 18.51 299.39 356.55 
CHOP096 50.84 258.54 38.32 222.99 365.56 
















B4. SVC Area Characteristics for EC and IA Models 
 
  












      
Extra Cardiac      
CHOA007 30.75 51.41 26.70 20.44 92.45 
CHOA008 21.01 126.05 46.92 46.43 198.16 
CHOP006 45.09 81.89 37.43 33.52 169.24 
CHOP007 38.01 128.67 33.11 74.94 167.94 
CHOP013 33.10 129.49 29.53 97.14 193.34 
CHOP067 37.81 169.66 34.40 131.89 272.30 
CHOP088 38.49 173.00 32.35 134.97 253.01 
CHOP089 38.90 149.91 34.71 99.23 234.63 
CHOP090 40.93 231.49 31.23 157.99 284.68 
CHOP091 29.61 195.48 35.99 151.92 254.77 
CHOP095 22.85 116.20 47.32 67.03 207.39 
CHOP116 34.12 183.37 49.30 110.82 247.21 
CHOP085 21.32 92.55 24.29 54.47 128.94 
      
Intra Atrial      
CHOA004 27.10 81.56 21.64 47.42 113.04 
CHOA009 28.93 119.60 27.56 56.70 145.96 
CHOA011 36.77 127.00 49.41 77.07 234.60 
CHOP008 49.41 156.28 34.56 100.46 196.95 
CHOP018 57.54 111.22 28.42 82.33 168.75 
CHOP030 44.62 120.74 29.76 76.14 179.87 
CHOP034 41.02 102.10 33.01 54.68 173.25 
CHOP037 46.71 118.64 16.78 69.44 139.19 
CHOP068 28.68 95.26 24.25 71.01 133.73 
CHOP073 41.70 128.27 51.48 54.86 190.40 
CHOP092 32.84 118.35 34.63 72.02 175.75 
CHOP096 42.36 124.69 28.96 83.83 196.97 


















B5. RPA Area Characteristics for EC and IA Models 
 
 












      
Extra Cardiac      
CHOA007 23.04 52.35 5.76 44.72 62.47 
CHOA008 42.62 25.59 15.27 6.18 59.58 
CHOP006 23.70 53.99 17.25 37.25 90.56 
CHOP007 66.89 74.64 32.26 31.72 151.12 
CHOP013 32.23 80.53 17.04 52.37 108.94 
CHOP067 28.66 79.15 21.14 33.51 103.72 
CHOP088 21.03 140.13 12.73 121.24 156.54 
CHOP089 18.62 138.63 21.63 109.33 168.21 
CHOP090 37.28 213.87 72.63 82.59 324.06 
CHOP091 26.65 85.54 13.73 72.26 121.72 
CHOP095 16.88 68.12 12.12 56.39 95.23 
CHOP116 29.27 152.95 26.06 107.40 192.98 
CHOP085 22.28 117.58 13.88 82.41 137.50 
      
Intra Atrial      
CHOA004 23.34 52.92 7.45 42.26 65.05 
CHOA009 16.11 66.57 29.41 25.78 105.32 
CHOA011 35.96 132.40 34.03 72.72 186.22 
CHOP008 30.46 82.41 27.82 27.24 133.10 
CHOP018 47.31 161.84 58.78 108.24 276.69 
CHOP030 37.40 99.99 17.65 62.00 129.20 
CHOP034 40.42 92.86 18.66 68.48 137.25 
CHOP037 33.58 96.44 30.64 50.20 138.77 
CHOP068 26.95 84.59 8.91 68.24 101.77 
CHOP073 30.83 155.84 56.41 84.46 263.19 
CHOP092 28.57 98.73 14.97 66.65 114.91 
CHOP096 20.29 115.46 8.32 100.47 124.83 















B6. LPA Area Characteristics for EC and IA Models 
 
 












      
Extra Cardiac      
CHOA007 20.34 33.12 23.37 6.47 85.06 
CHOA008 54.77 75.46 20.82 50.56 133.47 
CHOP006 47.07 33.70 16.52 9.04 62.88 
CHOP007 35.40 145.78 31.52 87.45 219.84 
CHOP013 51.62 38.89 25.50 9.20 91.45 
CHOP067 48.56 141.93 19.93 98.31 185.20 
CHOP088 28.89 66.45 28.48 35.86 128.53 
CHOP089 69.97 159.53 88.27 60.68 306.73 
CHOP090 59.22 162.69 35.69 113.17 219.12 
CHOP091 24.92 150.59 26.49 103.63 201.69 
CHOP095 43.56 44.44 18.73 24.32 97.73 
CHOP116 51.98 73.61 33.00 40.54 130.21 
CHOP085 35.19 130.74 19.57 98.28 161.31 
      
Intra Atrial      
CHOA004 35.06 72.36 37.41 12.59 137.67 
CHOA009 34.28 48.92 17.84 19.55 90.40 
CHOA011 52.09 80.18 16.91 55.28 134.83 
CHOP008 63.72 27.55 25.37 3.73 128.70 
CHOP018 51.97 100.26 62.29 28.09 253.79 
CHOP030 57.92 166.48 48.04 95.71 280.28 
CHOP034 67.82 153.43 67.23 73.05 274.15 
CHOP037 45.89 148.24 64.24 85.74 289.20 
CHOP068 42.71 80.17 15.32 55.65 137.08 
CHOP073 53.94 102.88 49.71 54.82 255.90 
CHOP092 44.29 38.39 23.26 14.25 77.94 
CHOP096 39.59 57.63 25.10 33.12 132.71 

















B7. Vessel Area Ratios between VC and PA for EC and IA Models 
 
 
Model LPA/IVC LPA/SVC RPA/IVC RPA/SVC 
     
Extra Cardiac     
CHOA007 0.23 0.64 0.37 1.02 
CHOA008 0.20 0.60 0.07 0.20 
CHOP006 0.17 0.41 0.27 0.66 
CHOP007 0.36 1.13 0.18 0.58 
CHOP013 0.17 0.30 0.35 0.62 
CHOP067 0.78 0.84 0.43 0.47 
CHOP088 0.17 0.38 0.35 0.81 
CHOP089 0.50 1.06 0.44 0.92 
CHOP090 0.52 0.70 0.68 0.92 
CHOP091 0.41 0.77 0.23 0.44 
CHOP095 0.22 0.38 0.34 0.59 
CHOP116 0.17 0.40 0.35 0.83 
CHOP085 0.40 1.41 0.36 1.27 
     
Intra Atrial     
CHOA004 0.38 0.89 0.28 0.65 
CHOA009 0.14 0.41 0.19 0.56 
CHOA011 0.14 0.63 0.24 1.04 
CHOP008 0.05 0.18 0.14 0.53 
CHOP018 0.36 0.90 0.59 1.46 
CHOP030 0.50 1.38 0.30 0.83 
CHOP034 0.46 1.50 0.28 0.91 
CHOP037 0.42 1.25 0.27 0.81 
CHOP068 0.24 0.84 0.25 0.89 
CHOP073 0.17 0.80 0.26 1.21 
CHOP092 0.12 0.32 0.30 0.83 
CHOP096 0.22 0.46 0.45 0.93 















B8. Vessel Curvatures and Collinearity for EC and IA Models 
 
 







IVC - SVC 
Collinearity 
       
Extra Cardiac       
CHOA007 0.27 0.21 0.18 0.10 0.65 
CHOA008 0.16 0.10 0.22 0.19 0.68 
CHOP006 0.24 0.18 0.44 0.56 0.59 
CHOP007 0.37 0.02 0.08 0.41 0.52 
CHOP013 0.10 0.52 0.06 1.62 0.31 
CHOP067 0.28 0.23 0.56 0.17 0.54 
CHOP088 0.12 0.52 0.11 0.38 0.66 
CHOP089 0.24 0.43 0.45 0.11 0.61 
CHOP090 0.02 0.09 0.04 0.51 0.45 
CHOP091 0.06 0.07 0.06 0.02 0.35 
CHOP095 0.35 0.42 0.20 0.15 0.63 
CHOP085 0.03 0.06 0.18 0.00 0.57 
CHOP116 0.11 0.04 0.14 0.16 0.52 
       
Intra Atrial       
CHOA004 0.05 0.31 0.35 0.04 0.73 
CHOA009 0.18 0.13 0.19 0.34 0.63 
CHOA011 0.06 0.03 0.03 0.13 0.30 
CHOP008 0.29 0.09 0.04 0.11 0.55 
CHOP018 0.12 0.04 0.11 0.09 0.30 
CHOP030 0.19 0.26 0.17 0.21 0.25 
CHOP034 0.65 0.62 0.27 0.31 0.34 
CHOP037 0.16 0.05 0.12 0.04 0.70 
CHOP068 0.58 0.15 0.31 0.30 0.37 
CHOP073 0.36 0.23 0.23 0.16 0.31 
CHOP092 0.18 0.19 0.06 0.03 0.33 
CHOP096 0.32 0.03 0.06 1.03 0.18 


















B9. Vessel Offset for EC and IA Models 
 
 
Model AP offset (mm) RL Offset (mm) PA-VC Offset (mm) 
        
Extra Cardiac       
CHOA007 2.28 3.35 5.42 
CHOA008 10.48 9.70 7.53 
CHOP006 2.01 2.50 10.72 
CHOP007 4.62 3.49 6.66 
CHOP013 1.05 4.33 5.52 
CHOP067 3.28 1.76 8.23 
CHOP085 1.63 3.81 8.82 
CHOP088 5.94 2.72 7.61 
CHOP089 1.56 2.56 7.61 
CHOP090 1.32 7.39 3.86 
CHOP091 0.03 0.65 6.86 
CHOP095 2.21 4.72 3.66 
CHOP116 3.15 7.88 8.69 
       
Intra Atrial      
CHOA004 0.05 12.64 4.35 
CHOA009 0.99 2.50 5.13 
CHOA011 4.12 5.10 9.40 
CHOA027 4.03 4.57 4.96 
CHOP008 0.33 5.41 10.89 
CHOP018 5.99 2.44 11.59 
CHOP030 0.90 2.11 8.90 
CHOP034 1.98 4.44 5.78 
CHOP037 3.87 7.76 5.49 
CHOP068 1.84 1.49 8.61 
CHOP073 1.69 0.26 9.94 
CHOP092 0.82 0.16 8.70 







Bi-directional Glenn as the 2nd stage  






B10. IVC Area Characteristics for Pre and Post Fontan Models 
 











      
Pair 1      
CHOA014 - - - - - 
CHOA027 57.75 372.11 92.33 254.79 526.02 
      
Pair 2      
CHOP053 - - - - - 
CHOP055 53.49 301.65 29.27 209.06 350.42 
      
Pair 3      
CHOP057 - - - - - 
CHOP084 34.62 330.89 24.78 273.26 372.06 
 
 
B11. SVC Area Characteristics for Pre and Post Fontan Models 
 











      
Pair 1      
CHOA014 19.70 110.66 10.76 86.55 126.64 
CHOA027 16.05 152.39 8.06 129.52 159.89 
      
Pair 2      
CHOP053 21.78 73.83 4.83 70.00 89.65 
CHOP055 21.33 63.38 6.19 57.49 83.40 
      
Pair 3      
CHOP057 18.97 173.56 17.26 152.83 210.75 
CHOP084 21.32 92.55 24.29 54.47 128.94 
 
B11.1 LSVC Area Characteristics for Pair2 
 











      
Pair 2      
CHOP053 21.88 103.59 11.09 88.43 118.69 
CHOP055 21.18 96.53 5.02 89.27 104.21 







B12. RPA Area Characteristics for Pre and Post Fontan Models 
 












      
Pair 1      
CHOA014 18.06 53.29 11.36 36.49 71.91 
CHOA027 21.88 159.40 42.57 111.87 243.77 
      
Pair 2      
CHOP053 21.25 128.61 17.21 91.55 148.72 
CHOP055 21.44 126.18 25.35 76.15 183.09 
      
Pair 3      
CHOP057 21.23 158.78 32.70 116.93 224.36 




B13. LPA Area Characteristics for Pre and Post Fontan Models 
 











      
Pair 1      
CHOA014 33.82 35.05 36.15 6.71 112.54 
CHOA027 30.15 103.73 32.66 68.47 166.63 
      
Pair 2      
CHOP053 34.13 114.77 28.11 71.86 158.41 
CHOP055 33.60 88.64 29.83 51.60 135.76 
      
Pair 3      
CHOP057 33.38 145.03 29.23 104.96 185.81 














B14. Vessel Curvatures for Pre and Post Fontans 
 
 









      
Pair 1      
CHOA014 - 0.16 - 0.18 0.43 
CHOA027 0.05 0.03 - 0.06 1.03 
           
Pair 2           
CHOP053 - 0.19 0.03 0.31 0.22 
CHOP055 0.21 0.10 0.01 0.57 0.13 
           
Pair 3           
CHOP057 - 0.01 - 0.14 0.13 





















B15: Experimental Power loss at Equal Pulmonary resistance and MRI cardiac output along with 













































             
CHOA007 17.93 44.72 110.69 20.44 0.79 0.00002 0.00006 0.00014 0.00003 2.00 13.80 2.19 x108
CHOA008 50.56 6.18 296.77 46.43 0.69 0.00007 0.00001 0.00043 0.00007 2.00 5.44 6.57 x107
CHOP013 9.20 52.37 166.27 97.14 0.83 0.00001 0.00006 0.00020 0.00012 2.60 8.65 6.88 x107
CHOA009 19.55 25.78 181.27 56.70 0.58 0.00003 0.00004 0.00031 0.00010 2.00 9.70 8.28 x107
CHOA011 57.54 72.72 264.64 77.07 1.21 0.00005 0.00006 0.00022 0.00006 4.00 13.76 6.39 x107
CHOP034 73.05 68.48 147.29 54.68 1.19 0.00006 0.00006 0.00012 0.00005 4.00 13.24 5.95 x107






B16: Experimental Power loss at MRI flow split and MRI cardiac output along with normalized 


































Loss (PL x 
BSA2 /Q3)
             
CHOA007 17.93 44.72 110.69 20.44 0.79 0.00002 0.00006 0.00014 0.00003 2.00 19.03 3.01 x108 
CHOA008 50.56 6.18 296.77 46.43 0.69 0.00007 0.00001 0.00043 0.00007 2.00 6.72 8.12 x107 
CHOP013 9.20 52.37 166.27 97.14 0.83 0.00001 0.00006 0.00020 0.00012 2.60 11.50 5.95 x107 
CHOA009 19.55 25.78 181.27 56.70 0.58 0.00003 0.00004 0.00031 0.00010 2.00 11.94 1.02 x108 
CHOA011 57.54 72.72 264.64 77.07 1.21 0.00005 0.00006 0.00022 0.00006 4.00 21.42 9.95 x107 
CHOP034 73.05 68.48 147.29 54.68 1.19 0.00006 0.00006 0.00012 0.00005 4.00 14.59 6.55 x107 

















B17: Experimental Power loss at 50-50 flow split and MRI cardiac output along with normalized 

































Loss (PL x 
BSA2 /Q3)
             
CHOA007 17.93 44.72 110.69 20.44 0.79 0.00002 0.00006 0.00014 0.00003 2.00 19.03 3.01 x108 
CHOA008 50.56 6.18 296.77 46.43 0.69 0.00007 0.00001 0.00043 0.00007 2.00 4.60 5.56 x107 
CHOP013 9.20 52.37 166.27 97.14 0.83 0.00001 0.00006 0.00020 0.00012 2.60 135.99 7.04 x108 
CHOA009 19.55 25.78 181.27 56.70 0.58 0.00003 0.00004 0.00031 0.00010 2.00 11.94 1.02 x108 
CHOA011 57.54 72.72 264.64 77.07 1.21 0.00005 0.00006 0.00022 0.00006 4.00 13.26 6.16 x107 
CHOP034 73.05 68.48 147.29 54.68 1.19 0.00006 0.00006 0.00012 0.00005 4.00 12.56 5.64 x107 



















B18: CFD Power loss at Equal Pulmonary resistance and MRI cardiac output along with 

































             
CHOP018 28.09 108.24 186.47 82.33 1.23 0.00002 0.00009 0.00015 0.00007 3.10 7.79 8.00x107
CHOP022 55.50 49.35 102.91 49.82 1.01 0.00005 0.00005 0.00010 0.00005 2.95 4.85 3.92 x107
CHOP034 73.05 68.48 147.29 54.68 1.19 0.00006 0.00006 0.00012 0.00005 5.24 23.51 4.69 x107
CHOP037 85.74 50.20 163.46 69.44 1.49 0.00006 0.00003 0.00011 0.00005 4.10 13.56 8.89 x107
CHOP055 51.60 76.15 209.06 57.49 0.63 0.00008 0.00012 0.00033 0.00009 1.49 0.67 1.61 x107
CHOP067 98.31 33.51 143.87 131.89 1.06 0.00009 0.00003 0.00014 0.00012 3.75 63.12 2.75 x108
CHOP088 35.86 121.24 319.98 134.97 0.54 0.00007 0.00022 0.00059 0.00025 1.47 0.97 1.85 x107
CHOP089 60.68 109.33 284.60 99.23 0.87 0.00007 0.00013 0.00033 0.00011 2.64 2.84 2.39 x107
CHOP090 113.17 82.59 278.82 157.99 1.15 0.00010 0.00007 0.00024 0.00014 3.44 1.21 8.00 x106


















B19: CFD Power loss at MRI flow split and MRI cardiac output along with normalized minimum 


























Q at MRI 
CO 
(L/min) 





(PL x BSA2 
/Q3) 
             
CHOP018 28.09 108.24 186.47 82.33 1.23 0.00002 0.00009 0.00015 0.00007 3.10 18.56 1.91 x108 
CHOP022 55.50 49.35 102.91 49.82 1.01 0.00005 0.00005 0.00010 0.00005 2.95 7.53 6.08 x107 
CHOP034 73.05 68.48 147.29 54.68 1.19 0.00006 0.00006 0.00012 0.00005 5.24 43.57 8.70 x107 
CHOP037 85.74 50.20 163.46 69.44 1.49 0.00006 0.00003 0.00011 0.00005 4.10 18.83 1.24 x108 
CHOP055 51.60 76.15 209.06 57.49 0.63 0.00008 0.00012 0.00033 0.00009 1.49 0.9368 2.26 x107 
CHOP067 98.31 33.51 143.87 131.89 1.06 0.00009 0.00003 0.00014 0.00012 3.75 61.53 2.68 x108 
CHOP088 35.86 121.24 319.98 134.97 0.54 0.00007 0.00022 0.00059 0.00025 1.47 1.77 3.37 x107 
CHOP089 60.68 109.33 284.60 99.23 0.87 0.00007 0.00013 0.00033 0.00011 2.64 2.84 2.39 x107 
CHOP090 113.17 82.59 278.82 157.99 1.15 0.00010 0.00007 0.00024 0.00014 3.44 3.467 2.29 x107 


















B20: CFD Power loss at 50-50 flow split and MRI cardiac output along with normalized minimum 


























Q at MRI 
CO 
(L/min) 





Loss (PL x 
BSA2 /Q3)
             
CHOP018 28.09 108.24 186.47 82.33 1.23 0.00002 0.00009 0.00015 0.00007 3.10 31.56 3.24 x108 
CHOP022 55.50 49.35 102.91 49.82 1.01 0.00005 0.00005 0.00010 0.00005 2.95 5.83 4.71 x107 
CHOP034 73.05 68.48 147.29 54.68 1.19 0.00006 0.00006 0.00012 0.00005 5.24 34.53 6.90 x107 
CHOP037 85.74 50.20 163.46 69.44 1.49 0.00006 0.00003 0.00011 0.00005 4.10 25.61 1.68 x108 
CHOP055 51.60 76.15 209.06 57.49 0.63 0.00008 0.00012 0.00033 0.00009 1.49 0.6819 1.65 x107 
CHOP067 98.31 33.51 143.87 131.89 1.06 0.00009 0.00003 0.00014 0.00012 3.75 61.87 2.69 x108 
CHOP088 35.86 121.24 319.98 134.97 0.54 0.00007 0.00022 0.00059 0.00025 1.47 0.83 1.58 x107 
CHOP089 60.68 109.33 284.60 99.23 0.87 0.00007 0.00013 0.00033 0.00011 2.64 2.84 2.39 x107 
CHOP090 113.17 82.59 278.82 157.99 1.15 0.00010 0.00007 0.00024 0.00014 3.44 1.3742 9.09 x106 





















B22:  Inter-Personal Error Computed for the Point Where Vessel Meets the TCPC 
 
 
Model PVR SVR BSA (m2) PVR/BSA SVR/BSA min.PA/BSA












CHOP022 1.50 20.70 1.01 1.49 20.50 4.89x10-05 3.92 x10+07 6.08 x10+07 4.71 x10+07 
CHOA007 2.7 19.2 0.79 3.42 24.30 2.27 x10-05 2.19 x10+08 3.01 x10+08 9.41 x10+07 
CHOA008 0.9 7.6 0.69 1.30 11.01 8.96 x10-06 6.57 x10+07 8.12 x10+07 1.74 x10+07 
CHOA009 2.0 20.3 0.58 3.45 35.00 3.37 x10-05 6.88 x10+07 1.02 x10+08 3.18 x10+07 
CHOA011 3.52 18.77 1.21 2.91 15.51 4.76 x10-05 8.28 x10+07 9.95 x10+07 1.54 x10+08 
Person IVC SVC LPA RPA 
 X Y Z X Y Z X Y Z X Y Z 
1 109.22 -101.60 -97.81 108.15 -98.57 -70.59 132.03 -102.19 -80.69 105.54 -87.22 -81.67 
2 108.58 -102.14 -100.36 108.09 -98.34 -71.59 127.47 -99.25 -83.54 105.54 -87.22 -81.67 
3 109.22 -101.60 -97.81 107.94 -98.19 -75.62 127.47 -99.25 -83.54 107.38 -87.75 -80.80 
4 111.95 -99.60 -94.37 107.51 -97.62 -74.51 126.75 -98.44 -83.29 105.54 -87.22 -81.67 
5 109.22 -101.60 -97.81 108.12 -98.76 -69.56 126.12 -97.60 -82.69 107.38 -87.75 -80.80 
             
Mean 109.64 -101.31 -97.63 107.96 -98.29 -72.37 127.97 -99.34 -82.75 106.28 -87.43 -81.32 
Difference 2.31 1.71 3.26 0.45 0.68 2.13 1.22 0.91 0.54 0.74 0.21 0.34 
             







 C PROGRAMS AND TECPLOT MACRO 
 
All the programs and the macro files used to generate skeletals of the Fontan models 




C1: Tecplot Macro for geometry slicing 
 
This Tecplot macro is used to generate slices of a given geometry 
  
#!MC 1000 
# Macro for geometry slicing 
# AUTHOR: RESMI KRISHNAN 
# DATE; JUNE 2006 
 
$!VarSet |MFBD| = “C:\skeletonization\Input\Model1”    Enter Input file name 
$!VarSet |position| =-88   Enter initial slice position 
$!GLOBALSLICE SLICESURFACE = XPLANES 
$!GLOBALSLICE POSITION1{X = |position|} 
$!GLOBALTHREED SLICE{NORMAL{Z = 0}} 
$!GLOBALTHREED SLICE{NORMAL{X = 1}} 
$!GLOBALTHREED SLICE{NORMAL{y = 0}} 
$!While |position| <=-11 Enter final slice position 
$!GLOBALSLICE POSITION1{X = |position|} 
$!GLOBALTHREED SLICE{ORIGIN{X = |position|}} 
$!CREATESLICEZONEFROMPLANE 
  SLICESOURCE = SURFACEZONES 








 FORCEEXTRACTIONTOSINGLEZONE = YES 
 
$!WRITEDATASET  " C:\skeletonization\Model1\slices_1.dat" Enter Output file name 
  INCLUDETEXT = NO 
  INCLUDEGEOM = NO 
  INCLUDECUSTOMLABELS = NO 
  ASSOCIATELAYOUTWITHDATAFILE = NO 
  ZONELIST =  [2-|NUMZONES|] 
  BINARY = NO 
  USEPOINTFORMAT = YES 
  PRECISION = 9 










C2: C Program for centroid and area computation 
 
This C program computes the centroid and area of the slices from the initial slicing  
 
 
//TITLE: PROGRAM TO CALCULATE THE CENTROID OF A FONTAN //GEOMETRY 
//AUTHOR: RESMI KRISHNAN 









/* Input files to the program are the slices of the geometry and output is the centroid file. 
   Resolution of the slices has been fixed as one tenth of the vessel radius */ 
 







//char *path_SI_slices = {"C:\\Documents and Settings\\resmi\\Desktop\\Resmi\\CFD 
Velocity Registration\\0doffset\\V3slices_0doffset_rotate.dat"}; 
char *path_LR = {"C:\\Documents and Settings\\resmi\\Desktop\\Resmi\\CFD Velocity 
Registration\\0doffset\\V1_centroid_0doffset_rotate.dat"}; 
char *path_RL = {"C:\\Documents and Settings\\resmi\\Desktop\\Resmi\\CFD Velocity 
Registration\\0doffset\\V1_centroid_other_0doffset_rotate.dat"}; 
//char *path_SI = {"C:\\Documents and Settings\\resmi\\Desktop\\Resmi\\CFD Velocity 
Registration\\0doffset\\V3_centroid_0doffset_rotate.dat"}; 





//char *path_SI_slices = {"C:\\Documents and Settings\\resmi\\Desktop\\Resmi\\CFD 
Velocity Registration\\Hemi Vs Glenn\\chop036\\SVCslices_p36.dat"}; 
//char *path_IS = {"C:\\Documents and Settings\\resmi\\Desktop\\Resmi\\CFD Velocity 
Registration\\Hemi Vs Glenn\\chop036\\SVC_centroid_p36.dat"}; 
//char *path_SI = {"C:\\Documents and Settings\\resmi\\Desktop\\Resmi\\CFD Velocity 
Registration\\Hemi Vs Glenn\\chop036\\SVC_centroid_other_p36.dat"}; 
 
 
const int DEBUG=1; 
int  num_slice=0,elements[2000]; 
 
typedef struct Point{ 
        double x,y,z; 
  Point *P1,*P2; 
} Point; 
 
typedef struct Slice{ 
   int NUM; 
      Point *points; 
   Point avg_point; 





void load_slicepoints(char *path);  
void initialize_slices(char *path); 
double get_centroid(Slice *S, Point *C);   //function that take slices and returns centroid 
Point * find_closest_point(Point *C,Slice *S); 
double distance(Point *X, Point *Y); 
double get_triangle_center(Point *A, Point *B, Point *C, Point *center); 












/* Main program starts here 
   ------------------------ 
*/ 
 










void skelitalize(char *path, char *outfile1, char *outfile2){ 
    Point center;  
 int i,FLAG; 
 FILE *out; 




 printf("Number of slices: %d\n",num_slice); 
  
 if(slices[0].points[0].x != slices[0].points[1].x) FLAG = 1; else FLAG = 0; 
 
 out = fopen(outfile1,"w"); 
 //from last slice to first slice  
 for(i=1;i<=num_slice;i++) { 
  if(i==1 && FLAG == 0) { 
   center.y = slices[num_slice-1].avg_point.y; 
   center.z = slices[num_slice-1].avg_point.z; 
    
  } 
  if(i==1 && FLAG == 1) { 
   center.y = slices[num_slice-1].avg_point.y; 
   center.x = slices[num_slice-1].avg_point.x; 
    
  } 
  if(FLAG==0) center.x = slices[num_slice-i].points[0].x; 
  if(FLAG==1) center.z = slices[num_slice-i].points[0].z; 
  area = get_centroid(&(slices[num_slice-i]),&center); 




 out = fopen(outfile2,"w"); 
 //from first slice to last slice 
 for(i=0;i<num_slice;i++) { 
  if(i==0 && FLAG == 0) { 






   center.z = slices[0].avg_point.z; 
    
  } 
  if(i==0 && FLAG == 1) { 
   center.y = slices[0].avg_point.y; 
   center.x = slices[0].avg_point.x; 
    
  } 
  if(FLAG == 0) center.x = slices[i].points[0].x; 
  if(FLAG == 1) center.z = slices[i].points[0].z; 
  area = get_centroid(&(slices[i]),&center); 









// Centroid calculation is done here 
 
double get_centroid(Slice *S, Point *C){ 
 double triangle_area,sum_area;  
 Point *closest_point,*current_point,*next_point; 
 Point *triangle_centroid,*temp;  /*triangle_centers*/ 
 Point slice_centroid; 
 int count,first_time; 
 
 closest_point = find_closest_point(C,S); 
 current_point = closest_point; 
 next_point = current_point->P1; 
 count = 0; 
 
 triangle_centroid = (Point *)malloc(sizeof(Point)); 
  
 slice_centroid.x = 0.0;  
 slice_centroid.y = 0.0;  
 slice_centroid.z = 0.0;  
 sum_area = 0.0; 
 first_time = 1; 
 
 while((current_point != closest_point) || (first_time == 1)) { 
  triangle_area = 
get_triangle_center(C,current_point,next_point,triangle_centroid); 
  slice_centroid.x += triangle_area*triangle_centroid->x; 
  slice_centroid.y += triangle_area*triangle_centroid->y; 
  slice_centroid.z += triangle_area*triangle_centroid->z; 
  sum_area += triangle_area; 
  temp = current_point;  






  if(next_point->P1 != temp) { next_point = next_point->P1;} 
  else {next_point = next_point->P2;} 
  first_time = 0; 
 } 
 
 slice_centroid.x /= sum_area; 
 slice_centroid.y /= sum_area; 
 slice_centroid.z /= sum_area; 
  
 C->x = slice_centroid.x; 
 C->y = slice_centroid.y; 
 C->z = slice_centroid.z; 
 printf("Centroid: %lf %lf %lf\nSlice Area: %lf\n",C->x,C->y,C->z,sum_area); 




// Next 3 functions calculate the centroid of each triangles in the specific slices, its 
closest points and distance b/w 2 points 
 
double get_triangle_center(Point *A, Point *B, Point *C, Point *center) { 
 double a,b,c,s,area; 
 a = distance(A,B); 
 b = distance(B,C); 
 c = distance(A,C); 
 s = (a+b+c)/2; 
 area = sqrt(s*(s-a)*(s-b)*(s-c)); 
 center->x = (A->x+B->x+C->x)/3.0; 
 center->y = (A->y+B->y+C->y)/3.0; 
 center->z = (A->z+B->z+C->z)/3.0; 
 
 return area; 
} 
 
Point *find_closest_point(Point *C,Slice *S) { 
 int i;  
 double temp,dist = 1.0E100; 
 Point *closest_point; 
 for(i=0;i<elements[(S->NUM)-1];i++) { 
  if((temp=distance(C,&(S->points[i]))) <= dist ) { 
   dist = temp; 
   closest_point = &(S->points[i]); 
   printf("%lf %lf %lf %lf\n",closest_point->x,closest_point-
>y,closest_point->z,dist); 
  } 
 } 











 double out; 
 out = sqrt(pow((X->x-Y->x),2)+pow((X->y-Y->y),2)+pow((X->z-Y->z),2)); 
 return out; 
} 
 
// Initialise the slices for the program 
 
void initialize_slices(char *path){ 
       FILE *in; 
    char word[200]; 
    int  i=0,j=0; 
    in = fopen(path,"r"); 
    while(!feof(in)){ 
   fscanf(in,"%s",word); 
   if(strcmp(word,"ZONE") == 0){ 
     num_slice++; 
   } 
   else if(word[0]=='N' && word[1]=='=') { 
               sscanf(&(word[2]),"%d",&(elements[num_slice-1])); 
   } 
    } 
    fclose(in); 
     
    for(i = 0;i<num_slice;i++) 
   printf("Slice =%d \tELEMENTS =%d \n",i+1,elements[i]); 
    slices = (Slice*)malloc(num_slice*sizeof(Slice)); 
    for(i = 0;i<num_slice;i++){ 
     slices[i].points = (Point*)malloc(elements[i]*sizeof(Point)); 
     for(j=0;j<elements[i];j++) { 
      slices[i].points[j].P1 = NULL; 
      slices[i].points[j].P2 = NULL; 
     } 





void release_slices() { 
 int i; 
    for(i = 0;i<num_slice;i++)  free(slices[i].points); 
 free(slices); 
 num_slice = 0; 
} 
 
// Load each slice points to the memory along with the information on its neighboring 
points 
 
void load_slicepoints(char *path){ 
    FILE *in; 






 int p,c1,c2,j,i; 
 int count = 0, count1 = 0; 
 double x,y,z; 
 char word[200]; 
 in=fopen(path,"r"); 
    if(DEBUG==1) printf("%s\n",path); 
 while(!feof(in)) { 
  p=fscanf(in,"%lf%lf%lf\n",&x,&y,&z); 
  if(p==3){ 
   count1++; 
   if(count1<=elements[count-1]){ 
    slices[count-1].points[count1-1].x = x; 
    slices[count-1].points[count1-1].y = y; 
    slices[count-1].points[count1-1].z = z; 
    if(count1 == elements[count-1]) { 
     for(i=0;i<elements[count-1];i++) { 
      fscanf(in,"%d%d\n",&c1,&c2); 
      if(slices[count-1].points[c1-1].P1 == NULL) 
slices[count-1].points[c1-1].P1 = &(slices[count-1].points[c2-1]); 
      else slices[count-1].points[c1-1].P2 = 
&(slices[count-1].points[c2-1]); 
      if(slices[count-1].points[c2-1].P1 == NULL)
 slices[count-1].points[c2-1].P1 = &(slices[count-1].points[c1-1]); 
      else slices[count-1].points[c2-1].P2 = 
&(slices[count-1].points[c1-1]); 
     } 
    } 
   } 
     
  } 
  else { 
   fscanf(in,"%s",word); printf("%s\n",word); 
   if(strcmp(word,"ZONE") == 0){ 
     count++; count1=0; 
     slices[count-1].NUM = count; 
   } 




 for(i=0;i<num_slice;i++) { 
  avg.x = 0; 
  avg.y = 0; 
  avg.z = 0; 
  for(j=0;j<elements[slices[i].NUM-1];j++) { 
   avg.x += slices[i].points[j].x; 
   avg.y += slices[i].points[j].y; 
   avg.z += slices[i].points[j].z; 
  } 
  slices[i].avg_point.x = avg.x/elements[slices[i].NUM-1]; 






















C3: C Program for generating macro for normal slicing 
 
This C program re-slices the geometry in directions perpendicular to the geometry axes.  
 
 
//TITLE: PROGRAM TO GENERATE TECPLOT MACRO TO DO SLICING OF FONTAN 
GEOMETRYBASED ON THE NORMAL VECTORS OF CENTROID POINTS WE GET 
FROM 1ST ITERATION 
//AUTHOR: RESMI kRISHNAN 








/* Input files to the program are the geometry centroid we got from 1st iteration and 
output is the macro for getting slices for next iterations. 
   Resolution of the slices has been fixed as one tenth of the vessel radius */ 
 
char *centroid_in = {"C:\\Documents and Settings\\resmi\\Desktop\\Resmi\\CFD Velocity 
Registration\\0doffset\\V1_centroid_other_0doffset_rotate.dat"}; 
char *macro_out = {"C:\\Documents and Settings\\resmi\\Desktop\\Resmi\\CFD Velocity 
Registration\\0doffset\\V1_0doffset_rotate_normalslice_macro1.mcr"}; 
 
//char *centroid_in = {"C:\\Documents and Settings\\resmi\\Desktop\\Resmi\\CFD 
Velocity Registration\\Hemi Vs Glenn\\chop036\\SVC_centroid_other_p36_iter2.dat"}; 
//char *macro_out = {"C:\\Documents and Settings\\resmi\\Desktop\\Resmi\\CFD Velocity 










typedef struct Point{ 







void write_macro(char *outfile); 
void load_initial_centroid(char *filein); 
 
 
/* Main program starts here 











// Tecplot macro has been written here 
 
void write_macro(char *outfile){ 
 
 FILE *macro; 
    double vector_mag; 
 
 macro = fopen(outfile,"a"); 
 
 //To get the slicing correctly go till N-2, N is the number of slices 
 for(int i=0; i<=slice_num-2; i++){ 
 
  vector_mag = sqrt(pow((centroid[i+1].x - 
centroid[i].x),2)+pow((centroid[i+1].y - centroid[i].y),2)+pow((centroid[i+1].z - 
centroid[i].z),2)); 
 
/*  fprintf(macro,"#!MC 1000\n"); 
  fprintf(macro,"$!VarSet |MFBD| = 'C:\\Program Files\\TEC100'\n"); 
  fprintf(macro,"$!GLOBALTHREED SLICE{ORIGIN{X = 
%lf}}\n",centroid[i].x); 
  fprintf(macro,"$!GLOBALTHREED SLICE{ORIGIN{Y = 
%lf}}\n",centroid[i].y); 







  fprintf(macro,"$!GLOBALTHREED SLICE{NORMAL{X = 
%lf}}\n",(centroid[i+1].x - centroid[i].x)/vector_mag); 
  fprintf(macro,"$!GLOBALTHREED SLICE{NORMAL{Y = 
%lf}}\n",(centroid[i+1].y - centroid[i].y)/vector_mag); 
  fprintf(macro,"$!GLOBALTHREED SLICE{NORMAL{Z = 
%lf}}\n",(centroid[i+1].z - centroid[i].z)/vector_mag); 
  fprintf(macro,"$!CREATESLICEZONEFROMPLANE \n"); 
  fprintf(macro,"  SLICESOURCE = SURFACEZONES\n"); 
  fprintf(macro,"  FORCEEXTRACTIONTOSINGLEZONE = YES\n"); 
  fprintf(macro,"$!RemoveVar |MFBD|\n\n\n");  




  // Taking the average of 2 centroid points to get the slice, which will give a 
2nd order accuracy for slicing 
 
  fprintf(macro,"#!MC 1000\n"); 
  fprintf(macro,"$!VarSet |MFBD| = 'C:\\Program Files\\TEC100'\n"); 
  fprintf(macro,"$!GLOBALTHREED SLICE{ORIGIN{X = 
%lf}}\n",(centroid[i].x + centroid[i+1].x) /2); 
  fprintf(macro,"$!GLOBALTHREED SLICE{ORIGIN{Y = 
%lf}}\n",(centroid[i].y + centroid[i+1].y) /2); 
  fprintf(macro,"$!GLOBALTHREED SLICE{ORIGIN{Z = 
%lf}}\n",(centroid[i].z + centroid[i+1].z) /2); 
   
  fprintf(macro,"$!GLOBALTHREED SLICE{NORMAL{X = 
%lf}}\n",centroid[i+1].x - centroid[i].x); 
  fprintf(macro,"$!GLOBALTHREED SLICE{NORMAL{Y = 
%lf}}\n",centroid[i+1].y - centroid[i].y); 
  fprintf(macro,"$!GLOBALTHREED SLICE{NORMAL{Z = 
%lf}}\n",centroid[i+1].z - centroid[i].z); 
  fprintf(macro,"$!CREATESLICEZONEFROMPLANE \n"); 
  fprintf(macro,"  SLICESOURCE = SURFACEZONES\n"); 
  fprintf(macro,"  FORCEEXTRACTIONTOSINGLEZONE = YES\n"); 









// Centroid from first iteration is loaded to memory here 
 
void load_initial_centroid(char *filein){ 
 FILE *in; 
 int test=0; 







 centroid = (Point*)malloc(2000*sizeof(Point)); 
 
 in = fopen(filein,"r"); 
 while(!feof(in)){ 
  test = fscanf(in,"%lf %lf %lf\n",&x,&y,&z); 
  if (test == 3){ 
   centroid[slice_num].x = x; 
   centroid[slice_num].y = y; 
   centroid[slice_num].z = z; 
   slice_num++; 
   printf("%lf %lf %lf \n", x,y,z); 
  } 
 } 



































EQUAL PULMONARY RESISTANCE CALCULATION 
 
 
For experimental and CFD study cases, an important test condition to be analyzed is the 
situation where both the right and left lungs have equal pulmonary resistance (eq.PR). 













Figure D1: Schematic showing the set up to compute equal pulmonary resistance along 
with the notations used in this document.  P is the pressure in mm HG, Q is the flow rate 








D.1 Equal Pulmonary Resistance Calculation 
As mentioned above, an uncontrolled, steady-state circulation with equal left and right 
lung properties is assumed in this case. For our studies, we assume both lungs to have 
a similar resistance: pulmonary resistance Rp is set to be 1.8mmHg/(L/min) [DeZelicourt, 
2005].  Arterial and pulmonary compliances are neglected.   
Then the pressure in each lung can be written using Darci’s relation as: 
rpappvrpa QRPP ⋅+=          (D.1) 
lpappvlpa QRPP ⋅+=          (D.2) 
where, Prpa and Plpa are the pressures in the right and left lungs, Qlpa and Qrpa  are the 
flow rates of the left and right pulmonary arteries, Rp is the pulmonary resistance and  
Ppv is the pressure in the pulmonary venous return. 
Pressure difference between the two pulmonary artery branches can then be 
found by subtracting equation (D.2) from (D.1). The resulting equation is a function of 
right pulmonary flow rate for a given total cardiac output QT.  
( )rpaTprpalpa QQRPP ⋅−⋅=− 2        (D.3) 
From power loss experiments or CFD calculations we can also obtain the pressure 
difference between left and right pulmonary arteries and plot it as a function of Qrpa. This 
experimental curve, which is a characteristic of the TCPC and Equation (D.3) are both 
linear. When plotted together, they intersect at a single point which gives the Qrpa for the 
same lung resistances. A sample graph obtained by plotting Qrpa vs. the pressure 
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Figure D.2:  Plot used to calculate eq.PR for the standard one-diameter offset model 
using CFD results. Here the Equal Lung Resistance condition is found to be at 48% 
(Qrpa/QT). This operation point varies little with different lung resistance. 
 
As seen in the figure AD.2 the linear regression should have a negative slope; i.e, more 
flow to the LPA, which means the difference will be more negative. 
 From this plot you get the equation Plpa - Prpa = B + A(Qlpa / QT) 
  where A and B are the slope and the intercept of the regression line seen in figure AD2.  
 Solving for Qlpa, we get: 
  
Qlpa = (B + Rp QT) / (2Rp + (A/ QT)) 
  
Then Qrpa is just QT - Qlpa     
Make sure that all dimensions are in the same unit system.  
Though this above detailed method is commonly used to compute eq.PR, there could be 






porous material structure for the left atrium and lungs. However, this assumption could 
be questioned as there is still some large veins and arteries involved in the model.  
Since the nonlinearity brought by the large vessels on the linear pressure drop term 
(P=QR) is negligible compared to the huge Darcy resistance there is no problem in 
assuming this linear relationship. This brings up another question as to why not use the 
total pressure (static pressure + kinetic pressure) for computation instead of using just 
the static pressure? The answer is that we compute the resistance in terms of Wood’s 
unit, and the pressure calibrations for this unit are based on the static pressure 
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